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Resumo 
 
O glutamato é responsável pela maioria da transmissão sináptica excitatória no 
cérebro através da sua ligação a receptores do glutamato dos tipos ionotrópico e 
metabotrópico, os quais desempenham um papel muito importante em alterações 
fisiológicas da eficácia sináptica. Os receptores ionotrópicos do glutamato formam canais 
iónicos e são agrupados em três subtipos com base na sua estrutura molecular, 
farmacologia e propriedades electrofisiológicas: receptores AMPA, NMDA e cainato. Os 
receptores do tipo AMPA e cainato medeiam a resposta sináptica rápida ao glutamato, 
enquanto que os receptores do tipo NMDA são responsáveis por uma resposta mais lenta. 
O número, composição e localização dos receptores de glutamato nos neurónios, bem 
como a sua fosforilação, são factores determinantes na resposta dos neurónios ao 
neurotransmissor glutamato. Deste modo, a expressão funcional dos receptores pode ser 
regulada não apenas ao nível da transcrição e da tradução, mas também ao nível da 
sinapse. 
O BDNF é uma proteína que pertence à família das neurotrofinas, um grupo de 
proteínas envolvido em mecanismos de plasticidade sináptica importantes para a 
aprendizagem e memória. As neurotrofinas são também importantes para a sobrevivência, 
diferenciação, crescimento e morte neuronal. Os efeitos do BDNF são parcialmente 
mediados pela ligação ao seu receptor, TrkB, seguida da interacção de proteínas 
adaptadoras com o receptor e activação de várias cascatas de sinalização intracelular. 
Neste estudo foi investigado o efeito do BDNF nos receptores do tipo AMPA e NMDA 
em culturas primárias de neurónios de hipocampo. As células foram mantidas em cultura 
durante 7 dias e, posteriormente, incubadas com BDNF. Ensaios de Western Blot 
mostraram que a neurotrofina induz aumentos distintos na quantidade de proteína das 
subunidades GluR1, GluR2 e GluR3 dos receptors AMPA. Pequenos aumentos foram 
observados após 15 min de estimulação com BDNF, enquanto que os efeitos máximos 
ocorreram à 1 h, 2 h e 30 min de incubação para o GluR1, GluR2 e GluR3, respectivamente. 
Para períodos mais longos (24 h) de incubação com a neurotrofina, a abundância destas 
subunidades diminuiu para valores semelhantes ao controlo. O BDNF induziu também 
aumentos na abundância das subunidades NR1, NR2A e NR2B dos receptors NMDA. Os 
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níveis da subunidade NR1 aumentaram de um modo contínuo e duradouro face à 
estimulação com BDNF (30 min até às 12 h de estimulação). A quantidade de NR2A 
aumentou apenas quando a estimulação com BDNF foi de longa duração (de 3 h a 12 h), 
enquanto que os níveis de NR2B aumentaram para tempos curtos de estimulação com 
BDNF (1 h a 3 h). Estes incrementos estão relacionados com o aumento da transcrição 
induzido pelo BDNF, como comprovam os estudos com inibidores específicos da transcrição 
(α-amanitina e actinomicina D) e os aumentos do mRNA observados para as diferentes 
subunidades através do ensaio de PCR em tempo real. A inibição da tradução com emetina 
ou anisomicina também impediu os aumentos na quantidade das subunidades dos 
receptores AMPA e NMDA induzidos pela incubação com BDNF. A estimulação com BDNF 
de culturas de neurónios de hipocampo com 14 dias aumentou também os níveis das 
subunidades dos receptores NMDA, mas não teve qualquer efeito nas subunidades dos 
receptores AMPA. Contudo, quando se quelatou o BDNF endógeno presente no meio 
extracelular com a proteína de fusão Trk-IgG, os níveis de proteína da subunidade GluR1 
diminuíram em relação ao controlo. No entanto, não foram observados quaisquer efeitos 
para as subunidades GluR2, NR1, NR2A e NR2B em neurónios de hipocampo com 14 dias. 
A incubação de neurónios de hipocampo em cultura durante 7 dias com a neurotrofina NT3 
fez também aumentar os níveis de proteína das subunidades NR2A e NR2B.  
Ensaios de biotinilação revelaram que a aplicação de BDNF aumenta a expressão à 
superfície dos neurónios das subunidades GluR1, NR1, NR2A e NR2B. O aumento 
verificado na membrana plasmática para a subunidade GluR1 foi abolido pela emetina, 
sugerindo que o endereçamento do GluR1 para a membrana está dependente da síntese de 
novas proteínas. O aumento da expressão das subunidades AMPA na membrana relaciona-
se com os resultados obtidos nos estudos de electrofisiologia, que mostraram que o BDNF 
também induz o endereçamento da subunidade GluR1-GFP para a sinapse em fatias de 
hipocampo que sobrexpressam esta proteína. Neste sistema, o BDNF induziu a fosforilação 
do receptor Trk, bem como da Ser 831 do GluR1, mas não da Ser 845 do GluR1 ou da Ser 
880 do GluR2. A fosforilação da Ser 831 da subunidade GluR1 foi impedida pela queleritrina 
e pelo KN93, que inibem a PKC e a CaMKII, respectivamente. A incubação com BDNF 
também ampliou o aumento da concentração intracelular de cálcio em resposta à 
estimulação com NMDA, em culturas primárias de hipocampo.  
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Os aumentos na abundância das várias subunidades dos receptores AMPA em 
neurónios em desenvolvimento e o seu endereçamento para a membrana, em particular 
para a sinapse, podem explicar, pelo menos em parte, as alterações sinápticas induzidas 
pelo BDNF. Os aumentos dos níveis das subunidades dos receptores NMDA, quer totais 
quer na membrana plasmática, e o aumento da resposta ao NMDA na concentração 
intracelular de cálcio podem explicar também efeito do BDNF na transmissão sináptica e na 
plasticidade sináptica. 
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Abstract 
 
Glutamate mediates most excitatory neurotransmission in the brain through the 
activation of ionotropic and metabotropic glutamate receptors, which play an important role 
in physiological modifications of synaptic efficacy. Ionotropic glutamate receptors form ion 
channels, and are grouped into three main subtypes on the basis of their molecular, 
pharmacological and electrophysiological characteristics: AMPA, NMDA and kainate 
receptors. AMPA and kainate receptors primarily mediate rapid responses to glutamate, 
whereas NMDA receptors mediate a slower phase of neurotransmission. The number, 
composition, and location of glutamate receptors in neurons, together with receptor 
phosphorylation, are critically important factors in determining the neuron's response to the 
neurotransmitter glutamate. The functional expression of the receptors may thus be 
regulated at the transcription and translation level and locally, at the level of the individual 
synapses. 
BDNF is a protein that belongs to the neurotrophin family of trophic factors. This 
class of proteins is involved in the mechanisms of synaptic plasticity, which are important for 
learning and memory formation. Neurotrophins are also important for neuronal survival, 
differentiation, growth and apoptosis. The effects of BDNF are mediated, in part, by binding 
to its receptor, TrkB, and this leads to the recruitment of several intracellular adaptor proteins 
and activation of various signalling pathways. 
In this study, we investigated the effect of BDNF on AMPA and NMDA receptors in 
hippocampal neurons. As demonstrated by Western Blot, stimulation of 7 DIV cultured 
hippocampal neurons with BDNF induced a rapid and transient increase of the protein levels 
of the AMPA receptor subunits GluR1, GluR2 and GluR3, with small effects already 
observed after 15 min of BDNF stimulation. Maximal effects were observed upon incubation 
with BDNF for 1 h, 2 h and 30 min for GluR1, GluR2 and GluR3, respectively. For longer 
periods (24 h) of incubation with the neurotrophin, the abundance of these subunits 
decreased to values similar to the control. BDNF also differentially upregulated the NMDA 
receptor subunits NR1, NR2A and NR2B. The levels of the NR1 subunits were increased by 
BDNF in a long-lasting manner (30 min to 12 h of incubation). NR2A protein levels were 
upregulated for longer periods of BDNF incubation (3 h to 12 h), while NR2B protein levels 
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were increased by short periods of stimulation with BDNF (1 h to 3 h). These effects required 
transcription activity, as demonstrated by the use of specific transcription inhibitors (α-
amanitine and actinomycin D), and by the enhancement of the mRNA levels of these 
subunits, observed by real time PCR. Translation inhibitors (emetine and anisomycin) were 
also tested and were found to inhibit the upregulation of the subunit protein levels induced by 
BDNF. Fourteen DIV hippocampal neurons were also treated with BDNF, but no effects were 
observed for AMPA receptor subunits. In contrast, NMDA receptor subunits were found to be 
upregulated by BDNF in 14 DIV hippocampal neurons, with a kinetics similar to that 
observed for 7 DIV cultures. Moreover, chelation of endogenous extracellular BDNF with 
TrkB-IgG fusion protein decreased GluR1 protein levels, but was without effect on GluR2, 
NR1, NR2A and NR2B in 14 DIV cultures of hippocampal neurons. Incubation of 7 DIV 
cultured hippocampal neurons with NT3 also increased the protein levels of the NMDA 
receptor subunits NR2A and NR2B. 
Biotinylation assays demonstrated that incubation of hippocampal cell cultures with 
BDNF increases the number of plasma membrane-associated GluR1, NR1, NR2A and 
NR2B. The BDNF-induced increase of GluR1 subunits associated with the plasma 
membrane was blocked by emetine, indicating that delivery of GluR1 to the plasma 
membrane was dependent on the synthesis of new proteins. The increase in the surface 
expression of AMPA receptor subunits correlates with the results obtained in 
electrophysiology studies, which showed synaptic delivery of GluR1 receptors induced by 
BDNF, in hippocampal slices overexpressing the GluR1-GFP subunit. In this system, BDNF 
was shown to promote phosphorylation of the Trk receptor as well as Ser 831 in the GluR1 
subunit, but not Ser 845 in GluR1 or Ser 880 in GluR2 subunit. BDNF-induced 
phosphorylation of GluR1 on Ser 831 was abrogated by chelerythrine and KN93, which 
inhibit PKC and CaMKII, respectively. BDNF also upregulated the NMDA-induced increase 
in the intracellular concentration of calcium, in hippocampal neuronal cultures. 
 
The observed increase in the abundance of AMPA receptors in developing neurons 
and their delivery to the membrane, as well as the phosphorylation, cell surface and synaptic 
delivery of AMPA receptors, may explain some of the synaptic effects of BDNF. 
Furthermore, the upregulation of NMDA receptor subunits induced by BDNF, and the 
increase in the intracellular calcium response to NMDA following exposure to the 
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neurotrophin may also explain, at least in part, the short- and long-term effects of BDNF on 
synaptic plasticity.  
Chapter 1. Introduction
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1.1 The synapse and glutamatergic transmission 
 
Synapses are specialized cell-cell junctions that allow neurons to communicate with 
each other and with other neuronal targets. Upon neuronal stimulation, neurotransmitters are 
released from the presynaptic terminal into the synaptic cleft. Neurotransmitters diffuse 
across this intercellular space and bind to neurotransmitter receptors on the postsynaptic 
membrane to induce a postsynaptic response. Synapses can be classified as excitatory or 
inhibitory depending on the effect of presynaptic stimulation on the postsynaptic potential. 
Stimulation of excitatory synapses induces an excitatory postsynaptic potential (EPSP) that 
depolarizes the post-synaptic membranes towards the threshold required for activation of an 
action potential. Conversely, activation of inhibitory synapses hyperpolarizes the post-
synaptic membrane away from the threshold potential [(inhibitory postsynaptic potential; 
IPSP); (reviewed in Sheng and Lin, 2001)]. 
Glutamate is the major excitatory neurotransmitter in the vertebrate central nervous 
system (CNS) and plays an important role in a large number of CNS functions. This 
neurotransmitter is believed to underlie learning processes and memory formation, and is 
also involved in several neurological disorders, such as epilepsy and ischemia (Dingledine et 
al., 1999). 
Glutamate is a nonessential amino acid that does not cross the blood-brain barrier. It 
was early considered an excitatory neurotransmitter since 1) it is stored in synaptic vesicles 
in the presynaptic terminal, from where it can be released into the synapse in a calcium-
dependent manner; 2) glutamate containing vesicles are specifically associated with 
excitatory synapses; 3) high-affinity glutamate transporters are present in the pre-synaptic 
membrane, as well as in the neighboring glial cells, providing a mechanisms for rapid 
glutamate uptake and signal termination; 4) exogenously applied glutamate induces an 
excitatory postsynaptic response identical to that elicited by presynaptic stimulation and, 
finally, 5) a high concentration of glutamate receptors is specifically found at the postsynaptic 
site in excitatory synapses (reviewed in Sheng and Lin, 2001). 
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1.1.1 Glutamate Receptors 
 
Glutamate receptors are transmembrane proteins that bind specifically to glutamate on 
the extracellular side of the membrane. Upon binding of glutamate, glutamate receptors are 
activated and transduce this signal into intracellular responses. Depending on their functional 
and pharmacological properties glutamate receptors can be divided in several classes. 
Glutamate receptors can be subdivided into ionotropic (ligand-gated cation channels) and 
metabotropic (coupled to G-protein second messenger systems) receptors. 
 
Table 1.1- Ionotropic receptor subunits and pharmacology 
 
Receptor Family Subunit Agonists Antagonists 
 
AMPA 
GluR1 
GluR2 
GluR3 
GluR4 
 
Glutamate 
AMPA 
Kainate 
(S)-5-fluorowillardiine 
CNQX 
NBQX 
GYKI53655 
 
 
 
Kainate 
GluR5 
GluR6 
GluR7 
KA1 
KA2 
 
Glutamate 
Kainate 
ATPA 
 
CNQX 
LY294486 
LY382884 
NS 102 
 
 
 
NMDA 
NR1 
NR2A 
NR2B 
NR2C 
NR2D 
NR3A 
NR3B 
Glutamate 
Aspartate 
NMDA 
Glycine 
D-APV (or D-AP5) 
2R-CPPene 
MK-801 
Ketamine 
Phencyclidine 
 
  
 
There are three groups of metabotropic glutamate receptors, distinguished based on 
their sequence homology, signal transduction mechanisms and agonist selectivity. Group I 
includes mGluR1 and mGluR5, which are positively coupled to phospholipase C (PLC). 
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Activation of these receptors increases the plasma membrane levels of diacylglycerol (DAG) 
and the intracellular abundance of inositol 1,4,5-trisphosphate [Ins(1,4,5)P3], thereby 
activating protein kinase C (PKC) and releasing intracellular Ca2+, respectively. Group II 
metabotropic glutamate receptors includes mGluR2 and mGluR3, and group III includes 
mGluR4, mGluR6-8, which are negatively coupled to adenylyl cyclase, inhibiting cyclic 
adenosine monophosphate (cAMP) formation (reviewed in Pin and Acher, 2002). 
The ionotropic glutamate receptors have been classified into three distinct subgroups 
based upon their pharmacology, as well as molecular and electrophysiological properties 
(see table 1.1). These are the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA), N-methyl-D-aspartate (NMDA), and kainate (KA) receptors (Dingledine et al., 1999; 
Mayer, 2004). However, it is important to note that AMPA receptors are also responsive to 
kainate. Ionotropic glutamate receptors form channels permeable to cations, and binding of 
glutamate to the receptors leads to membrane depolarization. 
 
 
1.1.1.1 AMPA receptors 
 
AMPA receptors mediate fast and short-lasting excitatory synaptic 
neurotransmission in the vertebrate CNS. They are ligand-gated ion channels, permeable to 
Na+ and K+ and, depending on their subunit composition, they may also be permeable to 
Ca2+ (Swanson et al., 1997). The cation flux through AMPA receptor channels permits a net 
depolarization of the membrane (reviewed in Sheng and Lin, 2001). AMPA receptors are 
composed of four possible subunits, named GluR1 to GluR4, which associate in different 
stoichiometries to form receptors with distinct properties. Each subunit has a molecular 
weight of approximately 100 kDa and possesses three transmembrane segments (TM1, TM3 
and TM4) in addition to a specific membrane-inserted hydrophobic region (TM2 region) that 
forms the cation permeable channel pore. The N-terminal domain of each receptor subunit is 
extracellular while the C-terminal segment is intracellular. Each monomer carries its own 
glutamate-binding domain composed by two extracellular segments (Fig. 1.1). AMPA 
receptor subunits are homologous in their extracellular and transmembrane regions, but are 
distinct in their intracellular cytoplasmatic C-termini, which contain the phosphorylation sites 
  
    Chapter 1 
 
6
and are responsible for the interaction with different intracellular proteins (Gomes et al., 
2003; Palmer et al., 2005). GluR1, GluR4 and a splice variant of GluR2 (GluR2L) have long 
cytoplasmatic C-termini, whereas GluR2, GluR3 and an alternative splice form of GluR4 
(GluR4c) have shorter cytoplasmatic domains. There is a high homology among long forms, 
as well as among short forms of AMPA receptor subunits. In the adult hippocampus, 
receptors made of GluR1/GluR2 and GluR3/GluR2 predominate (Wenthold et al., 1996), 
whereas GluR4 is present in the immature hippocampus (Zhu et al., 2000). Receptors 
composed of subunits with short cytoplasmatic C-termini (GluR2/GluR3) cycle continuously 
in and out of the synapse, while receptors containing subunits with long cytoplasmatic C-
termini (GluR1, GluR2L and GluR4) are delivered to synapses upon synaptic activity 
(Hayashi et al., 2000; Zhu et al., 2000; Shi et al., 2001; Kolleker et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1- Schematic representation of the topology of an AMPA receptor subunit. Each subunit 
consists of an extracellular N-terminal domain, four transmembrane regions (TM1-4), and an 
intracellular C-terminal domain. The ligand-binding site is a conserved amino acid pocket formed from 
a conformational association between the N-terminus and the loop linking TM3 and TM4. A flip/flop 
alternative splice region is present within the TM3/TM4 loop. TM2 forms an intracellular re-entrant 
hairpin loop, which contributes to the cation pore channel and is also the site for Q/R RNA editing in the 
GluR2 subunit. The intracellular C-terminal contains the phosphorylation sites and conserved 
sequences that have been shown to interact with a number of intracellular proteins, including PDZ 
domain-containing proteins. 
 
Q/R editing site
PDZ binding 
domain
out
in
NH2
COOH
TM1
TM2
TM4TM3
Ligand binding domain
flip/flop region
Phosphorylation 
sites
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Splice variants 
Besides the alternative splicing at the region encoding the C-terminus of GluR2 and 
GluR4, to give rise to long or short isoforms, all four AMPA receptor subunits can also 
undergo alternative splicing in an extracellular region, between TM3 and TM4 domains, to 
generate “flip” or “flop” splice variants (Sommer et al., 1990) (see figure 1.1). Flip forms of 
AMPA receptor subunits are mainly expressed in embryonic stages of the CNS 
development, while flop forms are widely expressed in the adult brain. Alternative splicing 
modifies the kinetics of the receptors, with flip splice variants desensitizing four times slower 
than flop forms (Koike et al., 2000), and the pharmacological properties of the channel, 
conferring different sensitivity to allosteric modulators (Sekiguchi et al., 1998; Shen and 
Yang, 1999; Kessler et al., 2000).  
 
RNA Editing 
Ribonucleic acid (RNA) editing of glutamate receptors is a post-transcriptional 
mechanism that involves the enzymatic deamination of specific adenosines in the pre-mRNA 
of the glutamate receptor subunits, performed by specific RNA adenosine deaminases 
(ADARs). This event gives rise to the replacement of a gene-encoded amino acid by a 
different one, which modifies the physiological properties of the ion channel (Barbon et al., 
2003). In the GluR2 subunit, the RNA editing mechanism evokes the change of a crucial 
glutamine in the pore-forming region (Q/R site; see figure 1.1) of GluR2 subunit by an 
arginine. This Q/R substitution confers low Ca2+ permeability and low single-channel 
conductance to AMPA receptors containing the edited GluR2 subunit, because of the 
positive charge and size of the arginine residue (Burnashev et al., 1992; Burnashev et al., 
1996; Swanson et al., 1997). Conversely, GluR1, GluR3 and GluR4 subunits exist mainly in 
the non-edited form and when expressed as homo- or heteromers among themselves, the 
resultant channels are permeable to Ca2+. The glutamine residue located on the channel 
pore of GluR1, GluR3 and GluR4 confers inward-rectifying properties to these AMPA 
receptors, allowing the influx of cations. However, at positive potentials, intracellular 
polyamines enter the channel pore and block the efflux of cations through the channels. 
Because GluR2-containing AMPA receptors exist mainly in the edited form, the positive 
charge of the arginine present at the Q/R site prevents intracellular polyamines from entering 
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the pore, enabling the efflux of cations through the channel at depolarized potential and thus 
conferring the non-rectifying properties characteristic of these receptors. 
 
Interacting Proteins 
AMPA receptor surface expression at the postsynaptic membrane is dynamically 
regulated through multiple protein interactions. The AMPA receptor interacting proteins 
include PDZ (for Postsynaptic Density 95-Discs Large-Zona Occudens 1) domain and non-
PDZ domain-containing proteins. PDZ domains are modular protein interaction motifs that 
bind in a sequence-specific fashion, predominantly to short C-terminal peptides. Each PDZ 
domain binds only one ligand. Specific selectivity of PDZ motifs for different binding peptides 
is thought to be dependent upon small changes in the size and geometry of the hydrophobic 
pocket (Palmer et al., 2005). PDZ-domain containing proteins that bind AMPA receptors 
include the GRIP/ABP (Glutamate Receptor Interacting Protein/AMPA Receptor Binding 
Protein), PICK1 (Protein Interacting with C Kinases), syntenin, SAP97 (Synapse-Associated 
Protein) and Shank3. The group of AMPA receptor-binding proteins lacking PDZ domains 
includes stargazin, Lyn tyrosine kinase, Narp (Neuronal Activity-Regulated Pentraxin), NSF 
(N-Ethylmaleimide-Sensitive Fusion Protein), PKCγ, AP2 and the 4.1 protein. Proteins 
binding to specific AMPA receptor subunits and their role are summarized in table 1.2. 
 
 Phosphorylation 
 Phosphorylation of ligand-gated ion channels can regulate the properties of the 
channel, its intermolecular interactions and trafficking of the protein. The regulation of AMPA 
receptor by phosphorylation adds a further complex level of receptor modulation beyond 
subunit composition, splice variants, and other post-translational modifications (Carvalho et 
al., 2000; Gomes et al., 2003). Phosphorylation of AMPA receptors can occur under resting 
conditions or in response to specific changes in synaptic activity, and each AMPA receptor 
subunit has its own kinase profile.  
The role of GluR1 phosphorylation in synaptic plasticity has been studied in great 
detail (see section 1.1.2 Glutamate receptors and synaptic plasticity). GluR1 is 
phosphorylated in multiple sites at the C-terminus. PKC and Ca2+-calmodulin dependent 
protein kinase II (CaMKII) phosphorylate Ser 831 (Roche et al., 1996; Barria et al., 1997; 
Mammen et al., 1997), while protein kinase A (PKA) phosphorylates Ser 845 (Mammen et 
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al., 1997). Recently, it was also found that PKC may phosphorylate GluR1 at Ser 818 
(Boehm et al., 2006). Differential GluR1 phosphorylation on Ser 831 and Ser 845 occurs 
according to activity, leading to changes in synaptic efficacy. Phosphorylation of AMPA 
receptors at the postsynaptic density by CaMKII has been implicated in synaptic unsilencing 
and enhancement, in long-term potentiation (LTP) (Palmer et al., 2005), and in neuronal 
damage after brain ischemia (Takagi et al., 2003) and inflammation (Guan et al., 2004), due 
to an increase in the AMPA receptor-mediated currents and/or modulation of the interaction 
between GluR1 and a PDZ-containing protein (Palmer et al., 2005). Additionally, CaMKII 
activity is necessary for targeting of GluR1-containing receptors to synapses independently 
of Ser 831 phosphorylation (Hayashi et al., 2000; Esteban et al., 2003). PKA phosphorylation 
leads to potentiation of homomeric GluR1 peak currents, by increasing the peak open 
probability of the receptor channels, and leads to LTP in naïve synapses. GluR1 
phosphorylation at Ser 845 by PKA was also shown to be necessary, but not sufficient, for 
synaptic targeting of GluR1 homomeric receptors, and was suggested to stabilize GluR1 at 
the plasma membrane (Lee et al., 2003). Phosphorylation at both CaMKII and PKA sites 
controls synaptic incorporation of these receptors (Esteban et al., 2003). Furthermore, 
phosphorylation of GluR1 by PKC at Ser 818 is increased during LTP and is also critical for 
LTP expression (Boehm et al., 2006). Fyn, a Src family of tyrosine kinases, can also 
phosphorylate GluR1 in vitro, protecting the receptors from calpain truncation (Rong et al., 
2001). These phosphorylations may therefore regulate receptor integrity and modulate 
location and channel properties (Rong et al., 2001). 
The GluR2 subunit is phosphorylated by PKC at Ser 880, in the PDZ binding site. 
This phosphorylation differentially regulates binding of ABP/GRIP1 and PICK1, with a 
decrease in ABP/GRIP1 binding, but not PICK1, in response to phosphorylation. 
Phosphorylated GluR2 recruits PICK1 to synapses, causing the release of the GluR2-PICK1 
complex from synapses, facilitating its internalization (Chung et al., 2000) and long-term 
depression (LTD) (Xia et al., 2000; Chung et al., 2003). Furthermore, binding of ABP to 
GluR2 prevents PKC phosphorylation. GluR2 is also phosphorylated on tyrosine residues 
(Ahmadian et al., 2004). The Src family of tyrosine kinases phosphorylates GluR2 on Tyr 
876, resulting in a decreased interaction between GluR2 and GRIP1, possibly leading to 
endocytosis of the receptors (Hayashi and Huganir, 2004). 
 
  
    Chapter 1 
 
10
Table 1.2- AMPA receptor interacting proteins and their functions 
 
AMPA Receptor 
Interacting Protein 
AMPA Receptor  
Interacting Subunit 
Function 
GRIP/ABP GluR2, GluR3, GluR4c, GluR4 -Receptor traffic to dendrites 
-Membrane surface anchoring 
-Intracellular receptor stabilization 
 
PICK1 
 
GluR2, GluR3, GluR4c, GluR4 
-Receptor clustering 
-Receptor internalization 
-NMDA-induced AMPA receptor down-regulation
Syntenin GluR1, GluR2, GluR4, GluR2c, 
GluR3c 
-Unknown 
 
 
SAP97 
 
 
GluR1 
-Stabilization and synaptic incorporation 
-Recruitment of protein kinases and 
phosphatases through AKAP 
-Association with many proteins 
-Trafficking along the early secretory pathway 
-May be necessary for CaMKII to drive synaptic 
delivery of GluR1 
Shank3 GluR1 -Synaptic trafficking during development 
Stargazin GluR1, GluR2, GluR4 -Targeting receptors to the membrane surface 
Lyn GluR1, GluR2, GluR3, GluR4c -Activation of MAPK pathway upon AMPA 
receptor stimulation 
Narp GluR1, GluR2, GluR3 -Receptor clustering and excitatory synapse 
formation 
NSF GluR2, GluR3, GluR4c -Regulates the delivery and removal of GluR2-
containing AMPA receptors 
PKCγ GluR4 -Facilitates receptor phosphorylation 
AP2 GluR2 -NMDA-induced AMPA receptor internalization 
4.1N GluR1, GluR4 -Surface receptor stabilization 
     (reviewed in Gomes et al., 2003; Palmer et al., 2005; Uchino et al., 2006) 
 
The GluR4 subunit can be phosphorylated by PKC at Ser 842 (Carvalho et al., 
1999), increasing the synaptic delivery of recombinant receptors (Correia et al., 2003; 
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Esteban et al., 2003), and at Thr 830 (Carvalho et al., 1999). Ser 842 can also be 
phosphorylated by PKA, modulating the surface expression of the receptor (Gomes et al., 
2004). PKC phosphorylation also increases influx of Ca2+ through activated AMPA receptor 
channels in cultured retinal neurons, where GluR4 is the main AMPA receptor subunit 
(Carvalho et al., 1998; Carvalho et al., 2002). 
 
Trafficking of AMPA receptors 
AMPA receptor localization is a highly dynamic process, with AMPA receptors 
recycling in and out of synapses under a variety of situations related to synaptic plasticity 
and development. AMPA receptor trafficking in and out of the synapses is one of the core 
mechanisms for rapid changes in the number of functional receptors during synaptic 
plasticity (see section 1.1.2 Glutamate receptors and synaptic plasticity). AMPA receptors 
are transported along the dendrite through several kinesin motors and through protein linkers 
between AMPA receptors and microtubular motor proteins. Afterwards, AMPA receptors are 
delivered into specialized dendritic membrane by exocytosis (reviewed in Groc and Choquet, 
2006). Exocytosis of receptors, either coming from a pool of newly synthesized receptors or 
from a pool of recycling receptors, not only is required for the insertion in basal conditions, 
but also appears to be required for LTP (Park et al., 2004). Receptors could be either directly 
exocytosed at the synapse or first exocytosed in the extrasynaptic membrane, followed by 
lateral diffusion at the neuronal surface and trapping at synaptic sites (Tardin et al., 2003). 
These events are interdependent and regulated by neuronal activity and interaction with 
scaffolding proteins. However, recent findings (Ashby et al., 2006; Yang et al., 2006) support 
the second hypothesis. 
 
 
1.1.1.2 Kainate receptors 
 
Together with AMPA receptors kainate receptors are responsible for the fast 
neurotransmission in the CNS, since they also activate and desensitize very rapidly in 
response to glutamate. Moreover, AMPA and kainate receptors share several agonists and 
antagonists that can interact with both receptors. Therefore, AMPA and kainate receptors 
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are usually called non-NMDA receptors. However, the discovery that 2,3-benzodiazepines, 
particularly GYKI53655, antagonize AMPA, but not kainate receptors (Paternain et al., 
1995), has become a tool to elucidate the roles of both receptor types in synaptic 
transmission. 
Two kainate receptor subunits were first cloned, KA1 and KA2, which showed high 
affinity to kainate. However, they do not form functional ion channels when homomerically 
expressed in host cells. Three further kainate receptor subunits were subsequently cloned, 
GluR5, GluR6 and GluR7. These receptor subunits can form functional homomeric ion 
channels when recombinantly expressed. In addition, high affinity kainate receptor subunits 
(KA1 and KA2) are able to form functional heteromeric assemblies with GluR5 and GluR6 
kainate receptors. Kainate receptor subunits are structurally related with AMPA receptor 
subunits (Fig. 1.1), also containing an extracellular N-terminal followed by three 
transmembrane domains (TM1, TM3 and TM4), in addition to a membrane loop (TM2) and 
an intracellular C-terminal (Madden, 2002). Similarly to the AMPA receptor subunits, the 
kainate receptor subunits undergo alternative splicing and/or RNA editing (Dingledine et al., 
1999). RNA editing also occurs at the Q/R site in the pore region of GluR5 and GluR6, but 
not on GluR7. All splice variants differ on the sequence of their cytoplasmatic C-terminal 
domain (reviewed in Bleakman and Lodge, 1998; Jaskolski et al., 2005). 
In addition to the activity as ligand-gated ion channels, kainate receptors may signal 
through activation of G proteins, regulating voltage-dependent Ca2+ channels (Rodriguez-
Moreno and Lerma, 1998; Lauri et al., 2005). Although it is still unknown how the kainate 
receptors ion channel are coupled to G proteins, an intermediate protein is likely involved. 
This noncanonical signalling accounts for the inhibitory activity of kainate receptors 
(reviewed in Lerma, 2006). 
Kainate receptors maybe present at the postsynaptic and at the presynaptic 
membrane. Postsynaptic kainate receptors mediate part of the synaptic currents at certain 
synapses (Rodriguez-Moreno et al., 1997), while presynaptic receptors modulate the release 
of glutamate and GABA in a bidirectional fashion (Rodriguez-Moreno et al., 1997), therefore 
exerting a tight control of the excitability of brain networks. 
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1.1.1.3 NMDA receptors 
 
NMDA receptors mediate a relatively slow and long-lasting excitatory postsynaptic 
current component (EPSC). They are ligand-gated ion channels selectively permeable to 
divalent cations, particularly to Ca2+. The NMDA receptor family is made up of NR1, NR2 and 
NR3 subunits (Cull-Candy et al., 2001). NR1 is essential for the NMDA receptor function, but 
the glutamate–binding site is present in the NR2 subunit. Therefore, functional NMDA 
receptors are heteromeric complexes containing both NR1 and NR2 subunits (Prybylowski 
and Wenthold, 2004). Although it is still controversial, it has been suggested that each 
NMDA receptor represents a tetramer of two NR1 and two NR2 subunits (Prybylowski and 
Wenthold, 2004). NR3 subunits can assemble with NR1-NR2 complexes to depress NMDA 
receptor responses and can also assemble with NR1 alone to form excitatory glycine 
receptors, insensitive to glutamate or NMDA, calcium impermeable and resistant to 
magnesium blockade (Chatterton et al., 2002).  
NMDA receptor diversity arises from alternative splicing at three sites in the NR1 
messenger RNA (mRNA), generating eight distinct NR1 splice variants. The existence of 
four NR2 subunits (NR2A-D) and two NR3 subunits also contributes to this diversity. Each 
NR2 subunit is encoded by its own gene, and is unable to form functional channels on its 
own, but greatly enhances NMDA receptor function when coexpressed with NR1. NR2A and 
NR2B subunits form high conductance channels and are highly expressed in the mammalian 
forebrain (Cull-Candy et al., 2001). NR2B subunit expression predominates early in 
development, whereas NR2A expression increases with development (Stephenson, 2001). 
The NR2C subunit expression is confined mainly to the mature cerebellum whereas the 
NR2D subunit is particularly abundant in the young thalamus (Cull-Candy et al., 2001). 
Regional and developmental regulation of NR2 subunit expression underlies much of the 
diversity of NMDA receptor responses in the CNS (Wenthold et al., 2003). 
Each one of the NMDA receptor subunits shares a similar topology with the AMPA 
receptor subunits. They also contain an extracellular N-terminus, followed by three 
membrane-spanning domains (TM1, TM3 and TM4) and one membrane loop (TM2), 
resulting in an intracellular C-terminus (Mori and Mishina, 1996). 
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NMDA receptors possess several different modulatory sites (see figure 1.2). A 
glycine-binding domain is conferred by the NR1 subunits, and must also be occupied for the 
channel to open. Because neither glycine nor glutamate acting alone can open the receptor 
channel, they are referred to as coagonists of the NMDA receptors. These receptors also 
have a voltage-dependent magnesium-binding site within the channel, which blocks the 
NMDA receptor pore at the membrane resting potential. This voltage-dependent magnesium 
block allows receptor activation only at depolarized membrane potentials (see figure 1.2) 
(Cull-Candy et al., 2001). Another important endogenous allosteric inhibitor of NMDA 
receptor activation is pH. The frequency of NMDA receptor channel openings is reduced by 
protons over the physiological pH range. Furthermore, NMDA receptors are endowed with 
one or more modulatory polyamine binding sites. Occupancy of one of the polyamine sites 
relieves tonic proton block and, thus, potentiates NMDA receptor activation in a pH-
dependent manner. However, at higher concentrations polyamines act on the extracellular 
site to produce a voltage-dependent block of the ion channel, inhibiting receptor activation 
(Scatton, 1993). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2- Schematic structure of NMDA receptors, indicating the modulatory sites that control their 
activity. 
 
In addition to the regulatory mechanisms discussed above, an interesting form of 
Ca2+-dependent inactivation of NMDA receptors is brought by calmodulin. The complex 
Polyamine site
Glutamate site
Mg2+ site
H+ site
Glycine/ D-serine site
Na+ Ca2+
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Ca2+-calmodulin formed upon Ca2+ entry through the receptor channel interacts with the C-
terminus of the NR1 subunit, inactivating the receptor by reducing the channel opening 
frequency and opening time (Ehlers et al., 1996). 
 
Interacting Proteins 
Similarly to AMPA receptors, the NMDA receptors interact with numerous proteins, 
which affect their functional properties, trafficking, and synaptic distribution. One of the most 
highly studied interactions is with the membrane-associated guanylate kinases (MAGUKs). 
MAGUKs are a family of proteins highly expressed in neurons that includes SAP102, SAP97, 
postsynaptic density protein-93 (PSD-93) and PSD-95. The NMDA-MAGUK interaction is 
mediated by the PDZ binding domain of the NR2 subunits and the first or second PDZ 
domains of MAGUKs (reviewed in Hung and Sheng, 2002; McGee and Bredt, 2003). 
Although the NR2A and NR2B subunits contain identical PDZ-binding domains, there are 
differences in the preferences for MAGUK interactions between NR2A and NR2B (Townsend 
et al., 2003). NR2 subunits lacking the PDZ-binding domain show decreased expression at 
the synapse, suggesting that MAGUKs stabilize NMDA receptors at the synapse (Barria and 
Malinow, 2002; Prybylowski et al., 2002). Besides this function, MAGUKs are also involved 
in the trafficking of NMDA receptors to the synapse through binding to kinesin motor proteins 
(reviewed in Prybylowski and Wenthold, 2004). 
As described above, calmodulin may also interact with the NR1 subunit of NMDA 
receptors, promoting their inactivation. Furthermore, the complex Ca2+-calmodulin activates 
CaMKII (Hudmon and Schulman, 2002), which also interacts with NMDA receptors. This 
kinase is activated by NMDA receptor-mediated Ca2+ influx (Lisman et al., 2002), and 
interaction with the NR2B subunit appears to stabilize CaMKII in an active conformation 
(Bayer et al., 2001). 
The protein receptor for activated protein kinase C-1 (RACK1) is another critical 
interactor with the NR2B subunit that controls ethanol and Fyn kinase modulation of the 
NMDA receptor (Yaka et al., 2003). 
 
Phosphorylation 
The activity of NMDA receptors is also regulated through phosphorylation by various 
protein kinases. PKC phosphorylates the NR1 and NR2A subunits of NMDA receptors at 
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consensus sites located within their intracellular C-terminal tails. The NR1 phosphorylation 
sites are Ser 889, Ser 890, Ser 896 and Ser 897, which are phosphorylated following 
exposure to phorbol esters (Tingley et al., 1997). However, the functional consequences of 
these biochemical events are not well understood. In human embryonic kidney-293 
(HEK293) cells expressing NR1/NR2A, the activation of endogenous PKC by phorbol 12-
myristate 13-acetate (PMA) increases NMDA receptor desensitization (Jackson et al., 2006). 
In Xenopus oocytes injected with rat brain RNA, stimulation with phorbol esters dramatically 
enhance NMDA receptor responses (Urushihara et al., 1992). PKC phosphorylation of 
NMDA receptors was also found to be responsible for moving the receptors from synaptic to 
extrasynaptic sites in neurons (Groc et al., 2004). 
NMDA receptors are also phosphorylated at the C-terminus of NR2B, on Tyr 1472, 
which interferes with binding to PSD-95 and promotes clathrin-dependent endocytosis, 
presumably by facilitating the binding of AP2 to NR2B (Vissel et al., 2001). 
Dephosphorylation of Tyr 837 on NR1, and Tyr 842 on NR2A might affect AP2 binding, 
promoting clathrin-mediated endocytosis in a similar way (Vissel et al., 2001). Tyr 
dephosphorylation may also cause extrasynaptic NMDA receptor rundown, although the 
specific Tyr residues responsible for this effect are still unknown (Li et al., 2002).  
Other kinases and phosphatases have been shown to regulate the NMDA receptor 
function, including PKA (Raman et al., 1996), CaMKII (Soderling and Derkach, 2000) and 
Src family of protein kinases (Wang and Salter, 1994). 
 
Synaptic Localization 
Although NMDA receptors are concentrated at the postsynaptic membrane, a 
second population of receptors, extrasynaptic NMDA receptors, has been identified and may 
have important functional roles, distinct from those of synaptic receptors (Groc and Choquet, 
2006). Synaptic receptors can be replaced rapidly through lateral diffusion in the plasma 
membrane, presumably by extrasynaptic receptors (Tovar and Westbrook, 2002). On the 
other hand, synaptic and extrasynaptic NMDA receptors differ in their subunit composition, 
with extrasynaptic receptors containing mainly NR2B subunits, whereas synaptic receptors 
are endowed with NR2A subunits (Tovar and Westbrook, 1999). NMDA receptors also 
appear to be present at immature synapses before AMPA receptors (Petralia et al., 1999), 
producing “silent synapses”, which do not respond to synaptically released glutamate in the 
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absence of sufficient depolarization to remove the Mg2+ block of NMDA receptor. Synaptic 
and extrasynaptic receptors are also differently regulated by phosphorylation (Li et al., 2002). 
Neurons have a large pool of unassembled (intracellular) NR1 subunits, whereas 
NR2 subunits are assembled with NR1 and are mainly found on the cell surface (Wenthold 
et al., 2003). Overexpression of NR2 subunits by transfection increases the number of 
surface NMDA receptor channels in cerebellar granule cells (Prybylowski et al., 2002), 
suggesting that the production of functional NMDA receptors is limited, at least in part, by the 
availability of NR2 subunits. 
During development, changes in the subunit composition of NMDA receptors are 
also found. Hippocampal or cortical neurons express NR2B early in development, when 
NMDA receptors are predominantly nonsynaptic, whereas NR2A appears later in the 
development and increases over time, being incorporated at synapses (Tovar and 
Westbrook, 1999; Guillaud et al., 2003). 
 
NMDA receptor trafficking 
On the surface of living neurons there are mobile and immobile pools of NMDA 
receptors, at both synaptic and extrasynaptic sites (Groc et al., 2004). NMDA receptors can 
move from extrasynaptic to synaptic sites on the cell surface (Tovar and Westbrook, 2002), 
suggesting that the number of NMDA receptors at synapses might be rapidly modulated by 
lateral diffusion in the plasma membrane (Sharma et al., 2006). For example, Groc and 
collaborators reported that PKC activation increases diffusion of synaptic and extrasynaptic 
NMDA receptors (Groc et al., 2004). NMDA receptors may also move between intracellular 
compartments and the plasma membrane of neurons. Trafficking of NMDA receptor is 
regulated by an endoplasmatic reticulum-retention motif in the C-terminus of NR1, and their 
surface expression is facilitated by an interaction with a protein containing a PDZ domain 
(Standley et al., 2000). At synapses, NMDA receptors are stabilized by interaction with PSD-
95, but they can be rapidly internalized in response to the binding of L-glutamate (Roche et 
al., 2001) or glycine (Nong et al., 2003). Similarly to the AMPA receptors, the NR1/NR2B 
receptor complexes may be constitutively inserted into synapses early in the development 
and replaced by NR1/NR2A receptors in an activity-dependent manner (Barria and Malinow, 
2002). As described above, the association between NMDA receptors and PSD-95 and their 
consequent endocytosis is regulated by tyrosine phosphorylation. The surface expression of 
  
    Chapter 1 
 
18
NMDA receptor is also regulated by PKC (Lan et al., 2001b). Accordingly, activation of 
metabotropic glutamate receptor increases the surface expression of NMDA receptor in 
Xenopus oocytes via regulated exocytosis, probably through PKC activation (Lan et al., 
2001a). 
 
 
1.1.2 Glutamate receptors and synaptic plasticity 
 
LTP and LTD are forms of synaptic plasticity thought to underlie learning and 
memory processes (Braunewell and Manahan-Vaughan, 2001; Lynch, 2004). LTP refers to a 
persistent increase in efficacy of synaptic transmission, following a short period of pre-
synaptic high-frequency stimulation (tetanic stimulation) or pairing pre-synaptic low-
frequency stimulation with the depolarization of the postsynaptic membrane. Conversely, 
LTP is characterized by a reduction in the synaptic strength, following low-frequency 
synaptic stimulation (Fig. 1.3). 
Figure 1.3- Synaptic plasticity in the hippocampus. A) Schematic diagram of the rodent hippocampal 
slice preparation, showing the main excitatory pathways (AC, associational/commissural; MF, mossy 
fibre; PP, perforant path; SC, Schaffer collateral). Typical electrode placements for studying synaptic 
plasticity at Schaffer collateral-commissural synapses are indicated. The traces are field EPSPs 
recorded before (1) and during (2) LTP. B) Time-course plots showing alterations in field EPSP (rising 
slope normalized to baseline) against time, during LTP (100 Hz stimulation, 1 s, baseline intensity) or 
after the induction of de novo LTD (1 Hz stimulation, 15 min, baseline intensity). The black bar 
represents the time of the stimulus and the numbers (1 and 2) indicate the time points illustrated in A) 
(Collingridge et al., 2004). 
A B
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NMDA receptors are the most important known trigger for the long-term modification 
of synaptic strength. In the hippocampus, both plasticity mechanisms, LTP and LTD, require 
activation of NMDA receptors and Ca2+ influx through these receptors. The raise in the 
intracellular Ca2+ concentration ([Ca2+]i) to different levels is a signal that activates various 
signalling pathways: LTP induction is thought to be mediated by CaMKII activation (Silva et 
al., 1992), while LTD requires calcineurin (also known as phosphatase 2B) activation 
(Mulkey et al., 1994). These effects may cause either insertion or removal of AMPA 
receptors from the postsynaptic membrane, respectively (Beattie et al., 2000; Lin et al., 
2000; Lu et al., 2001; Collingridge et al., 2004). 
 
 
LTP 
One defining feature of LTP is its dependence on high levels of postsynaptic Ca2+. 
The primary source of Ca2+ influx during the induction of LTP are the NMDA receptors, which 
become active following binding of synaptically released glutamate and plasma membrane 
depolarization. The massive and transient increase in the [Ca2+]i lead to activation of 
kinases, like CaMKII. Alterations in NMDA receptor trafficking may further contribute to LTP 
and LTD. An increase in NMDA receptor surface expression has been reported after the 
induction of LTP in adult CA1 synapses (Grosshans et al., 2002). Conversely, a form of LTD 
that is induced by metabotropic glutamate receptor activation characterized by internalization 
of NMDA receptors (Snyder et al., 2001).  
Analysis of the subunit composition of the NMDA receptors has revealed that 
hippocampal LTP relies on the expression of NR2A, since gene disruption of this subunit 
resulted in impairment of LTP in hippocampus (Sakimura et al., 1995). Moreover, 
overexpression of the NR2B subunit was found to be associated with enhanced LTP (Tang 
et al., 1999). Association between active CaMKII and synaptic NMDA receptors is also 
required for synaptic plasticity. Synaptic NR2B-containing NMDA receptors bind CaMKII with 
high affinity, while those containing NR2A subunits bind with low affinity. Replacement of 
NR2B with NR2A was found to decrease LTP, an effect that was reversed by mutations on 
the NR2A subunit that increased the affinity for the active CaMKII. Therefore, association of 
active CaMKII and NR2B or NR2A may control different forms of synaptic plasticity (Barria 
and Malinow, 2005). 
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NMDA receptor activation may also contribute to synaptic plasticity by affecting 
AMPA receptor trafficking, but this effect depends on the subunit composition of NMDA 
receptors (Kim et al., 2005). In mature cultured neurons, NR2A-containing NMDA receptors 
promote, whereas NR2B containing NMDA receptors inhibit, the surface expression of 
GluR1, primarily by regulating its surface insertion. Moreover, in mature neurons, NR2B is 
coupled to inhibition of the Ras-ERK pathway, which drives surface delivery of GluR1 (Kim et 
al., 2005). 
 
Synaptic AMPA receptor levels can be rapidly regulated. Electrophysiology studies 
in the hippocampal CA1 region showed, for the first time, the existence of excitatory 
synapses containing NMDA receptors but not AMPA receptors (Isaac et al., 1995; Liao et al., 
1995). When these called “silent synapses” were depolarized, to enable NMDA receptor 
activation, AMPA receptor-mediated responses were then detected, suggesting that AMPA 
receptors could be rapidly inserted into synapses, making them active. This delivery of 
AMPA receptors and consequent synaptic activation may play an important role in the 
potentiation of synaptic transmission during LTP. Early in development, spontaneous 
neuronal activity drives GluR4-containing AMPA receptors to functional or silent synapses 
(Zhu et al., 2000), through a mechanism dependent on PKA phosphorylation of GluR4 Ser 
842 (Esteban et al., 2003). Ser 842 phosphorylation is necessary and sufficient for synaptic 
delivery of GluR4 homomeric AMPA receptors, and is thought to relieve a retention signal 
that traps the receptor intracellularly (Esteban et al., 2003).  
Furthermore, studies using sensory neurons showed that recruitment of AMPA 
receptors to silent synapses was inhibited by blocking the interaction of GluR2-GluR3 
subunits with GRIP (Li et al., 1999b), indicating that glutamate receptor interacting proteins 
also play an important role in receptor translocation to the membrane. 
 
As described above, in the hippocampus, most AMPA receptors are tetramers 
composed of GluR1-GluR2 or GluR2-GluR3 subunits. Induction of LTP promotes the rapid 
translocation of GFP-tagged GluR1 subunits to dendritic spines in hippocampal 
organotypical cultures, and this process is dependent on the activation of NMDA receptors 
(Shi et al., 1999). The same experimental approach also revealed that GluR2-containing 
AMPA receptors are constitutively delivered to the synapses and cycle continuously 
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(Malinow and Malenka, 2002), whereas GluR1-containing  AMPA receptors are inserted into 
the synapse in response to high frequency stimulation with consequent NMDA receptor 
activation and stimulation of CaMKII (Shi et al., 1999; Hayashi et al., 2000). The GluR4 
subunit plays the role of GluR1 at immature synapses (Zhu et al., 2000). This activity-
dependent synaptic delivery of AMPA receptors is relevant in the mechanism of LTP, with 
GluR1 being dominant over GluR2, since heteromeric receptors containing GluR1 and 
GluR2 subunits behave like the GluR1 subunit (Hayashi et al., 2000; Passafaro et al., 2001; 
Shi et al., 2001). 
 
Phosphorylation of AMPA receptor subunits may also mediate synaptic plasticity by 
affecting the electrophysiological properties of the receptors, in addition to the effect on 
synaptic trafficking and surface expression. Phosphorylation of GluR1 on Ser 831 and Ser 
845 increases the apparent single channel conductance (Derkach et al., 1999), and the 
apparent opening-channel probability (Banke et al., 2000), respectively, and may therefore 
mediate, at least in part, the potentiation of synaptic transmission during the early phase of 
LTP (Fig 1.4). 
 
Figure 1.4- Schematic illustration of the effect of GluR1 phosphorylation as a bi-directional switch in 
synaptic plasticity. 
 
 
GluR1 is phosphorylated by CaMKII during LTP in the hippocampus (Barria et al., 
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in hippocampal slices enhanced synaptic transmission and prevented further LTP induction 
(Pettit et al., 1994; Lledo et al., 1995), suggesting that CaMKII and LTP enhance synaptic 
transmission through the same mechanism. However, mutation of the CaMKII 
phosphorylation site Ser 831 in GluR1 for an alanine revealed that Ser 831 phosphorylation 
is not necessary for GluR1 delivery to synapses (Hayashi et al., 2000), suggesting that 
CaMKII-induced synaptic delivery of homomeric GluR1 receptors is dependent on GluR1 C-
terminal interaction with PDZ-domain containing proteins (Hayashi et al., 2000). Recently, 
the association of GluR1-SAP-97-4.1N complex was suggested to be necessary for actin-
mediated synaptic targeting of GluR1-containing AMPA receptors (Rumbaugh et al., 2003). 
Moreover, inhibition of CaMKII, or inhibition of calpains, suppressed the potentiation of 
synaptic transmission by NMDA in hippocampal slices, and the associated increase in the 
number of AMPA receptors present in synaptic membranes (Broutman and Baudry, 2001). 
Recently, the small GTPase Ras, a downstream effector of CaMKII, was shown to mediate 
the NMDA receptor and CaMKII signalling that drives synaptic delivery of AMPA receptors 
with long cytoplasmic tails during LTP (Zhu et al., 2002). Ras activity is thought to act 
through the p42/44 mitogen-activated protein kinase (MAPK) on the delivery of AMPA 
receptor subunits with a long C-termini (Zhu et al., 2002). Ras is known to activate 
phosphatidylinositol 3-kinase (PI3-K) and, therefore, activation of Ras by CaMKII may lead to 
activation of AMPA receptors bound to PI3-K, a lipid kinase necessary for glycine-induced 
delivery of AMPA receptors to the plasma membrane. 
In addition to Ser 831, GluR1 is also phosphorylated on Ser 845 when LTP is 
induced in hippocampal CA1 region (Lee et al., 2000). Phosphorylation of this site by PKA is 
required for synaptic incorporation of GluR1. However, PKA activation alone is not sufficient 
to induce synaptic delivery of GluR1 in hippocampal slices, indicating that PKA and CaMKII 
act in parallel to induce the translocation of the receptor to the membrane (Hayashi et al., 
2000; Esteban et al., 2003; Lee et al., 2003). Recent studies showed that PKC can also 
phosphorylate GluR1 on Ser 818, and phosphorylation of this site is increased during LTP 
and is important for LTP expression (Boehm et al., 2006). 
 
Exocytosis has been implicated in the continual exchange of a substantial pool of 
AMPA receptors at the spine surface, although recent findings suggest that lateral diffusion 
is also involved (Ashby et al., 2006). Cleavage and inactivation of soluble NSF attachment 
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protein receptors (SNAREs), a multiproteic complex of the membrane fusion machinery, by 
postsynaptic application of botulinum toxin, reduced LTP in the hippocampal CA1 region, 
indicating that membrane fusion events in the postsynaptic membrane are required for LTP 
(Lledo et al., 1998). Moreover, induction of LTP in cultured hippocampal neurons by 
stimulation of postsynaptic NMDA receptors with glycine evoked a rapid insertion of AMPA 
receptors at the surface of dendritic membranes, and an increased clustering in synaptic 
regions. Both processes are blocked by tetanus toxin (Lu et al., 2001), indicating that AMPA 
receptors are inserted into synapses via SNARE-dependent exocytosis during LTP. Synaptic 
potentiation induced by brief application of NMDA to rat hippocampal slices was also 
associated with increased levels of GluR1 and GluR2-GluR3 subunits in synaptic membrane 
preparations (Broutman and Baudry, 2001). This effect was inhibited by brefeldin A 
(Broutman and Baudry, 2001), a drug that inhibits exocytosis of newly synthesized protein 
from the Golgi apparatus to the cell membranes, suggesting that the upregulation in the 
number of plasma membrane-associated AMPA receptors requires a functional secretory 
pathway. Recent studies also reported that recycling endosomes supply AMPA receptors for 
LTP and provide a mechanistic link between synaptic potentiation and membrane 
remodeling during synapse modification (Park et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5- Schematic model for the mobilization of AMPA receptors during LTP. In resting conditions, 
AMPA receptor cycling is supported by trafficking of endosomal vesicles (EE). After LTP induction, 
NMDA receptors present in the post-synaptic density (PSD) are activated, raising the [Ca2+]i, which 
activate several kinases. One of these kinases is CaMKII that phosphorylates AMPA receptors present 
in recycling endosomes (RE), inducing the traffic of newly synthesized AMPA receptor to the 
postsynaptic membrane (from www.ehlerslab.org). 
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LTD 
The release of small amounts of glutamate, lower the those required to induced LTP, 
activate only a small percentage of NMDA receptors, thereby increasing the postsynaptic 
[Ca2+] to levels bellow the threshold for eliciting LTP. Similarly, when the density of NMDA 
receptors is low, small increases in the postsynaptic [Ca2+] are induced and may be sufficient 
to activate phosphatase 2B and generate LTD (Bear and Abraham, 1996).  
Cerebellar LTD involves down-regulation of functional synaptic AMPA receptors, 
which could be due to a loss of receptors from postsynaptic sites or to changes of single 
channel properties, such as kinetics, unitary conductance, glutamate activity and/or channel 
opening probability (Wang and Linden, 2000). The generation of LTD in vivo was also found 
to decrease the number of AMPA receptors in synaptoneurosomes, providing further 
evidence for the role of AMPA receptor endocytosis (Heynen et al., 2000). LTD induced by 
low frequency stimulation of cultured hippocampal neurons is also associated with a 
decrease in synaptic GluR1 subunits, due to the activation of NMDA receptors. These 
findings further suggest that AMPA receptors are removed from the post-synaptic membrane 
during LTD (Carroll et al., 1999). Application of NMDA to hippocampal slices also induces 
LTD (Lee et al., 1998), and occludes synaptically evoked LTD, suggesting that these two 
LTD-inducing stimuli occur through the same mechanism. In cultured hippocampal neurons, 
NMDA-induced LTD is primarily mediated by activation of extra-synaptic NMDA receptors 
(Lu et al., 2001). 
 
The mechanisms involved in receptor internalization following the induction of LTD in 
hippocampal CA1 neurons was investigated using peptides that block the interaction of the 
C-terminal region of GluR2/3 with PDZ proteins (Daw et al., 2000; Kim et al., 2001). Post-
synaptic intracellular perfusion with a peptide that disrupts the interaction of GluR2 with 
GRIP1, GRIP2/ABP and PICK1 inhibited LTD, but the role played by PICK1 is still 
controversial (Daw et al., 2000; Kim et al., 2001). Thus, induction of LTD in hippocampal 
slices increases GluR2 phosphorylation on Ser 880, which is within the GluR2 C-terminal 
PDZ binding domain (Kim et al., 2001). Phosphorylation of Ser 880 by PKC was shown to 
disrupt the interaction of GluR2 with GRIP, but still enables PICK1 interaction (Chung et al., 
2000; Matsuda et al., 2000). Therefore, it was proposed that phosphorylation of the GluR2 
subunit during LTD may prevent its interaction with GRIP1 and GRIP2/ABP at the synaptic 
                                       Introduction 
 25
plasma membrane. This may allow the receptors to be internalized, and then stabilized by 
interaction with PICK1 (Kim et al., 2001). The internalization of AMPA receptors during 
homosynaptic hippocampal CA1 LTD is mediated by clathrin (Man et al., 2000) and requires 
the participation of AP2, a clathrin adapter complex that associates with GluR2 (Lee et al., 
2002). In contrast, chemically-induced LTD in the CA1 region of the hippocampus causes a 
persistent decrease in the phosphorylation of GluR1 on Ser 845, but not of Ser 831 (Lee et 
al., 1998; Lee et al., 2000). Furthermore, reversal of LTP with low frequency stimulation is 
associated with a dephosphorylation of GluR1 on Ser 831, but not of Ser 845, indicating that 
the phosphorylation site modulated by low frequency stimulation depends on the previous 
experience of the synapse (Lee et al., 2000; Huang et al., 2001). Accordingly, induction of 
LTD in a hippocampal cell culture model is also correlated with a selective reduction in the 
number of GluR1 subunits clustered at synapses (Carroll et al., 1999). 
In hippocampal slices, Rap1, a member of the Ras superfamily of small GTPases, 
mediates the NMDA receptor-dependent removal of synaptic AMPA receptors (GluR2/GluR3 
subunits) during LTD, through p38 MAPK activation (Zhu et al., 2002). Furthermore, NR2A-
containing NMDA receptor activation stimulates Rap2, which was shown to control synaptic 
removal of AMPA receptors with long cytoplasmatic tails (GluR1/GluR2L) during 
depotentiation. This effect of Rap2 is mediated by activation of c-Jun N-terminal kinase 
(JNK) rather than by extracellular signal-regulated kinase 1 and 2 (ERK1/2) or p38 MAPK 
(Zhu et al., 2005). 
Cerebellar LTD is also associated with changes in the phosphorylation and 
trafficking of AMPA receptor subunits. Stimuli inducing LTD in cultured cerebellar granule 
neurons cause GluR2 phosphorylation at Ser 880, thereby reducing the affinity of the 
receptor subunit to GRIP (Matsuda et al., 2000; Xia et al., 2000), as reported in hippocampal 
neurons (see above). This may explain the disruption of GluR2 postsynaptic clusters 
followed by internalization of the protein observed under the same experimental conditions 
(Matsuda et al., 2000). Studies using peptides designed to disrupt the interaction PICK1-
GluR2/3, or using antibodies directed against the PDZ domain of PICK1, as well as 
expression of mutant PICK1-Glutathione S-transferase (GST) fusion proteins, showed that 
PICK1 binding to GluR2/3 plays an important role in cerebellar LTD (Xia et al., 2000). 
Expression of cerebellar LTD is also thought to require clathrin-mediated internalization of 
AMPA receptors (Wang and Linden, 2000), which depends upon the carboxy-terminal region 
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of GluR2/3 (Xia et al., 2000). Furthermore, LTD in the cerebellum requires PKC, which is 
crucial for the internalization of AMPA receptors in these cells (Xia et al., 2000), in contrast 
with the hippocampus where the kinase is not required for internalization of GluR2/3 (Kim et 
al., 2001). 
 
 
1.2 Neurotrophins 
 
Neurotrophins are a family of proteins that are essential for the development of the 
vertebrate nervous system. They mediate the survival, differentiation, growth, and apoptosis 
of neurons, as well as changes in synaptic activity (Lewin and Barde, 1996).  
Neurotrophins are synthesized as precursor proteins (pro-neurotrophins), with about 
32 kDa, which are cleaved within the trans-Golgi network and/or in immature secretory 
vesicles to produce the mature proteins (Mowla et al., 2001). Pro-neurotrophins are cleaved 
by furin at a highly conserved dibasic amino acid cleavage site to release the carboxy-
terminal mature proteins. However, some pro-neurotrophins may be released to the 
extracellular compartment, being biologically active (reviewed in Lu et al., 2005), and then 
cleaved extracellularly by plasmin (Lee et al., 2001). The mature proteins are about 14 kDa 
in size, form stable non-covalent dimers and are normally expressed at very low levels 
during development (Mowla et al., 2001). The neurotrophin family of trophic factors includes 
the nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT3) and neurotrophin-4 (NT4).   
 
 
1.2.1 Expression, transport and secretion of neurotrophins 
 
Expression 
Neurotrophin expression is regulated during development, but persists in many parts 
of the adult brain. It is well accepted that the expression of neurotrophins, in particular NGF 
and BDNF, is regulated by activity. Thus, increases of the BDNF mRNA levels are observed 
upon LTP-inducing stimuli (Patterson et al., 1992; Castren et al., 1993). Moreover, neuronal 
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depolarization of cultured neurons with glutamate or KCl also increases the level of BDNF 
and NGF mRNA (Lu et al., 1991; Zafra et al., 1991; Lindholm et al., 1994). In contrast, 
inhibition of neuronal activity by γ-aminobutyric acid (GABA) decreases the level of 
neurotrophin mRNA (Lindholm et al., 1994; Berninger et al., 1995). Seizure activity also 
induces a rapid increase in NGF and BDNF mRNA in the hippocampus and cerebral cortex 
(Gall and Isackson, 1989; Zafra et al., 1990; Ernfors et al., 1991). Interestingly, neuronal 
expression of NT3 and NT4 is not regulated by activity (Ernfors et al., 1991). 
Although, transcription of neurotrophin genes occurs in the cell body, the BDNF 
mRNA may also be found at dendrites where translation machinery is also available 
(Steward and Levy, 1982; Kang and Schuman, 1996; Casadio et al., 1999). 
 
Transport and secretion 
Neurotrophins that are synthesized and packed into vesicles in the soma are then 
transported to presynaptic axon terminals or to postsynaptic dendrites for local secretion. 
Postsynaptic dendrites that synthesize neurotrophins release them locally. Thus, the 
synaptic levels of neurotrophins may be regulated by the transport and targeting of 
neurotrophin-containing vesicles to the synapse, or by local translation of neurotrophin 
mRNA (Lu, 2003). Therefore, neurotrophins may be transported anterogradely, from the 
soma to the axon terminals, and accumulated presynaptically, from where they may be 
released in response to neuronal firing, to act on the postsynaptic neuron. Alternatively, 
neurotrophins may be secreted postsynaptically at dendrites (Hartmann et al., 2001), taken 
up by the presynaptic terminal and then retrogradely transported to the soma. Both models 
may co-exist in vivo, since there is evidence for both presynaptic and postsynaptic 
neurotrophin release (Poo, 2001). 
Synaptic activity also regulates the secretion of neurotrophins, in addition to the 
effect on their expression. In hippocampal slices or dissociated cell cultures, depolarization 
induced by veratridine, glutamate, KCl or patterned electrical stimulation evoked secretion of 
NGF and BDNF (Blochl and Thoenen, 1995; Goodman et al., 1996; Balkowiec and Katz, 
2000). Finally, neurotrophins themselves can function as the regulatory signal for 
neurotrophin secretion (Canossa et al., 1997; Kruttgen et al., 1998). Evidences for 
anterograde transport and secretion of neurotrophins are provided by the observed BDNF 
enrichment in a vesicular fraction isolated from brain synaptosomes (Fawcett et al., 1997), 
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and by results showing that exogenous application of NT3 into the eye of chick embryos 
leads to an uptake of the neurotrophin by retinal ganglion cells, followed by anterograde 
transport to axon terminals, where it is released and then taken up by the tectum cell (von 
Bartheld et al., 1996). The finding that BDNF is widely distributed in nerve terminals, even in 
brain areas lacking BDNF mRNA, such as striatum, and that inhibition of axonal transport by 
colchicine or de-afferentation depleted BDNF in these areas, further suggests that BDNF is 
transported anterogradely (Conner et al., 1997; Fawcett et al., 1997). Experiments using 
BDNF-Green fluorescence protein (GFP) also showed that the fusion protein was present in 
dendrites and in axons of transfected cortical neurons, and live imaging experiments 
revealed both anterograde and retrograde BDNF-GFP movements (Kohara et al., 2001). 
Moreover, BDNF-GFP was found on untransfected postsynaptic neurons innervated by 
BDNF-GFP-positive axons, demonstrating transfer of BDNF from pre- to postsynaptic 
neurons (Kohara et al., 2001). High-frequency activation of glutamatergic synapses also 
triggers the release of BDNF-GFP from synaptically localized secretory granules, and this 
effect depends on activation of postsynaptic ionotropic glutamate receptors and on 
postsynaptic Ca2+ influx. BDNF-GFP is also released from extrasynaptic dendritic vesicle 
clusters, suggesting that a possible spatial restriction of BDNF release to specific synaptic 
sites can only occur if the postsynaptic depolarization remains local (Hartmann et al., 2001). 
The somatodendritic localization of BDNF as well as BDNF and TrkB (the BDNF receptor; 
see next section) mRNAs in hippocampal neurons also suggests a postsynaptic release of 
this neurotrophin (Goodman et al., 1996; Tongiorgi et al., 1997). Moreover, KCl 
depolarization induces a shift of BDNF and TrkB mRNAs to more distal dendritic locations, 
with a concomitant increase in BDNF and TrkB protein levels in the distal portion of dendrites 
(Tongiorgi et al., 1997). This again confirms the postsynaptic release of BDNF. 
The neurotrophin NGF was also found to be retrogradely transported in central and 
peripheral nervous system (Hendry et al., 1974; Korsching and Thoenen, 1983). Moreover, 
strong evidences for postsynaptic secretion of NT4 were provided in studies using Xenopus 
nerve-muscle cultures (Wang and Poo, 1997), where activity-dependent synaptic 
potentiation occurs when NT4 is overexpressed at the postsynaptic myocyte but not at the 
presynaptic neuron (Wang and Poo, 1997). 
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1.2.2 Neurotrophins and their receptors 
 
Neurotrophins activate two distinct types of transmembrane receptors, the 
tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (RTKs) and the p75 
receptor, a member of tumor necrosis factor (TNF) receptor family. Each neurotrophin shows 
binding specificity for particular Trk receptors. NGF binds preferentially to TrkA, BDNF and 
NT4 to TrkB, and NT3 to TrkC. These interactions are of high affinity. NT3 can also bind to 
TrkB and TrkA receptors, although with lower affinity (Fig. 1.6) (Dechant, 2001; Patapoutian 
and Reichardt, 2001). Unlike Trk receptors, the p75 receptor binds all neurotrophins, 
although with similar and lower affinity. However, this receptor has a significantly higher 
affinity for the unprocessed forms of NGF and BDNF, and binding of these pro-neurotrophins 
is thought to be involved in apoptotic cell death (Chao and Bothwell, 2002; Teng et al., 
2005). p75 receptors may also interact with Trk receptors (Gargano et al., 1997; Yano and 
Chao, 2000) and this interaction is thought to increase Trk specificity towards its preferred 
neurotrophin (Esposito et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6- Interaction of the different neurotrophins with the respective Trk receptors. NGF is specific 
for the TrkA receptor, BDNF and NT4 interact specifically with TrkB, and NT3 binds preferentially to 
TrkC, although it can also bind to TrkA and TrkB with lower affinity. 
 
A new neurotrophin receptor was recently identified, Sortilin, which belongs to the 
family of Vps10p-domain transmembrane receptors and was previously characterized as a 
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receptor for the neuropeptide neurotensin. Sortilin has been shown to bind both unprocessed 
NGF (Nykjaer et al., 2004) and BDNF (Teng et al., 2005). As for Trk receptors, the p75 
receptor associates with sortilin when co-expressed in 293 cells, and the receptor complex 
displays an increased affinity to proNGF (Nykjaer et al., 2004). However, it is still unclear 
whether sortilin acts merely as a co-receptor together with the p75 receptor, or whether it 
can trigger signalling cascades of its own. 
 
 
1.2.3 Signalling mechanisms induced by neurotrophins 
 
Neurotrophins bind as dimers to Trk receptors, leading to the dimerization and 
transphosphorylation of the receptors on tyrosine residues located in the intracellular 
domain, and subsequent activation of cytoplasmatic signalling pathways. Trk receptors 
transmit positive signals such as enhanced survival and growth, in contrast with p75 
receptors, which transmit both positive and negative signals. The effects generated by both 
neurotrophin receptor types can either augment or oppose each other (Chao, 2003).  
Trk activation results in the phosphorylation of several conserved tyrosine residues 
present in the cytoplasmatic domains of each receptor. Transphosphorylation of human TrkA 
on Tyr 670, Tyr 674 and Tyr 675, localized in the activation loop, further potentiates tyrosine 
kinase activity. Phosphorylation of addional tyrosine residues creates docking sites for 
proteins containing phosphotyrosine-binding domains (PTB) or Src homology 2 (SH2) 
domains. The intracellular signalling events activated by these adaptor proteins include Ras-
Raf-ERK, PI3-K-Akt (also known by protein kinase B), PLCγ-Ca2+, NF-κB, and atypical 
protein kinase C pathways (Foehr et al., 2000; Kaplan and Miller, 2000; Huang and 
Reichardt, 2003) (Fig. 1.7). 
Tyr 490 and Tyr 785 are the major phosphorylated tyrosine residues on the TrkA 
receptor (and analogous residues on other Trks) away from the kinase activation domain 
(Stephens et al., 1994). Phosphotyrosine 490 interacts with Shc, fibroblast growth factor 
receptor substrate 2 (Frs2), and other adaptors. Binding of the adaptor Shc and its 
phosphorylation provides mechanisms for activation of the Ras-ERK pathway, through 
recruitment of Grb2 and Sos. However, the activation of this signalling cascade is transient  
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Figure 1.7- Schematic diagram of Trk receptor-mediated signal transduction pathways. Neurotrophin 
binding to a Trk receptor stimulates its dimerization and transphosphorylation, resulting in the 
recruitment of proteins that interact with specific phosphotyrosine residues in the cytoplasmatic 
domains of Trk receptors. These interactions trigger the activation of signalling pathways, such as the 
Ras, PI3-K, and PLCγ pathways, and ultimately result in activation of gene expression, neuronal 
survival, and neurite outgrowth (adapted from Huang and Reichardt, 2003). 
 
and its termination appears to be caused by ERK phosphorylation of Sos, resulting in the 
dissociation of the Sos-Grb2 complex (Kao et al., 2001). The binding of Shc to TrkA Tyr 490 
also activates the PI3-K pathway, either by direct interaction of Ras with PI3-K (Rodriguez-
Viciana et al., 1994), or through the recruitment of the adaptor protein Gab1 (Holgado-
Madruga et al., 1997). Gab1 can additionally recruit the SH2 domain-containing protein 
tyrosine phosphatase (Shp2) that is responsible for a sustained enhancement of the activity 
the Ras-ERK cascade (Yamada et al., 1999; Shi et al., 2000) (Fig. 1.7). Interaction of TrkA 
phosphotyrosine 490 with Frs2 leads to the phosphorylation of this adaptor protein, creating 
new binding sites for the adaptor proteins Grb2, Crk, Sph2 and Src, in addition to the cyclin-
dependent kinase substrate suc-1-associated neurotrophic factor target (SNT) (Meakin et al., 
1999) (Fig. 1.7). TrkA phosphorylation on Tyr 785 induces phosphorylation on tyrosine 
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residues and consequent activation of PLCγ, leading to the generation of DAG and 
Ins(1,4,5)P3 (Fig. 1.7). Ins(1,4,5)P3 promotes the release of Ca2+ from intracellular stores, 
activating Ca2+ dependent enzymes, such as the protein kinase CaMK. DAG stimulates 
DAG-regulated PKC isoforms, such as PKCδ that can be activated by NGF, and is required 
for NGF-induced ERK activation and neurite outgrowth (Corbit et al., 1999). 
 Two additional proteins, the adaptor protein with a pleckstrin homology and a SH2 
domains  (APS) and SH2B, bind to phosphotyrosine residues within the activation loop of all 
Trk receptors (Qian et al., 1998). These proteins are phosphorylated by Trk receptors at 
tyrosine residues, recruiting Grb2, which provides a link between ERK and PI3-K activation 
(Qian et al., 1998).  
Recently, neurotrophins have been shown to induce the phosphorylation of the 
ankyrin-rich membrane-spanning protein (ARMS), a 220 kDa membrane spanning protein, at 
Tyr 1096, through activation of the Trk receptors, in primary cultures of cerebrocortical 
neurons and PC12 cells. This phosphorylation was important for binding of ARMS to CrkL, a 
known binding partner of ARMS, through CrkL SH2 domain (Arevalo et al., 2006a). 
Phosphorylation of Tyr 1096 also leads to a long lasting MAPK response and to PC12 cells 
differentiation upon NGF treatment. However, mutation of Tyr 1096 impairs prolonged MAPK 
activation and PC12 cells differentiation (Arevalo et al., 2006a). 
 
Activation of PI3-K by Ras stimulates the activity of several other signalling proteins, 
including the serine/threonine kinase Akt, which is activated through phosphorylation by 3-
phosphoinositide-dependent kinase 1 (PDK1) and PDK2. In neurons, direct targets of Akt 
are the proteins Bad, an inhibitor of the Bcl-2 anti-apoptotic protein, pro-caspase-9, which is 
cleaved into the pro-apoptotic caspapse-9, and Forkhead, a transcription factor that induces 
apoptosis by increasing the levels of Fas ligand (FasL; see figure 1.7). Phosphorylation of 
these Akt substrates suppresses apoptosis. Bad phosphorylation induces its association with 
14-3-3, and prevents it from associating with and inactivating the anti-apoptotic Bcl-2 and 
Bcl-XL proteins (Datta et al., 1997; del Peso et al., 1997). Akt can also reduce the proteolytic 
cleavage of pro-caspase-9, thereby inhibiting caspase-9 activity (Fujita et al., 1999). 
Phosphorylation of the Forkhead transcription factor by Akt also suppresses its activity. 
Another potential target of PI3-K is the IAP (inhibitor of apoptosis) family of caspase 
inhibitors, which includes X-linked inhibitor of apoptosis (XIAP), neuronal apoptosis-inhibitory 
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protein (NAIP), and human inhibitor of apoptosis protein (HIAP). Therefore, activation of Ras 
and consequent activation of the signalling pathway consisting of PI3-K and Akt is the major 
regulator of neuronal survival by inhibiting the activity of apoptotic proteins (Kaplan and 
Miller, 2000). 
 
In contrast with the effects of the PI3-K pathway, the Ras-ERK pathway induces 
neuronal survival by stimulating the activity or expression of anti-apoptotic proteins, including 
Bcl-2 and Bcl-XL, and the transcription factor CREB (cAMP response element-binding 
protein; see figure 1.3). CREB has been shown to regulate genes whose products are 
essential for normal differentiation, survival and plasticity of neurons in vitro and in vivo. This 
pathway in neurons is also important for synaptic plasticity and long-term potentiation 
(reviewed by Lonze and Ginty, 2002). 
 
 Trk splicing 
The diversity of Trk receptors is further increased by differential splicing of their 
mRNAs, generating different isoforms of each one of the Trk receptors. These splice variants 
have truncations or insertions in the tyrosine kinase domains, affecting the specificity of Trk 
receptor responsiveness. An isoform of the TrkA receptor lacking a short insert on the 
juxtamembrane region is activated efficiently only by NGF, in contrast with the receptors 
containing this insert, which may also be activated by NT3 (Clary and Reichardt, 1994). 
Truncated TrkB isoforms can reduce the activation of full-length TrkB receptors by acting 
either as dominant negatives or BDNF scavengers (reviewed in Dechant, 2001). However, 
truncated TrkB receptors appear to be capable of initiating their own signalling mechanisms 
since expression of truncated TrkB.T1 and TrkB.T2 receptors triggers BDNF-mediated 
signalling in the absence of the full-length form (Baxter et al., 1997). In glial cells, activation 
of TrkB.T1 by BDNF was shown to activate a G protein that stimulates PLC, leading to the 
production of Ins(1,4,5)P3, Ca2+ release from intracellular stores and Ca2+ entry from the 
extracellular space (Rose et al., 2003). 
From the physiological point of view, the expression of full-length or truncated TrkB 
on visual cortex slices differentially regulates dendritic arborization (Yacoubian and Lo, 
2000). The truncated TrkB was also shown to regulate the surface expression of full-length 
TrkB (Haapasalo et al., 2002). TrkC receptor isoforms containing peptide insertions in their 
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PTK domain are phosphorylated in response to their ligands, but have different signalling 
potential (Garner and Large, 1994).  
 
 p75 receptor  
Neurotrophin binding to p75 receptors promotes survival of some cells and 
apoptosis of others, and affects the axon outgrowth both in vivo and in vitro. p75 exerts 
these diverse actions through a set of signalling pathways largely distinct from those 
activated by Trk receptors. Prosurvival pathways activated by p75 receptor include NFκB 
and Akt (Roux et al., 2001; Wooten et al., 2001), whereas the proapoptotic mediators include 
the JNK-p53 signalling cascade, activation of sphingomyelinase, and association with 
adaptor proteins (neurotrophin receptor interacting factor- NRIF, neurotrophin receptor-
interacting MAGE [melanoma antigen] homologue- NRAGE, p75 receptor-associated cell 
death executor- NADE) that directly promote cell cycle arrest and apoptosis (Mukai et al., 
2000; Salehi et al., 2000; Whitfield et al., 2001; Harrington et al., 2002). p75 receptors also 
activate the small G proteins Rac and Rho that directly affect growth cone motility 
(Harrington et al., 2002). 
The intracellular signalling activated by p75 neurotrophic receptors may be affected 
by simultaneous stimulation of Trk receptors. For example, Trk stimulation and subsequent 
Ras activation suppresses the p75-induced activation of the JNK cascade and the p53-
dependent apoptotic pathway (Mazzoni et al., 1999). Also, the sphingomyelinase activity 
induced by p75 receptors is completely suppressed by Trk signalling through PI3-K 
(Bilderback et al., 2001). On the other hand, p75 activation may facilitate Trk activation, 
either by presenting the neurotrophin to Trk receptors or by inducing a favorable 
conformational change in the receptor (Chao and Bothwell, 2002). 
 
Neurotrophin receptor internalization  
Ligand engagement of neurotrophins to Trk receptors stimulates their internalization 
into vesicles through clathrin-dependent and independent endocytosis (Grimes et al., 1997; 
Howe et al., 2001). This internalization appears to require Trk phosphorylation and PI3-K 
signalling (Howe et al., 2001), and the vesicles are then transported to the cell body. Some 
of the biological effects of neurotrophins require that signals be conveyed over long 
distances, from the nerve terminal to the cell body (Ginty and Segal, 2002). Both Trk and 
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p75 receptors undergo retrograde and anterograde transport, and several proteins are 
associated with both receptors during transport. Since the transported receptors are thought 
to keep the interaction with the neurotrophin, signalling activity persists after internalization 
(Grimes et al., 1997). For example, activation of Rap1 is completely dependent on Trk 
internalization, since this protein is localized intracellularly in the endocytic vesicle-like 
structures (York et al., 2000). Internalization of the receptors may also control their 
desensitization, and a rapid loss of neuronal response to BDNF is observed following 
stimulation with the neurotrophins, due to a rapid degradation of internalized TrkB receptors. 
Because the pathways activated by NGF and BDNF are differentially regulated, this type of 
desensitization is not observed for TrkA and NGF (Carter et al., 1995; Sommerfeld et al., 
2000). Recently, the identification of a specific E3 ubiquitin ligase molecule (Nedd4-2) that 
promotes TrkA ubiquitination and downregulation of the receptor in an NGF-dependent 
manner represents a potential mechanism to control the levels of Trk receptors in 
neurotrophin-responsive neurons. Although the structure of the various Trk receptors is 
highly similar, this event is specific to TrkA receptors, since the site of E3 ubiquitin ligase 
association is not conserved in TrkB and TrkC receptors (Arevalo et al., 2006b) 
 
Thus, the specificity of neuronal responses to neurotrophins can arise from 
differences in the type of receptor, differential splicing, and the availability of p75 receptors. 
 
 
1.2.4 Modulation of synaptic transmission by neurotrophins 
 
Activation of Trk receptors regulates the expression and activities of ion channels, 
neurotransmitter receptors and other tyrosine kinases, and modulates exocytosis and 
endocytosis of synaptic vesicles. Some of these effects are observed in seconds to minutes 
and clearly do not require protein synthesis, while other actions do involve regulation of gene 
expression through control of transcription factors. Protein phosphorylation, localization of 
proteins and organelles, local regulation of protein translation and the control of gene 
expression affects function of the synapse, and these mechanisms are attractive candidates 
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to mediate the important roles that neurotrophins play in regulating synaptic plasticity in the 
hippocampus. 
 
Neurotrophin effects on neurotransmitter release 
Neurotrophins have been reported to enhance excitatory synaptic transmission at 
central synapses (Kim et al., 1994; Lessmann et al., 1994; Kang and Schuman, 1995; Levine 
et al., 1995; Carmignoto et al., 1997; Li et al., 1998; Messaoudi et al., 1998; Sherwood and 
Lo, 1999), and to suppress inhibitory transmission in both slice and dissociated cell cultures 
(Kim et al., 1994; Tanaka et al., 1997; Frerking et al., 1998). These effects appear to rely on 
the modulation of pre-synaptic activity, possibly by an effect on the neurotransmitters 
release.  
Application of NT4 induced a transient augmentation of evoked synaptic currents 
and a transient increase in the frequency of miniature excitatory postsynaptic currents in 
cultured hippocampal neurons (Lessmann et al., 1994). However, the amplitudes of the 
AMPA receptor mediated miniature EPSC were unaffected, suggesting a presynaptic action 
of BDNF and NT-4. Accordingly, acute addition of BDNF to rat hippocampal nerve terminals, 
was shown to enhance the K+-evoked glutamate release, by a mechanism involving Ca2+ 
entry through the voltage-sensitive calcium channels (Canas et al., 2004). Similarly, 
application of exogenous BDNF to isolated adult rat hippocampal nerve terminals was found 
to moderately potentiate the K+-evoked release of glutamate, possibly by activating PLCγ 
(Pereira et al., 2006). In contrast, BDNF inhibited K+-evoked GABA release from 
hippocampal synaptosomes, by a mechanism independent of Ca2+ influx through voltage-
sensitive calcium channels. Moreover, blockade of the GABA transporters prevented the 
inhibitory action of BDNF upon GABA release, indicating that the effect of the neurotrophins 
is mediated by inhibition of the reversal of the GABA transporters present in the nerve 
terminals (Canas et al., 2004).  
The neurotrophin NGF was shown to rapidly and robustly enhance K+-evoked 
acetylcholine release from basal forebrain cultures. This effect persisted for several hours 
after NGF removal and was dependent on TrkA signalling, Ca2+, and voltage-gated calcium 
channels, but not dependent on de novo protein synthesis (Auld et al., 2001). 
BDNF was also shown to induce a rapid and transient release of glutamate from 
cultured cortical neurons by a mechanism independent of extracellular Ca2+ entry, but 
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dependent on intracellular Ca2+ (Takei et al., 1998). Surprisingly, botulinum toxin B was 
found not to inhibit the BDNF-induced release of glutamate, indicating that this secretion of 
glutamate was through a non-exocytotic pathway, presumably by reverse transport of 
glutamate transporters (Takei et al., 1998).  These results contrast with the effect of BDNF 
and NT3 on neurotransmitter release from hippocampal neurons, where the neurotrophins 
potentiate the depolarization-induced increases in the cytosolic Ca2+ (Berninger et al., 1993; 
Stoop and Poo, 1996), that eventually results in changes in the efficacy of synaptic vesicle 
exocytosis (Pozzo-Miller et al., 1999). Rapid and transient glutamate and aspartate release 
induced by BDNF were also observed in cultured cortical, hippocampal, striatal and 
cerebellar neurons (Numakawa et al., 1999). NGF and NT-3 also elicited neurotrophin-
induced release of glutamate as well as BDNF from the cerebellar granule neurons. This 
release was dependent on intracellular Ca2+ mobilization. However, because these cells do 
not possess TrkA mRNA, the results suggest that NGF-elicited release was not mediated by 
Trks (Numakawa et al., 1999). Other evidences have implicated synaptic vesicle-associated 
proteins like synapsin (Jovanovic et al., 2000), synaptophysin and synaptobrevin (Pozzo-
Miller et al., 1999) as downstream targets of the BDNF signalling pathway. 
In Xenopus nerve-muscle cultures overexpression of NT4 induced a high level of 
spontaneous synaptic activity and enhanced evoked synaptic transmission. The NT4 effects 
involved a potentiation of presynaptic neurotransmitter release as well as a lengthening of 
the mean burst duration of postsynaptic low conductance acetylcholine channels (Wang and 
Poo, 1997). 
Neurotrophins may also affect synaptic transmission in developing synapses. 
Indeed, application of BDNF or NT3 (but not NGF) to Xenopus nerve-muscle cultures 
enhanced the spontaneous and evoked transmitter secretion, and this effect persisted for as 
long as the factor was present (Lohof et al., 1993). In cultures of sympathethic neurons or 
PC12 cells, withdrawal of NGF from the culture medium resulted in a gradual collapse of 
filapodia in the neuritic growth cone, and reintroduction of NFG caused the reappearence of 
active filapodia (Phelan et al., 1991). In the developing visual cortex, BDNF was shown to 
accelerate the maturation of inhibitory pathways and overexpression of BDNF in transgenic 
mice increases the number of synapses in sympathetic ganglia (Huang et al., 1999). 
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Postsynaptic effects of neurotrophins 
In addition to the presynaptic effects, neurotrophins may also modulate the 
postsynaptic activity. Accordingly, BDNF rapidly enhanced synaptic efficacy through an 
increased postsynaptic responsiveness via a phosphorylation-dependent mechanism 
(Levine et al., 1995). BDNF application to cultured hippocampal neurons dramatically 
increased the spontaneous firing rate, as well as the frequency and amplitude of excitatory 
postsynaptic currents. Interestingly, NT3 potentiates GABA-induced postsynaptic currents in 
cultured immature hypothalamic neurons in a developmental stage during which GABA 
induces depolarizing currents (Gao and van den Pol, 1999).  However, in mature 
hypothalamic neurons and cortical neurons, where GABA evokes inhibitory hyperpolarizing 
currents, NT3 has an inhibitory action on GABA-induced currents (Gao and van den Pol, 
1999). 
 
Role of neurotrophins in synaptic plasticity 
The effects of neurotrophins on synaptic transmission are relevant to understand the 
mechanisms underlying LTP or LTD. Thus, genetic deletion of BDNF in mice disrupted 
normal induction of LTP in the CA1 region of the hippocampus (Korte et al., 1995; Xie et al., 
2000), and this defect was rescued by reintroducing BDNF, through transfection of 
hippocampal slices with BDNF-expressing adenovirus or by supplying exogenous BDNF 
(Korte et al., 1996; Patterson et al., 1996). Moreover, chelation of endogenously secreted 
BDNF with TrkB–IgG or using antibodies against BDNF reduces LTP (Figurov et al., 1996; 
Kang et al., 1997), and the same LTP phenotype is observed in TrkB mutant mouse lines 
(Minichiello et al., 1999). Therefore, BDNF seems to be a permissive factor required for the 
induction, expression or maintenance of LTP, rather than a signal to potentiate basal 
synaptic transmission in the CA1 region of the hippocampus. This is supported by the finding 
that BDNF reduces tetanus-induced depression of transmitter release at CA3–CA1 synapses 
of young rats, allowing sufficient postsynaptic activation for the induction of LTP (Figurov et 
al., 1996). At dentate synapses, pairing of a brief puff of BDNF with a weak presynaptic 
stimulation also elicits a robust LTP (Kovalchuk et al., 2002). Furthermore, exogenous BDNF 
was found to block LTD induced by low frequency stimulation and to enhance tetanus-
induced LTP in slices of visual cortex (Akaneya et al., 1996; Huber et al., 1998; Kinoshita et 
al., 1999), without affecting basal synaptic transmission. BDNF is also required for the 
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maintenance of late phase potentiation in the CA1 region of the hippocampus after the 
induction of LTP (Kang et al., 1997; Korte et al., 1998). 
The signalling pathways contributing to the effect of TrkB receptors on LTP in the 
hippocampus were characterized by preventing PLCγ signalling concomitantly at the 
presynaptic and postsynaptic level (Gartner et al., 2006). This blocking was shown to reduce 
LTP to levels comparable with those in TrkB and BDNF knock-out mice. However, blockade 
of presynaptic or postsynaptic PLCγ signalling alone did not result in a significant reduction 
of LTP (Gartner et al., 2006). Moreover, mutant mice expressing TrkB receptors lacking the 
PLCγ docking site were found to have deficits on LTP. BDNF stimulation of primary neurons 
derived from PLCγ mutant mice fully retained their ability to activate MAP kinases, but the 
induction of CREB and CaMKIV phosphorylation was strongly impaired (Minichiello et al., 
2002).  
Mutant mice expressing TrkB receptors lacking the Shc binding site were also a 
valuable tool in the understanding of the signalling mechanisms involved in BDNF 
modulation of certain forms of synaptic plasticity (Korte et al., 2000; Minichiello et al., 2002). 
This mutation did not affect the induction-rate or magnitude of early LTP and late LTP 
induced by theta-burst or tetanus stimulation, suggesting that the Shc-binding site in the 
TrkB receptor and its downstream signalling cascade are not required for LTP at Schaffer-
collateral/CA1 synapse in mouse hippocampus (Korte et al., 2000; Minichiello et al., 2002). 
In contrast, a conditional mutation of the Trk gene results in deficits in memory acquisition 
and consolidation in several hippocampus-dependent learning tasks. 
 
Modulation of synaptic currents 
Neurotrophins have been shown to influence both the frequency and amplitude of 
synaptic currents in various experimental systems. Thus, BDNF and NT3 produce rapid 
increases in synaptic strength in nerve-muscle synapses, as well as increases in excitatory 
postsynaptic currents in hippocampal neurons (Lohof et al., 1993; Kang and Schuman, 1995; 
Levine et al., 1995). In contrast, BDNF was found to block postsynaptic AMPA receptor-
mediated currents in a subset of nucleus tractus solitarius cells (Balkowiec et al., 2000). The 
catalytic activity of TrkB receptors is required for the decrease in AMPA receptor activity, 
implying that there might be a close association between TrkB and AMPA receptors. The 
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exo- and endocytosis of AMPA receptors, which determine activity dependent changes of 
synaptic efficacy, could also be influenced by BDNF signalling. 
Increasing number of interactions between Trk receptors and ion channels are being 
discovered. Electrophysiological measurements in cultured rat olfactory bulb neurons 
showed that acute BDNF exposure induces the tyrosine phosphorylation of Kv1.3 channels 
and suppresses their currents, although no effect is observed in the channel kinetics of 
inactivation or deactivation (Tucker and Fadool, 2002). In contrast, chronic exposure (days) 
of the same cells to BDNF increased the magnitude of Kv1.3 current and accelerated the 
inactivation and deactivation of the channel (Tucker and Fadool, 2002). Therefore, 
depending on the stimulation used, BDNF may have depolarizing (acute stimulation) or 
hyperpolarizing (chronic stimulation) effects in cultured rat olfactory bulb neurons. 
A depolarizing response to BDNF may also be mediated through activation of the 
Nav1.9 sodium channels (Blum et al., 2002), since an inward sodium current was detected 
within milliseconds of BDNF treatment in hippocampal neurons. The time course of Nav1.9 
activation by phosphorylation is considerably longer than the observed response to BDNF, 
suggesting that TrkB and Nav1.9 exist in a complex. According to this model, a change in the 
conformation of TrkB receptors may lead to the activation of the Nav1.9 channels. Low 
concentrations of BDNF and NT4 also activate a Na+ conductance as rapidly as glutamate, 
in the CA1 area of the hippocampus and in the brain cortex and cerebellum (Kafitz et al., 
1999). This rapid response to BDNF or NT4 again suggests that the Na+ channels are very 
likely to physically associate with TrkB receptors. Activation of Na+ channels and the 
resulting inward currents lead to membrane depolarization and gate voltage–dependent Ca2+ 
channels, thereby inducing Ca2+ influx. Accordingly, BDNF and NT4 have been shown to 
activate postsynaptic Ca2+ currents in dentate granule cells (Bramham and Messaoudi, 
2005). Dendritic spines appear to be the exclusive site of rapid activation of these voltage–
dependent Ca2+ channels by BDNF and, together with the resulting influx of Ca2+ through 
NMDA receptors, induce robust LTP (Bramham and Messaoudi, 2005). 
Trk receptor activation has also been shown to activate several members of the 
transient receptor potential family of cation channels (TRPC). Many members of this family 
have previously been shown to be activated through PLC. TRPC3 is a non-voltage-gated 
and store-operated cation channel that is highly expressed in brain regions where TrkB 
receptors are found (Li et al., 1999a). Treatment of pontine neurons with BDNF resulted in 
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an increase in cation inward currents, through a PLC-dependent mechanisms (Li et al., 
1999a) 
 
Activity dependent effects 
Synaptic modulation by neurotrophins also depends on a cytoplasmic signalling 
activity and on the neuronal electrical activity. This is supported by the finding that synaptic 
potentiation by BDNF is greatly facilitated by presynaptic activity at developing 
neuromuscular junctions (Boulanger and Poo, 1999). Brief depolarization (or spiking) of the 
presynaptic neuron in the presence of a low BDNF concentration resulted in a marked 
potentiation of spontaneous and evoked transmitter secretion, whereas exposure to either a 
low BDNF concentration or depolarization alone had no effect. This depolarization of the 
presynaptic terminal was mediated by an elevation of cAMP levels (Boulanger and Poo, 
1999). Thus, electrically active nerve terminals may be more susceptible to synaptic 
potentiation by secreted neurotrophins than inactive terminals. This may constitute a 
mechanism for activity dependent synapse refinement. High-frequency neuronal activity and 
synaptic transmission were also shown to elevate the number of TrkB receptors on the 
surface of cultured hippocampal neurons (Du et al., 2000), and may therefore facilitate the 
synaptic action of BDNF. Neuronal or synaptic activity is also known to promote the effects 
of neurotrophins on dendritic arborization in cortical slices (McAllister et al., 1996) and the 
survival of cultured retinal ganglion cells (Meyer-Franke et al., 1995). In the latter case, the 
activity elevates cAMP levels to enhance the responsiveness of the neuron to neurotrophins, 
apparently by recruiting extra TrkB receptors to the plasma membrane (Meyer-Franke et al., 
1998). Taken together, these findings indicate that the response of a given synapse to BDNF 
may depend on its recent history. 
 
BDNF modulation of AMPA receptors 
The effect of BDNF on AMPA receptors has been investigated mainly in studies 
where neurons were subjected to chronic stimulation with the neurotrophin. Daily application 
of BDNF increases the protein expression of AMPA receptor subunit GluR1 and 
GluR2/GluR3 in cultured rat neocortical neurons (Narisawa-Saito et al., 1999a), through a 
mechanism dependent on the activity of Fyn, a non-receptor-type protein tyrosine kinase 
belonging to the Src-family (Narisawa-Saito et al., 1999b). BDNF was also shown to trigger a 
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surface translocation of AMPA receptors by an exocytotic process, within a period of 3 h, as 
determined using an [3H]AMPA binding assay. Studies performed in a transfected cell line 
suggested that the BDNF-evoked translocation of GluR2-containing AMPA receptors to the 
membrane depends on the interaction of GluR2 with NSF (Narisawa-Saito et al., 2002). 
Similarly, chronic treatment of neocortical neurons with BDNF elevated total and surface 
GluR1 and GluR2/3 subunits of the AMPA receptors (Nagano et al., 2003). However, no 
changes in the messenger RNA (mRNA) for the AMPA receptor subunits were detected in 
cerebral neocortical neurons subjected to chronic stimulation with BNDF (Narisawa-Saito et 
al., 1999a). In contrast, BDNF treatment for two days increased the promoter activity of a 
fragment of the GluR2 gene in a transfected human neuroblastoma cell line (differentiated 
cell line SH-SY5Y) (Brene et al., 2000). This effect was accompanied by increased 
expression of endogenous GluR2 protein in those cells, and appeared to be mediated via 
neuron-restrictive silencer element (NSRE) (Brene et al., 2000). 
Chronic stimulation of rat neocortical neurons with BDNF was also shown to 
upregulate the expression of some postsynaptic density proteins, which interact with AMPA 
receptors (SAP97, GRIP1, Pick1), and to increase the mRNA levels of GRIP1 and PICK1, 
but with no changes on SAP97 mRNA (Jourdi et al., 2003). Conversely, BDNF gene 
disruption reduced the levels of SAP97, GRIP1, and Pick1 protein in neocortex. Under the 
same conditions there was an increase in the interaction between GluR1 and SAP97, as well 
as between GluR2 and GRIP1, which may play a role in the upregulation of AMPA receptors 
by BDNF (Jourdi et al., 2003). 
BDNF was also shown to play a role in the regulation of AMPA receptor activity. 
Multipolar cortical GABAergic neurons chronically treated with BDNF showed a marked 
increase in the inward membrane currents evoked by AMPA (Nagano et al., 2003). However, 
in this case, the sustained stimulation of neurotrophin receptors from early in development 
may have caused changes in cell phenotype. Also, under these conditions no effect on 
mRNA for the receptor subunits was observed. On the other hand, long-term treatment of 
hippocampal cultures with BDNF potentiated excitatory transmission by augmenting the 
amplitude of AMPA receptor-mediated miniature EPSCs (Bolton et al., 2000). In contrast, 
BDNF was shown to strongly inhibit postsynaptic AMPA receptor-mediated currents in a 
large subset of newborn nucleus tractus solitarius neurons (Balkowiec et al., 2000). These 
BDNF induced-changes in synaptic activity may be due to the insertion or removal of AMPA 
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receptors from potentiated and depressed synapses (Carroll et al., 1999; Lissin et al., 1999), 
respectively, or to changes in the phosphorylation state of AMPA type glutamate receptors 
(Wu et al., 2004). 
Translation of mRNA may also be modulated by BDNF, through stimulation of TrkB 
receptors coupled to activation of the mammalian target of rapamycin (mTOR). This 
regulation of the translation initiation complex (Bramham and Messaoudi, 2005) can be 
activated by the PI3-K-Akt  and the Ras-Raf-ERK pathways, which act downstream of TrkB 
receptor activation (see section 1.2.3 Signalling mechanisms induced by neurotrophins). 
Inhibition of mTOR with rapamycin prevents forms of protein synthesis-dependent synaptic 
activity and blocks both late LTP induced by high-frequency stimulation and BDNF-induced 
LTP at CA3-CA1 synapses (Tang et al., 2002; Cammalleri et al., 2003). The effects of mTOR 
may be, at least in part, mediated by an upregulation of GluR1 protein level, since BDNF 
was shown to upregulate this receptor subunit in synatoneurosomes through the mTOR–PI3-
K pathway (Schratt et al., 2004). Therefore, this pathway may contribute to increase locally 
the amount GluR1 after high-frequency stimulation (Schratt et al., 2004).  
BDNF was also found to induce gene expression through phosphorylation and 
activation of the transcription factor CREB (Finkbeiner et al., 1997) and CREB-binding sites 
are present in the promoter region of GluR1. However, there are no evidences for a role of 
CREB in the regulation of GluR1 promoter activity (Borges and Dingledine, 2001).  
Studies in a heterologous system showed that the expression of GluR2 can be 
regulated by BDNF, through a mechanism involving a NRSE present within the GluR2 
promoter (Brene et al., 2000). Another transcription factor that controls GluR2 expression is 
nuclear factor of activated T-cells isoform 4 (NFATc4) (Weik et al., 2005). In hippocampal 
neurons, BDNF activates NFAT-dependent transcription via TrkB receptors, PLCγ signalling 
and calcineurin (Groth and Mermelstein, 2003). However, this transcription factor was shown 
to bind to the gene encoding the GluR2 subunit and to repress GluR2 gene expression, 
decreasing the abundance of GluR2 mRNA and protein (Weik et al., 2005). These results 
contrast with the effects observed in cerebrocortical neurons chronically exposed to BDNF, 
where no change in the mRNA for GluR2 was observed (Narisawa-Saito et al., 1999a). 
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BDNF modulation of NMDA receptors   
Less is known about the effect of BDNF on NMDA receptors. BDNF increases 
NMDA single channel open probability in cultured hippocampal neurons (Levine et al., 1998; 
Levine and Kolb, 2000), probably by enhancing the phosphorylation of NR1 and NR2B 
subunits in hippocampal and cortical neurons (Suen et al., 1997; Lin et al., 1998; Alder et al., 
2005). The effect of the neurotrophin on the activity of NMDA receptors in cultured 
hippocampal neurons is sensitive to inhibitors of NR2B (Crozier et al., 1999; Levine and 
Kolb, 2000) and, accordingly, BDNF was shown to acutely increase tyrosine phosphorylation 
of NR2B (but not NR2A) subunits in cortical and hippocampal postsynaptic densities (Lin et 
al., 1998), and in cultured hippocampal neurons (Alder et al., 2005). Phosphorylation of 
NR2B may be mediated by Fyn, a member of the Src family, since this kinase is activated by 
TrkB receptors (Narisawa-Saito et al., 1999b), and increases currents mediated by 
recombinant NMDA receptors (Kohr and Seeburg, 1996). Fyn was also suggested to 
contribute to the increase of glutamatergic synaptic transmission by BDNF (Alder et al., 
2005). The BDNF-induced phosphorylation of NR2B may contribute, at least in part, to the 
observed tyrosine phosphorylation of this receptor subunit in LTP in the hippocampal CA1 
region (Nakazawa et al., 2001).   
The activity of NMDA receptors in CNS neurons was shown to increase following 
intracellular application of recombinant Src (Wang and Salter, 1994; Kalia et al., 2004; Salter 
and Kalia, 2004), and Fyn-mediated interaction between BDNF signalling and NMDA 
receptors may play an important role in spatial learning and memory (Mizuno et al., 2003). 
The signalling activity induced by BDNF may also affect NMDA receptors through PKC, 
which modulates NMDA receptor trafficking and gating in cultured hippocampal neurons 
(Lan et al., 2001b). In fact, activation of Trk receptors promotes PLCγ activity, giving rise to 
DAG, which activates PKC. 
In addition to these rapid effects of BDNF on NMDA receptors, recent studies 
showed that BDNF increases the translation of the NR1 subunit mRNA in cultured 
cerebrocortical neurons (Schratt et al., 2004), suggesting that the neurotrophin may also 
regulate the abundance of NMDA receptors in the hippocampus. NR1 expression is 
regulated by different transcription factors, including the NF-κB (Liu et al., 2004) and CREB 
(Lau et al., 2004), and the latter is a major mediator of neuronal neurotrophin responses 
(Finkbeiner et al., 1997). NR2B expression is also regulated by CREB (Rani et al., 2005), in 
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addition to AP-1 (Qiang and Ticku, 2005), which may also be activated by BDNF-induced 
signalling (Li et al., 2004). NT4 was shown to upregulate NR2A through the immediate early 
transcription factor Egr-1 in cultured cerebrocortical neurons (Choi et al., 2004). 
 
 
1.3 Objectives of the present study 
 
The main goal of this study was to investigate the effect of BDNF on AMPA and 
NMDA receptors, which may account, at least in part, for the role of the neurotrophins in 
synaptic plasticity. Hippocampal cultures were chosen as an experimental model since 
AMPA and NMDA receptors are highly expressed in this region and because synaptic 
plasticity in the hippocampus is though to underlie memory formation and learning. BDNF, 
besides controlling neuronal growth and development, is also responsible for modifications 
on synaptic transmission and localization of the BDNF-Trk complex in glutamatergic 
synapses makes this system an attractive regulator of excitatory transmission and plasticity. 
Therefore, it was of interest to further investigate the relationship between BDNF activity and 
AMPA and NMDA receptors. 
 
The study of the effect of BDNF on glutamate receptors was divided in two different, 
but interconnected parts, which are included in chapters 2 and 3. The first focuses on the 
effect of BDNF on AMPA receptors, and the second concerns the effect of the neurotrophin 
on NMDA receptors. In both cases, we first studied the effect of BDNF on the abundance of 
AMPA and NMDA receptor subunits by Western blot. Because BDNF was shown to 
upregulate several AMPA and NMDA receptor subunits, and since BDNF is known to 
modulate translation and transcription (Finkbeiner et al., 1997; Schratt et al., 2004; Bramham 
and Messaoudi, 2005), two different translation and transcription inhibitors were used and 
the levels of AMPA and NMDA receptor subunits were evaluated. This question was further 
addressed by performing real-time PCR experiments to measure the mRNA levels of the 
different subunits.  
Since a large pool of receptors is intracellular and therefore unable to respond to the 
neurotransmitter glutamate, we have also examined the effect of BDNF on plasma 
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membrane expression of AMPA and NMDA receptor subunits by performing biotinylation 
assays. Since BDNF induced the translocation of AMPA and NMDA receptors to the plasma 
membrane, functional studies were performed in order to determine whether the 
neurotrophin upregulates the activity of the receptors. Thus, the effect of BDNF on NMDA 
receptor activity was studied by measuring the [Ca2+]i response to addition of the NMDA 
receptor agonists in single-cell cultured hippocampal neurons, using the Fura-2 fluorescent 
probe.  Synaptic delivery of AMPA receptors upon BDNF stimulation was also studied by 
electrophysiology techniques in cultured hippocampal slices overexpressing GluR1-GFP, by 
infection with Sindbis virus. Since BDNF was shown to promote the synaptic delivery of the 
GluR1 subunit, the phosphorylation of specific residues on this subunit was also examined. 
Chapter 2. BDNF regulates the expression and
synaptic delivery of AMPA receptor subunits in
hippocampal neurons
Results in this chapter were resubmitted for publication as:
Caldeira MV,  Melo CV, Pereira DB, Carvalho R, Correia S, Backos
DS, Carvalho AL, Esteban JA & Duarte CB (2007) J Biol Chem
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BDNF plays an important role in 
synaptic plasticity in the hippocampus, but 
the mechanisms involved are not fully 
understood. The neurotrophin couples 
synaptic activation to changes in gene 
expression underlying long-term potentiation 
and short-term plasticity. Here we show that 
BDNF acutely upregulates GluR1, GluR2 
and GluR3 AMPA receptor subunits in 7 DIV 
cultured hippocampal neurons. The increase 
in GluR1 and GluR2 protein levels in 
developing cultures was impaired by K252a, 
a Trk inhibitor, and by translation (emetine 
and anisomycin) and transcription inhibitors 
(α-amanitine and actinomycin D). 
Accordingly, BDNF increased the mRNA 
levels for GluR1 and GluR2 subunits. 
Biotinylation studies showed that stimulation 
with BDNF for 30 min selectively increased 
the amount of GluR1 associated with the 
plasma membrane, and this effect was 
abrogated by emetine. Under the same 
conditions, BDNF induced GluR1 
phosphorylation on Ser831 through 
activation of PKC and CaMKII. Chelation of 
endogenous extracellular BDNF with TrkB-
IgG selectively decreased GluR1 protein 
levels in 14 DIV cultures of hippocampal 
neurons. Moreover, BDNF promoted 
synaptic delivery of homomeric GluR1 AMPA 
receptors in cultured organotypic slices, by a 
mechanism independent of NMDA receptor 
activation. Taken together, the results 
indicate that BDNF upregulates the protein 
levels of AMPA receptor subunits in 
hippocampal neurons and induces the 
delivery of AMPA receptors to the synapse. 
 
 
INTRODUCTION 
 
Neurotrophins are essential for the 
development of the vertebrate nervous 
system, modulate synaptic function and play 
an important role in synaptic plasticity (Poo, 
2001; Vicario-Abejon et al., 2002). Brain-
derived neurotrophic factor (BDNF) has been 
implicated in activity-dependent synaptic 
plasticity, particularly in long-term 
potentiation (LTP) induced by high-frequency 
stimulation. Accordingly, LTP is impaired in 
the hippocampal CA1 region of animals 
deficient in BDNF, but it can be rescued by 
supplying the neurotrophin (Korte et al., 
1995; Korte et al., 1996; Patterson et al., 
1996). Chelation of endogenous BDNF also 
prevents the induction of LTP by theta burst 
stimulation and reduces late-phase LTP 
induced by high-frequency stimulation 
(Figurov et al., 1996; Kang et al., 1997). 
Furthermore, the late-phase LTP induced by 
tetanic stimulation was not observed in slices 
from BDNF-knockout mice and was also 
abrogated when TrkB receptors were 
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blocked (Korte et al., 1998). Taken together, 
the available evidences point to a direct role 
of BDNF in the early and late phases of LTP.  
Binding of BDNF to TrkB receptors is 
followed by activation of intracellular 
signalling pathways, including the 
Ras/extracellular signal-regulated protein 
kinase-, phospholipase C-γ (PLCγ)-, 
phosphatidylinositol-3-kinase/Akt- and Src-
pathways (Narisawa-Saito et al., 1999b; 
Kaplan and Miller, 2000; Huang and 
Reichardt, 2003). TrkB receptors are located 
on axon terminals and in the post-synaptic 
density of glutamatergic synapses (Drake et 
al., 1999; Aoki et al., 2000; Pereira et al., 
2006), but whether the effects of BDNF on 
synaptic plasticity are mediated by pre- 
and/or post-synaptic receptors is not fully 
elucidated. BDNF was originally shown to 
induce a long-lasting potentiation of 
excitatory synaptic transmission in the 
hippocampal CA1 region, acting at a 
presynaptic site [(Kang and Schuman, 
1995); for conflicting results see (Figurov et 
al., 1996; Patterson et al., 1996; Tanaka et 
al., 1997; Frerking et al., 1998; Gottschalk et 
al., 1998)], and subsequent studies showed 
that BDNF was selectively required for those 
forms of LTP that recruit a presynaptic 
component (Zakharenko et al., 2003). 
However, activation of postsynaptic TrkB 
receptors generates intracellular Ca2+ 
concentration transients in dentate granule 
cells, which induce LTP when paired with 
weak synaptic stimulation (Kovalchuk et al., 
2002). The enhancement of synaptic 
transmission by BDNF observed in the 
dentate gyrus in vivo (Messaoudi et al., 
1998) may also be due, at least in part, to 
the activation of post-synaptic receptors 
(Messaoudi et al., 2002; Ying et al., 2002). 
Nevertheless, a postsynaptic role of BDNF in 
synaptic plasticity, and the potential 
mechanisms involved, remain controversial.  
The number, composition and 
location of α-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA) receptors in 
neurons, together with receptor 
phosphorylation, are critically important 
factors in determining the neuronal response 
to glutamate, and play an important role in 
the mechanisms of synaptic plasticity 
(Gomes et al., 2003). AMPA receptors are 
formed by the association of GluR1-GluR4 
subunits, and their delivery to the synapse is 
tightly controlled by the intracellular 
signalling activity. In this work, we 
characterized the effect of BDNF on the 
abundance of AMPA receptors in cultured 
hippocampal neurons and on their cellular 
distribution. Furthermore, we investigated 
the effect of BDNF on the synaptic delivery 
of GluR1-containing AMPA receptors in CA1 
hippocampal neurons, which could account 
for the postsynaptic effects of the 
neurotrophin in the early phase of LTP. 
 
 
EXPERIMENTAL PROCEDURES 
 
Hippocampal cultures- Primary cultures of 
rat hippocampal neurons were prepared 
from the hippocampi of E18-E19 Wistar rat 
embryos, after treatment with trypsin (0.06%, 
15 min, 37 ºC; GIBCO Invitrogen, Paisley, 
UK) and deoxyribonuclease I (5.36 mg/ml), 
in Ca2+- and Mg2+-free Hank’s balanced salt 
solution (HBSS; 5.36 mM KCl, 0.44 mM 
KH2PO4, 137 mM NaCl, 4.16 mM NaHCO3, 
0.34 mM Na2HPO4.2H2O, 5 mM glucose, 1 
mM sodium pyruvate, 10 mM HEPES and 
0.001% phenol red). The hippocampi were 
then washed with HBSS containing 10% 
fetal bovine serum (BioWhittaker Europe, 
Belgium), to stop trypsin activity, and 
transferred to Neurobasal medium (GIBCO 
Invitrogen) supplemented with B27 
supplement (1:50 dilution; GIBCO 
Invitrogen), 25 µM glutamate, 0.5 mM 
glutamine and 0.12 mg/ml gentamycin. The 
cells were dissociated in this solution and 
were then plated in 6 well plates (91.6x103 
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cells/cm2), coated with poly-D-lysine (0.1 
mg/mL). The cultures were maintained in a 
humidified incubator of 5% CO2/95% air, at 
37 °C, for seven or fourteen days. Cultures 
were stimulated with 100 ng/ml BDNF (kind 
gift from Regeneron, Tarrytown, NY) for the 
indicated periods of time. When appropriate, 
200 nM K252a, 2.0 µM emetine, 2.0 µM 
anisomycin, 1.5 µM α-amanitine, 1.5 µM 
actinomycin D (Calbiochem, La Jolla, CA), 5 
µM chelerythrine (Sigma, Sintra, Portugal) or 
10 µM KN-93 (Sigma) were added 30 min 
before stimulation, as indicated. Scavenging 
of endogenous extracellular BDNF was 
performed with TrkB-IgG (1 µg/ml; Sigma) 
for 24 h. 
Hippocampal slices were prepared 
from young rats (postnatal days 5–6) and 
cultured on semiporous membranes as 
previously described (Gahwiler et al., 1997). 
 
Preparation of extracts- Hippocampal 
neurons were washed twice with ice-cold 
PBS buffer and once more with PBS buffer 
supplemented with 1 mM DTT and a cocktail 
of protease inhibitors (0.1 mM PMSF, 1 
µg/ml chymostatin, 1 µg/ml leupeptin, 1 
µg/ml antipain, 1 µg/ml pepstatin; Sigma-
Aldrich Química, Sintra, Portugal). The cells 
were then lysed with RIPA (150 mM NaCl, 
50 mM Tris-HCl, pH 7.4, 5 mM EGTA, 1% 
Triton, 0.5% DOC and 0.1% SDS at a final 
pH 7.5) supplemented with with 50 mM NaF, 
1.5 mM sodium orthovanadate and the 
cocktail of protease inhibitors. After 
centrifugation at 16,100 g for 10 min, protein 
in the supernatants was quantified using the 
BCA method, and the samples were diluted 
with a 2x concentrated denaturating buffer 
(125 mM Tris, pH 6.8, 100 mM glycine, 4% 
SDS, 200 mM DTT, 40% glycerol, 3 mM 
sodium orthovanadate, and 0.01% 
bromophenol blue).  
Extracts from treated hippocampal 
slices were prepared in homogenisation 
buffer containing protease and phosphatase 
inhibitors (10 mM HEPES, 500 mM NaCl, 10 
mM EDTA, 10 mM NaF, 1 µM Microcystin, 
0.1 mM PMSF, 2 µg/ml chymostatin, 2 µg/ml 
leupeptin, 2 µg/ml antipain, 2 µg/ml 
pepstatin, 10 µM sodium orthovanadate, and 
1% Triton X-100). Samples were centrifuged 
at 16,100 g for 4 min and the protein present 
in the supernatant was quantified using the 
BCA method, and denaturated with 
denaturating buffer at 95 ºC for 5 min. The 
proteins of interest were then analysed by 
Western blot. 
 
Total RNA isolation and reverse transcription 
for Real-Time PCR- Total RNA from cultured 
hippocampal neurons was extracted with 
TRIzol reagent (Invitrogen, Barcelona, 
Spain), according to the instructions of the 
manufacturer. The full content of a 6 well cell 
cluster plate, with 870,000 cells/well (DIV 7), 
was collected for each experimental 
condition. For first strand cDNA synthesis, 3 
µg of total RNA were reverse-transcribed 
with AMV Reverse Transcriptase (Roche, 
Carnaxide, Portugal) using Random Primer 
p(dN)6 (3.2 µg), dNTPs (1 mM each), MgCl2 
(25 mM), RNase inhibitor (50 units) and 
Gelatine (0.01 µg/µl) in Reaction Buffer (10 
mM Tris, 50 mM KCl, pH 8.3) in a total 
volume of 40 µl. The reaction was performed 
at 25 ºC for 10 min, followed by 60 min at 42 
ºC, for primer annealing to the RNA template 
and cDNA synthesis, respectively. The 
Reverse Transcriptase was then denatured 
during 5 min at 99 ºC, and the sample was 
cooled to 4 ºC for 5 min and finally stored at 
-80 ºC until further use. 
 
Real-Time PCR- Real-Time PCR analysis of 
gene expression was performed using the 
LightCycler System II (Roche, Portugal). The 
PCR reactions were performed using 
LightCycler FastStart DNA Master SYBR 
Green I (Roche et al.) in 20 µl capillaries. 
The primers used for amplification of genes 
encoding AMPA receptor subunits were, 
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respectively, RGR1F2271- 5'GAA CCA TCC 
GTG TTT GTT CG3´ and RGR1R2937- 
5'TTC CTG TCT GCT CCA GTT AC3´ for 
GluR1; and RGR2F2522 - 5'GAA GCC TTG 
TGA CAC CAT GA3´ and RGR2R3008 - 
5'AGC CTT GCC TTG CTC CTC AT3´ for 
GluR2. RGR3F2431 - 5'CAA AGG CTA TGG 
TGT GGC AA3´ and RGR3R2927 - 5'ACA 
CCA GGG AGA GTG AAA TC3´ for GluR3; 
S2288 - 5´TGG AGG GCG TGG CTC GTG 
TC3´and R2800 - 5’TTG GGG CAG TCA 
GGG GTA AG3´ for GluR4. The primers 
used for the amplification of endogenous 
control gene 18S rRNA were those included 
in the Applied Biosystems TaqMan 
Ribosomal RNA Control Reagents Kit (Porto, 
Portugal).  Each primer of a pair was added 
to the reaction mixture (10 µl) at a final 
concentration of 0.8 µM with 3 mM MgCl2, in 
addition to the “Hot Start” LightCycler Fast 
Start DNA Master SYBR Green I mix (1x) 
and 1.2 µl of cDNA sample. Thermal cycling 
was initiated with activation of the FastStart 
Taq DNA Polymerase by denaturation during 
10 min at 95 ºC followed by 45 cycles of a 30 
s melting step at 95 ºC, a 5 s annealing step 
at 58 ºC, and a 25 s elongation step at 72 
ºC. All temperature transition rates at 20 
ºC/s. After amplification for 45 cycles, at 
least 10 cycles beyond the beginning of the 
linear phase of amplification, samples were 
subjected to a melting curve analysis 
according to the instructions of the 
manufacturer in order to confirm the absence 
of unspecific amplification products and 
primer-dimers. In all experiments, samples 
containing no template were included as 
negative controls. 
 
mRNA quantitative analysis- The mRNA 
levels of the constitutively expressed 
housekeeping gene encoding 18S ribosomal 
RNA were used as a control, in all 
experiments. The relative changes in the 
mRNA levels of glutamate receptor subunits 
in cultured hippocampal neurons were 
determined using the ∆∆Cp method. 
Accordingly, for each experimental condition 
(unstimulated neurons and neurons treated 
with 100 ng/ml BDNF for 30 min or 3 h) the 
“Crossing point” (Cp) values given by the 
LightCycler system II software, for each 
target gene, were subtracted by the 
respective Cp value determined for the 18S 
gene from the same sample and condition 
(∆Cp). This allows normalizing changes in 
target gene expression. Afterwards, the ∆Cp 
values were subtracted by the respective 
values of the control for the target gene 
giving ∆∆Cp. The derivation to the formula 2-
(∆∆Cp) sets each control at the unity (or 
100%), since ∆∆Cp (control)=0, and the 
stimuli conditions at a percentage relative to 
the control. 
 
Surface biotinylation and precipitation- 
Hippocampal cell cultures were treated or 
not with 100 ng/ml BDNF and then incubated 
with 1 mg/ml EZ-LinkTM Sulfo-NHS-SS-biotin 
(Pierce, Madison, WI) in ice-cold PBS 
containing 1 mM CaCl2 and 1 mM MgCl2, for 
30 min (Gomes et al., 2004). The non-bound 
biotin was removed by washing the cells with 
PBS containing 100 mM glycine. Cell lysates 
were obtained as described above, and were 
incubated with UltraLink Plus™ immobilized 
streptavidin or UltraLink® immobilized 
NeutrAvidinTM plus beads (Pierce), for 2 h at 
4 °C, under constant agitation. Non-
biotinylated proteins were removed by 
centrifugation at 2,500 g for 3 min, and the 
beads were washed three times with RIPA 
buffer. Biotinylated proteins were then eluted 
with denaturating buffer at 95 °C for 5 min 
(Fig 6A, C and D), or at 65 °C for 15 min 
(Fig. 6B). Samples were then processed for 
Western blotting analysis. 
 
Western blotting- Protein samples were 
separated by SDS-PAGE, in 6% 
polyacrylamide gels, transferred to 
polyvinylidene (PVDF) membranes (BioRad, 
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Amadora, Portugal), and immunoblotted. 
Blots were incubated with primary antibodies 
(overnight at 4 ºC), washed and exposed to 
alkaline phosphatase-conjugated secondary 
antibodies (1:20000 dilution; 1 h at room 
temperature). Alkaline phosphatase activity 
was visualized by ECF on the Storm 860 Gel 
and Blot Imaging System (Amersham 
Biosciences, Buckinghamshire, UK), or by 
ECL (Fig. 8A). The following primary 
antibodies were used: anti-GluR1 (1:1500; 
Upstate, Waltham, MA), anti-GluR2 (1:600; 
Chemicon International, Temecula, CA), 
anti-GluR3 (1:200; Zymed, San Francisco, 
CA), anti-GluR4 (1:200; Chemicon 
International), anti-pGluR1 Ser831 (1:1000; 
Chemicon International or 1:1500; Tocris, 
UK), anti-pGluR1 Ser845 (1:1000; Chemicon 
International), anti-pGluR2 Ser880 (1:1000; 
Chemicon International), anti-pTrk (1:1000; 
Cell Signalling, Beverly, MA) and anti-TrkB 
(clone 47, 1:1000; BD Bioscience, San Jose, 
CA). Anti-α-Tubulin (1:1000; Zymed), anti-β-
Tubulin I (1:150000; Sigma), anti-Actin 
(1:20000; Chemicon), and anti-transferrin 
receptor (1:3000; Zymed) antibodies were 
used in loading controls. 
 
Electrophysiology- After 3–5 days in culture, 
the organotypic cultures of rat hippocampal 
slices, prepared as previously described 
(Gahwiler et al., 1997),  were infected (36 h) 
with the Sindbis virus expressing 
recombinant GluR1 or GluR1 plus the 
constitutive active αCaMKII (as indicated), 
tagged to GFP. Voltage-clamp whole-cell 
recordings were obtained from infected and 
uninfected CA1 pyramidal neurons, under 
visual guidance using fluorescence and 
transmitted light illumination. The recording 
chamber was perfused with 119 mM NaCl, 
2.5 mM KCl, 4 mM CaCl2, 4 mM MgCl2, 26 
mM NaHCO3, 1 mM NaH2PO4, 11 mM 
glucose, 0.1 mM picrotoxin, 0.1 mM (D,L)-2-
amino-5-phosphono valeric acid (APV), and 
2 µM 2-chloroadenosine (pH 7.4), gassed 
with 5% CO2/95% O2. Patch recording 
pipettes (4–7 MΩ) were filled with the 115 
mM cesium methanesulfonate, 20 mM CsCl, 
10 mM HEPES, 2.5 mM MgCl2, 4 mM 
Na2ATP, 0.4 mM Na3GTP, 10 mM sodium 
phosphocreatine, 0.6 mM EGTA, and 0.1 
mM spermine (pH 7.25). Whole-cell 
recordings were carried out with a 
MultiClamp 700A amplifier (Axon 
Instruments, Union City, CA). Synaptic 
responses were evoked with two bipolar 
electrodes with single voltage pulses 
(duration of 0.3 ms, up to 20 V). The 
stimulating electrodes were placed over 
Schaffer collateral fibers between 200 and 
300 µm from the recorded cells. Synaptic 
AMPA receptor-mediated responses were 
collected at -60 mV and +40 mV with glass 
electrodes placed in CA1 stratum radiatum 
and averaged over 50–60 trials; their ratio 
was used as an index of rectification. All 
electrophysiological data were collected with 
pCLAMP software (Axon Instruments). When 
the effect of K252a (200 nM) was tested, the 
drug was added to the perfusion medium 30 
min prior to incubation with 100 ng/ml BDNF. 
Incubation with BDNF was performed from 
30 min to 2.5 h. When the effect of NMDA 
receptor activity on AMPA delivery to the 
synapse was studied, NMDA receptor 
mediated responses were blocked 
pharmacologically using 0.1 mM DL-APV  
 
Statistical Analysis- Statistical analysis was 
performed using one-way ANOVA analysis 
of variance followed by the Dunnett’s test or 
Bonferroni test, or using the Student´s t test, 
as indicated in the figure captions. 
 
 
RESULTS 
 
Effect of BDNF on the total protein levels of 
AMPA receptors subunits- To determine 
whether acute stimulation with BDNF affects 
the abundance of glutamate receptor 
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Figure 1- BDNF upregulates the protein levels of the GluR1, GluR2 and GluR3 AMPA receptor subunits in
developing cultured hippocampal neurons. 7 DIV (A, C, E, F) or 14 DIV (B, D) cultured neurons were incubated with
or without 100 ng/ml BDNF (15 min, 30 min, 1h, 2 h, 3 h, 5 h, 6 h, 12 h and 24 h) as indicated. Total GluR1 (A),
GluR2 (C), GluR3 (E) and GluR4 (F) protein levels were determined by Western blot for 7 DIV, and GluR1 (B) and
GluR2 (D) protein levels were also determined for 14 DIV. Control (0 h) protein levels of AMPA receptor subunits
were set to 100%. α-tubulin or β-tubulin were used as loading controls. The results are the average ± SEM of 5-9
independent experiments, performed in independent preparations. Statistical analysis was performed by One Way
ANOVA, followed by the Dunnett’s test. *P<0.05, **P<0.01. 
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subunits, 7 DIV cultured hippocampal 
neurons were incubated with or without 100 
ng/ml BDNF, for various periods of time (15 
min - 24 h). The AMPA receptor subunit 
(GluR1, GluR2, GluR3 and GluR4) protein 
levels were determined by Western blotting 
(Fig.1). BDNF rapidly upregulated GluR1-
GluR3 protein levels, in a transient manner, 
with small effects observed already after 15 
min of stimulation with the neurotrophin (Fig. 
1A, C and E). In contrast, BDNF did not 
change GluR4 protein levels (Fig. 1F). The 
increases in GluR1, GluR2 and GluR3 had 
distinct kinetics, and the maximal effects 
were observed after incubation with BDNF 
for 1 h, 2 h and 30 min, respectively. For 
longer periods of BDNF stimulation (12 h - 
24 h), the abundance of GluR1-GluR3 
subunits decreased to values similar to the 
control. Since there was little GluR3 
immunoreactivity with the antibody used, the 
effect of BDNF on this subunit was not 
further examined.  
In contrast with the results obtained 
using 7 DIV hippocampal neurons, BDNF did 
not affect GluR1 and GluR2 protein levels in 
neurons cultured for 14 DIV, for incubation 
periods with the neurotrophin of 2 – 24 h 
(Fig. 1B and D). However, when the 
endogenous extracellular BDNF was 
chelated with the fusion protein TrkB-IgG for 
24 h, the levels of GluR1 significantly 
decreased (Fig. 2A), while no changes were 
observed for the GluR2 subunit (Fig. 2B). 
These results indicate that endogenous 
BDNF regulates the GluR1 protein levels in 
14 DIV cultures of hippocampal neurons. 
Activation of Trk neurotrophin 
receptors was required for upregulation of 
GluR1 and GluR2 AMPA receptor subunits 
by BDNF in 7 DIV cultures, since no effect of 
the neurotrophin was observed when the 
experiments were conducted in the presence 
of K252a (200 nM), an inhibitor of this family 
of receptors (Fig. 3).  
In order to test whether the effect of 
BDNF was due to an increase in protein 
synthesis, we used two translation inhibitors, 
emetine and anisomycin. Hippocampal 
neurons were stimulated with BDNF for 3 h, 
in the presence or in the absence of the 
translation inhibitors. Emetine (2 µM) and 
Figure 2- Chelation of endogenous released BDNF with the fusion protein TrkB-IgG decreases the protein levels of
GluR1, but was without effect on GluR2 protein levels. Fourteen DIV neurons were incubated with or without 1 µg/ml
TrkB-IgG for 24 h. Total GluR1 and GluR2 protein levels were measured by Western blot. Control protein levels of
AMPA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ±
SEM of 5-6 independent experiments, performed in independent preparations. Statistical analysis was performed by
One Way ANOVA, followed by the Dunnett’s test. **P<0.01. 
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anisomycin (2 µM) abrogated the effect of 
BDNF on GluR1 and GluR2 subunits (Fig. 
4). None of the protein synthesis inhibitors 
reduced the GluR1 or GluR2 protein levels 
under control conditions, in agreement with 
the long half-life of AMPA receptor subunits 
(Archibald et al., 1998; O'Brien et al., 1998; 
Huh and Wenthold, 1999). Taken together, 
our findings indicate that the effect of BDNF 
on AMPA receptor subunits is mediated by 
activation of TrkB receptor, and is due to an 
upregulation of protein synthesis instead of a 
reduction in protein degradation. 
 
BDNF upregulates AMPA receptor subunits 
by promoting transcription activity- BDNF 
may stimulate either transcription of genes 
(Messaoudi et al., 2002), or stimulate protein 
synthesis by activating translation cascades 
(Takei et al., 2001). Therefore, in order to 
test for the role of transcription in the 
upregulation of glutamate receptor subunits 
by BDNF we used two different transcription 
inhibitors, α-amanitine (1.5 µM) and 
actinomycin D (1.5 µM). Both transcription 
inhibitors blocked the effect of BDNF on 
GluR1 and GluR2 protein levels, but were 
without effect on the abundance of the 
receptor subunits in the absence of the 
neurotrophin (Fig. 5). In agreement with 
these observations, real-time PCR using the 
SYBR green assay showed that BDNF 
stimulation for 30 min increased significantly 
the mRNA levels for GluR1, and when the 
cells were incubated with the neurotrophin 
for 3 h a significant increase in the mRNA for 
GluR1 and GluR2 was also observed (Fig. 
6). Taken together, the results indicate that 
BDNF regulates GluR1 and GluR2 AMPA 
receptor subunits at the transcription level. In 
contrast with the results obtained for GluR1 
and GluR2, no effect of BDNF was observed 
on the mRNA levels for GluR3 and GluR4. 
 
Effect of BDNF on GluR1 and GluR2 protein 
levels at the plasma membrane- Because a 
significant percentage of glutamate receptors 
expressed in neurons is intracellular (Hall 
and Soderling, 1997), and therefore do not 
participate in the response to the 
Figure 3- Inhibition of Trk activity blocks the BDNF-induced upregulation of GluR1 and GluR2 protein levels.
Neurons (7 DIV) were incubated with or without 100 ng/ml BDNF for 2 h, in the presence or in the absence of
K252a (200 nM). When the inhibitor was present it was pre-incubated 30 min before stimulation with BDNF. Total
GluR1 and GluR2 protein levels were measured by Western blot. Control (unstimulated) protein levels of AMPA
receptor subunits were set to 100%. Actin was used as loading control. The results are the average ± SEM of 7-18
independent experiments, performed in independent preparations. Statistical analysis was performed by One Way
ANOVA, followed by the Bonferroni test.  ***P<0.001. 
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neurotransmitter glutamate, we tested 
whether BDNF can affect the translocation of 
AMPA receptor subunits to the plasma 
membrane. To study the effect of BDNF on 
the cell surface distribution of the AMPA 
receptor subunits GluR1 and GluR2, 7 DIV 
cultured hippocampal neurons were treated 
with or without 100 ng/ml BDNF (30 min, 3 h 
and 24 h). Following treatment, proteins on 
the cell surface were biotinylated, collected 
with streptavidin or neutravidin-coupled 
beads, and subjected to Western blotting 
(Fig. 7). GluR1 protein associated with the 
plasma membrane was markedly increased 
by BDNF treatment during 30 min when 
compared with non-treated cells. However, 
incubation with BDNF for 3 h was without 
effect (Fig. 7A). The increase observed by 
BDNF treatment during 30 min was blocked 
by emetine (Fig. 7B), indicating that the 
Figure 4- Translation inhibitors impair the BDNF-induced upregulation of GluR1 and GluR2 protein levels. Neurons 
(7 DIV) were incubated with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of emetine (2.0
µM) or anisomycin (2.0 µM). When the inhibitors were used the cells were pre-incubated with the compounds for 30 
min before stimulation with BDNF. Total GluR1 and GluR2 protein levels were measured by Western blot. Control
(unstimulated) protein levels of AMPA receptor subunits were set to 100%. Actin was used as loading control. The 
results are the average ± SEM of 6-12 independent experiments, performed in independent preparations. Statistical 
analysis was performed by One Way ANOVA, followed by the Bonferroni test.  **P<0.01, ***P<0.001. 
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BDNF-induced upregulation in the amount of 
plasma membrane-associated GluR1 
requires de novo protein synthesis. In 
contrast, BDNF did not affect significantly the 
GluR2 protein levels at the plasma 
membrane (Fig. 7D). These results indicate 
that BDNF has a differential effect on the 
traffic of AMPA receptor subunits in 
developing cultured hippocampal neurons. 
Also, the distinct time-courses for the 
increase in surface and total GluR1 
expression suggest that the effects of BDNF 
on total GluR1 content and receptor 
trafficking may be mediated by separate 
signalling pathways. In contrast with the 
results obtained in developing neurons, 
BDNF did not affect the surface expression 
of GluR1 in 14 DIV cultured hippocampal 
neurons (Fig. 7C). 
The delivery of GluR1 subunits to 
Figure 5- Transcription inhibitors prevent the BDNF-induced upregulation of the GluR1 and GluR2 protein levels.
Neurons (7 DIV) were incubated with or without 100 ng/ml BDNF for 3 h, in the presence or in the absence of α-
amanitine (1.5 µM) or actinomycin D (1.5 µM). When the inhibitors were used the cells were pre-incubated with the
compounds for 30 min before stimulation with BDNF. Total GluR1 and GluR2 protein levels were measured by
Western blot. Control (unstimulated) protein levels of AMPA receptor subunits were set to 100%. Actin was used
as loading control. The results are the average ± SEM of 5-10 independent experiments, performed in
independent preparations. Statistical analysis was performed by One Way ANOVA, followed by the Bonferroni
test. *P<0.05 
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the synapse is regulated by phosphorylation 
in the C-terminal region. GluR1 is 
phosphorylated on Ser831 during LTP, 
although this phosphorylation is not sufficient 
to induce synaptic delivery of AMPA 
receptors (Roche et al., 1996; Hayashi et al., 
2000; Lee et al., 2000; Gomes et al., 2003). 
Stimulation of cultured hippocampal neurons 
(7 DIV) with 100 ng/ml BDNF increased the 
phosphorylation of GluR1 on Ser831, as 
determined by Western blot using a 
phosphospecific antibody (Fig. 7E). 
However, since the total amount of GluR1 
present in the cells was also increased upon 
stimulation with the neurotrophin, the 
percentage of total protein that was 
phosphorylated was not significantly 
changed (Fig. 7F; see also Fig. 1A). To 
better understand which signalling pathways 
may be involved in GluR1 phosphorylation 
following Trk receptor activation, and since 
Ser831 is a phosphorylation site for protein 
kinase C (PKC) and Ca2+-calmodulin-
dependent protein kinase II (CaMKII) (Roche 
et al., 1996; Gomes et al., 2003), the effect 
of the kinase inhibitors chelerythrine (5 µM) 
and KN-93 (10 µM) was tested. Inhibition of 
PKC and CaMKII with chelerythrine and KN-
93, respectively, inhibited GluR1 
phosphorylation on Ser831, suggesting that 
both pathways contribute to the effect of 
BDNF (Fig. 7E).  
 
Effect of BDNF on synaptic delivery of AMPA 
receptors- We next examined the role of 
BDNF in the trafficking of AMPA receptors 
into the synapse, in CA1 neurons of rat 
hippocampal organotypic slices expressing 
GluR1-GFP. Overexpression of GluR1-GFP, 
with a Sindbis virus expression system, 
leads to the formation of homomeric AMPA 
receptors containing the GluR1 subunit 
(Hayashi et al., 2000). These GluR2-lacking 
receptors are inwardly rectifying (Boulter et 
al., 1990; Hollmann et al., 1991; Verdoorn et 
al., 1991), and therefore their recruitment to 
the synapse increases the inward currents at 
–60 mV, with no effect on the outward 
currents. Hence, synaptic delivery of GluR1-
containing AMPA receptors to the synapse 
can be monitored as an increase in the ratio 
between the currents at –60 mV versus the 
currents at +40 mV (rectification index) 
(Hayashi et al., 2000). As expected, 
overexpression of GluR1 in CA1 
hippocampal neurons did not increase the 
rectification index of synaptic responses (Fig. 
8A and B; compare first and second column 
in Fig. 8B), confirming that GluR1 is not 
spontaneously delivered into synapses 
(Hayashi et al., 2000). In marked contrast, 
the rectification index of homomeric GluR1- 
expressing neurons was significantly 
increased upon incubation with BDNF (100 
ng/ml) for 30 min to 3 h (Fig. 8A and 7B; 
Figure 6- BDNF increases the mRNA levels of the
GluR1 and GluR2 AMPA receptor subunits. The
variation of GluR1 and GluR2 mRNA levels was
assayed by SYBR Green Real-Time PCR of total RNA
samples, converted to cDNA in reactions normalized to
contain equal amounts of mRNA. The cells (7 DIV)
were incubated in the presence or in the absence of
100 ng/ml BDNF, during 30 min (gray columns) or 3 h
(black columns). The results are presented as mean
percentage ± SEM compared to the control
(unstimulated), and normalized to the reference gene
18S, and are the average ± SEM of 3-7 independent
experiments, performed in independent preparations.
Statistical analysis was performed by One Way
ANOVA, followed by the Dunnett’s test. *P<0.05,
***P<0.001. 
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Figure 7- BDNF increases the GluR1 subunit in the plasma membrane, but not the GluR2 subunit, in developing
cultured hippocampal neurons. 7 DIV (A, B, D) or 14 DIV (C) cultured neurons were treated with or without 100 ng/ml
BDNF (30 min, 3 h and 24 h) as indicated. In panel B, 7 DIV neurons were pre-incubated or not with emetine (2.0
µM), for 30 min, before stimulation with BDNF, for 30 min, in the presence or in the absence of the inhibitor.
Following treatment, cell surface proteins were labelled by biotinylation, followed by precipitation with streptavidin
beads. The abundance of each subunit in the plasma membrane was then determined by Western blot. Control
(unstimulated) levels of AMPA subunits protein was set to 100%. The transferrin receptor was used as loading
control. The effect of BDNF on GluR1 phosphorylation on Ser831 (pGuR1 Ser831) is shown in panel E. Seven DIV  
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compare second and forth column in Fig. 
8B). BDNF had no significant effect on the 
rectification index of non-infected cells (Fig. 
8B; compare first and third column). The 
effect of BDNF was similar to that observed 
in cells where GluR1 was coexpressed with 
a constitutively active form of αCaMKII 
(tCaMKII; Fig. 8A and 7B; compare forth and 
seventh columns in Fig. 8B), which is known 
to induce synaptic delivery of GluR1-
containing AMPA receptors (Hayashi et al., 
2000; Poncer et al., 2002). Inhibition of the 
Trk receptors with K252a (200 nM) 
completely prevented synaptic delivery of 
AMPA receptors induced by BDNF (Fig. 8B; 
compare forth and fifth columns). Taken 
together, the results indicate that BDNF 
induces a very efficient delivery of GluR1 
homomeric receptors into synapse and that 
this effect is mediated by binding of BDNF to 
Trk receptors.  
Tetanic stimulation was shown to 
induce a rapid delivery of GFP-GluR1-
containing AMPA receptors into dendritic 
spines and cause receptor clustering in 
dendrites by a mechanism requiring 
activation of NMDA receptors (Shi et al., 
1999). In order to determine whether 
synaptic delivery of GFP-GluR1-containing 
AMPA receptors induced by BDNF requires 
activation of NMDA receptors, experiments 
were performed in the presence of the 
NMDA receptor antagonist APV. Pre-
incubation of the slices with APV (100 µM) 
for 30 min did not affect the increase in the 
rectification index induced by BDNF (Fig. 8B; 
compare forth and sixth column). 
Stimulation of hippocampal slices 
with BDNF (100 ng/ml) for 30 min increased 
GluR1 phosphorylation on Ser831 (Fig. 9A e 
B), in agreement with the results obtained in 
monolayer cultures of hippocampal neurons 
(Fig. 7E). In contrast, no change in GluR1 
phosphorylation was detected on Ser845 
(Fig. 9A). The activation of Trk receptors by 
BDNF was confirmed by Western blot, using 
an antibody that recognizes phosphotyrosine 
490 in TrkA, a residue conserved in the other 
Trk receptors. Stimulation of hippocampal 
slices with BDNF for 30 min significantly 
increased Trk (presumably TrkB) 
phosphorylation. Control experiments 
showed that the total GluR1 and Trk protein 
levels did not change significantly in the 
slices under the experimental conditions 
used (Fig. 9A). The effect of BDNF on GluR1 
phosphorylation was specific, since no 
phosphorylation of GluR2 on the PKC 
phosphorylation site [Ser 880; (Gomes et al., 
2003)] was observed (Fig. 9A). 
 
 
DISCUSSION 
 
It is well known that BDNF plays an 
important role in synaptic plasticity (Poo, 
2001; Lu, 2003; Alder et al., 2005), 
particularly in LTP induced by high-
frequency stimulation (Chen et al., 1999; 
Schuman, 1999; Ernfors and Bramham, 
2003), which late phase requires 
transcription activation and protein synthesis 
(Nguyen and Kandel, 1996). Accordingly, 
LTP is impaired in the hippocampal CA3- 
CA1 region of bdnf null mutant and 
forebrain-specific trkB knockout mice 
Figure 7 (cont)- cultured hippocampal neurons were incubated for 30 min with or without BDNF, in the presence or
absence of chelerythrine (5 µM) or KN-93 (10 µM). The phosphorylation of GluR1 on Ser831 was measured by
Western blot, using a phosphospecific antibody. Control (unstimulated) phosphorylation of GluR1 was set to 100%.
β-tubulin was used as loading control. The total amount of GluR1 was determined after striping the membranes, and
the ratio between pGluR1 Ser831 and the total amount of GluR1 is plotted in panel F.  The results are the average ±
SEM of 3-13 independent experiments, as indicated, performed in independent preparations. Statistical analysis
was performed by One Way ANOVA, followed by the Dunnett’s (A, C and D) or Bonferroni test (B, E). **P<0.01. 
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(Korte et al., 1995; Patterson et al., 1996; 
Minichiello et al., 1999; Xu et al., 2000). In 
the later case, a compromised learning 
ability was also shown (Minichiello et al., 
1999). However, the mechanisms whereby 
BDNF contributes to LTP are not fully 
understood. In this study, we show that Trk 
receptor activation (presumably TrkB) by 
BDNF rapidly upregulates GluR1 and GluR2 
protein levels in cultured hippocampal 
neurons, by increasing transcription activity. 
Although BDNF also upregulated GluR3 
protein levels, no effect on the mRNA for this 
receptor subunit was observed. The 
neurotrophin also induced phosphorylation of 
GluR1 on Ser831, most likely by activating 
PKC and CaMKII, and promoted synaptic 
delivery of GluR1-containing AMPA 
receptors in the CA1 region of the 
hippocampus. 
Short incubation periods with BDNF 
(30 min) upregulated GluR1 and GluR2 
Figure 8- BDNF increases the delivery of the AMPA receptors to the synapse. AMPA receptor-mediated
responses were recorded at -60 mV and +40 mV from CA1 neurons and the rectification index was calculated as
the ratio between the responses at these holding potentials (I-60 mV/I+40 mV). A) AMPA receptor-mediated responses
at -60 mV and +40 mV in neurons infected with Sindbis virus expressing recombinant GluR1 or GluR1 plus the
constitutive active αCaMKII tagged to GFP. GluR1 infected cells were incubated (grey line) or not (black line) with
100 ng/ml BDNF. B) Rectification values were obtained from uninfected neurons, and from neurons infected with
recombinant GluR1 or GluR1 plus the constitutive active αCaMKII (as indicated), tagged to GFP. Where indicated
the cells were stimulated with 100 ng/ml BDNF for 30 min - 3 h. Since no difference was found between the results
obtained for the various preincubation periods tested, the results were pooled together. The effect of 200 nM
K252a and 0.1 mM DL-APV on the BDNF-induced increase on the rectification index was also tested by perfusing
the hippocampal slices with these compounds for 30 min prior to BDNF incubation and during the recordings. The
results are the average ± SEM of the indicated number of experiments. Statistical analysis was performed using
the Students t test. **P<0.01, ***P<0.001. 
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protein levels to about the same extent in 
cultured hippocampal neurons (Fig. 1A and 
C), but selectively increased the amount of 
GluR1 subunits associated with the plasma 
membrane (Fig. 7). These findings indicate 
that the delivery of GluR1 and GluR2 
subunits to the membrane is differentially 
regulated, as shown for synaptic delivery of 
the AMPA receptor subunits in the adult 
hippocampus (Passafaro et al., 2001; Shi et 
al., 2001). Furthermore, we found that the 
BDNF acutely increases GluR1 subunit 
associated with the plasma membrane by 
enhancing the translation activity (Fig. 7B). 
This may be due to the delivery of newly 
synthesized receptors to the plasma 
membrane and/or to an increased stability of 
the plasma membrane-associated receptors 
by interaction with protein(s) synthesized 
following Trk receptor stimulation. The acute 
effects of BDNF on the plasma membrane 
GluR1 protein levels may require continuous 
signalling activity by Trk receptors, since 
after 3 h stimulation with BDNF, when Trk 
receptors are desensitized to some extent 
(Almeida et al., 2005), the receptor subunits 
found in the membrane were similar to the 
control. In contrast with the results obtained 
in 7 DIV cultures, when synaptogenesis is 
particularly active (Fletcher et al., 1991), 
addition of BDNF had no effect on GluR1 
and GluR2 protein levels in hippocampal 
neurons cultured for 14 DIV (Fig. 1B, D). In 
these cultures, chelation of endogenous 
extracellular BDNF with the fusion protein 
chimera TrkB-IgG selectively decreased the 
GluR1 levels, indicating that BDNF has a 
tonic effect on GluR1 protein levels (Fig. 2). 
These results suggest that the lack of effect 
of BDNF on total GluR1 protein levels in 14 
DIV hippocampal cultures (Fig. 1B), and on 
the total amount of surface receptors (Fig. 
7C), may be due the activity of endogenous 
BDNF, which controls to some extent the 
abundance of GluR1, thereby precluding an 
effect of exogenous addition of the 
neurotrophin. This may also explain the 
results showing no effect of BDNF on total 
GluR1 protein levels in the organotypic slices 
(Fig. 9A).  
Electrophysiology studies have also 
shown that BDNF induces synaptic delivery 
of GluR1-containing AMPA receptors in CA1 
neurons of hippocampal organotypic slices 
Figure 9- BDNF induces the phosphorylation of GluR1 on Ser 831. A) Hippocampal slices were stimulated with 100
ng/ml, for 30 min, and Trk, GluR1 and GluR2 phosphorylation was analysed by western blot, using phosphospecific
antibodies. BDNF induces phosphorylation of Trk receptor, and GluR1 phosphorylation at Ser831 but not at Ser845.
GluR2 phosphorylation at Ser 880 is not affected by BDNF (panels A and B). The phosphorylation of GluR1 on
Ser831 and the phosphorylation of Trk were normalized to GluR1 and Trk receptor protein levels, respectively. The
results are the average ± SEM of 3-4 independent experiments. Statistical analysis was performed using the
Students t test. *P<0.05, ***P<0.001. 
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expressing GluR1-GFP, by a mechanism 
independent of NMDA receptor activity (Fig. 
8B). This contrasts with the role of NMDA 
receptors in synaptic delivery of GluR1-
containing AMPA receptors following tetanic 
stimulation (Shi et al., 1999). The synaptic 
delivery of GluR1 induced by BDNF was 
sensitive to the Trk inhibitor K252a, and was 
associated with the phosphorylation of the 
protein in Ser831, the CaMKII and PKC 
phosphorylation site (Gomes et al., 2003). 
Interestingly, GluR1 phosphorylation in 
Ser831 was also observed upon induction of 
LTP in naïve synapses (Lee et al., 2000). In 
contrast, BDNF did not affect GluR1 
phosphorylation in Ser845, which is 
preferentially phosphorylated upon high-
frequency stimulation of previously 
depressed synapses (Lee et al., 2000). 
Since GluR1 phosphorylation in Ser831 is 
not sufficient to induce synaptic delivery of 
AMPA receptors (Hayashi et al., 2000), the 
effect of BDNF may also involve GluR1 
phosphorylation on Ser818. Phosphorylation 
of this site is significantly increased during 
hippocampal LTP, playing an important role 
in synaptic incorporation of GluR1 (Boehm et 
al., 2006). Alternatively, BDNF may induce 
the phosphorylation of a regulatory protein, 
leading to the release of a retention 
interaction and allowing the incorporation of 
GluR1 subunits into the synapse. 
Phosphorylation of GluR1 on Ser831 may 
also allow the interaction with a protein that 
anchors the receptor at the plasma 
membrane. 
The effect of BDNF on synaptic 
delivery of GluR1 was similar to that 
observed in cells where a constitutively 
active form of αCaMKII was coexpressed, 
suggesting that analogous signalling 
mechanisms may be involved. In fact, 
treatment of cultured hippocampal neurons 
also increased the phosphorylation of GluR1 
on Ser831 and this effect was abolished by 
inhibition of PKC and CaMKII, suggesting 
that both pathways are involved in the 
BDNF-induced GluR1 phosphorylation and 
possibly on the delivery of AMPA receptors 
to the synapse. In agreement with the role of 
PKC and CaMKII in BDNF-induced GluR1 
phosphorylation, activation TrkB receptors 
stimulates the PLCγ pathway, giving rise to 
diacylglycerol, which activates PKC, and 
inositol-1,4,5-trisphosphate, which mobilizes 
Ca2+ from intracellular stores (Kaplan and 
Miller, 2000; Huang and Reichardt, 2003). 
Interestingly, this signalling pathway is 
involved in the synaptic changes resulting 
from local application of BDNF to the 
Xenopus laevis optic tectum, which cause 
rapid modifications of synaptic inputs at the 
dendrites of retinal ganglion cells by 
upregulating AMPA receptors at the retinal 
ganglion cells (Du and Poo, 2004). 
Furthermore, recruitment of PLCγ by active 
TrkB receptors was shown to play a role in 
hippocampal LTP (Minichiello et al., 2002).  
Although activation of NMDA 
receptors induces a rapid delivery of GluR1 
containing AMPA receptors to the synapse, 
and their clustering in dendrites (Shi et al., 
1999), this does not account for the effect of 
BDNF since we found no effect of the NMDA 
receptor antagonist APV on BDNF-induced 
delivery of GluR1 subunits to the synapse. 
Interestingly, inhibition of NMDA receptors 
was also shown not to affect BDNF-induced 
LTP at medial perforant path→granule cell 
synapses in the rat dentate gyrus, in contrast 
with the high frequency stimulation-induced 
LTP, which depended on the activation of 
NMDA receptors (Messaoudi et al., 2002). 
In addition to the rapid effects on 
delivery of GluR1 subunits to the synapse in 
hippocampal CA1 neurons, and to the 
plasma membrane in developing cultured 
hippocampal neurons, BDNF also rapidly 
upregulated GluR1, GluR2 and GluR3 
protein levels in the latter preparation. This 
effect was transient, most likely due to the 
desensitisation of the Trk receptors, followed 
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by a decrease in intracellular signalling 
activity (Sommerfeld et al., 2000; Almeida et 
al., 2005). The upregulation in AMPA 
receptor subunits induced by BDNF was due 
to an increase in transcription activity, as 
demonstrated by the effect of transcription 
inhibitors, followed by synthesis of the 
receptor subunits. The role of transcription 
activity on the effect of BDNF on the protein 
levels of the GluR1 and GluR2 subunits is 
not surprising, since BDNF is known to 
regulate transcription of several genes 
(Ernfors and Bramham, 2003; Groth and 
Mermelstein, 2003) and to modulate 
transcription during the late phase LTP 
(Messaoudi et al., 2002). In agreement with 
the present findings, chronic treatment of 
cultured cerebrocortical neurons with BDNF 
also increased GluR1 and GluR2/3 protein 
levels, but no effect on the mRNA for the 
receptor subunits was found under these 
conditions (Narisawa-Saito et al., 1999a; 
Nagano et al., 2003). However, in this case, 
the sustained stimulation of neurotrophin 
receptors from early in development may 
have caused changes in cell phenotype.  
The signalling mechanisms involved 
in the rapid increase in the transcription of 
GluR1 and GluR2 in hippocampal neurons 
exposed to BDNF remain to be identified. 
Previous studies have shown GluR1 protein 
levels may be regulated by the serum- and 
glucocorticoid-inducible kinase 3 (SGK3), 
one of the downstream targets of 
phosphatidylinositol-3-kinase (Strutz-
Seebohm et al., 2005), and by the tyrosine 
kinase Fyn, which also regulates GluR2/3 
(Narisawa-Saito et al., 1999b). Studies in a 
heterologous system showed that the 
expression of GluR2 can be regulated by 
BDNF, through a mechanism involving a 
neuron-restrictive silencer element (NRSE) 
present within the GluR2 promoter (Brene et 
al., 2000). These results are in agreement 
with our results, and contrast with the effects 
observed in cerebrocortical neurons 
chronically exposed to BDNF, where no 
change in the mRNA for GluR2 was 
observed (Narisawa-Saito et al., 1999a). 
In addition to the effect of BDNF on 
the mRNA levels for GluR1 and GluR2, 
which accounted for the upregulation in the 
AMPA receptor subunits in cultured 
hippocampal neurons, a recent study 
showed that BDNF also increased GluR1 
protein levels in synaptoneurosomes 
(Schratt et al., 2004). This effect, mediated 
by a mammalian target of rapamycin 
(mTOR) – phosphatidylinositol 3-kinase-
dependent pathway, may contribute to 
increase locally the amount GluR1 after 
high-frequency stimulation. Delivery of these 
receptors to the synapse may contribute to 
LTP. Chronic stimulation of neocortical 
neuronal cultures with BDNF also increased 
the abundance of the AMPA receptor 
interacting proteins SAP97, GRIP1, and 
PICK1 (Jourdi et al., 2003). Under the same 
conditions there was an increase in the 
interaction between GluR1 and SAP97, as 
well as between GluR2 and GRIP1, which 
was suggested to play a role in the 
upregulation of AMPA receptors by BDNF 
(Jourdi et al., 2003). It remains to be 
determined whether BDNF induces a local 
synthesis and increase in the protein levels 
of these AMPA receptor interacting proteins, 
which may contribute to stabilize the 
receptors at the synapse. 
In conclusion, our results strongly 
suggest that BDNF plays a direct role in the 
early phase of synaptic plasticity by 
triggering the delivery of GluR1 subunits to 
the synapse. Furthermore, BDNF rapidly 
upregulated AMPA receptor subunits in 
developing hippocampal neurons, and 
induced an overall increase in the number of 
receptors associated with the membrane, at 
a period of active synaptogenesis. 
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The neurotrophin BDNF regulates 
the maturation of the postsynaptic density of 
hippocampal synapses and is a key 
modulator of activity-dependent 
modifications of synaptic strength in the 
CNS. Physiological and biochemical 
evidence implicates the NMDA glutamate 
receptor as one of the targets for BDNF 
modulation. In the present study, we 
investigated the effect of BDNF on the 
expression and plasma membrane 
abundance of NMDA receptor subunits. 
Acute stimulation of hippocampal neurons 
with BDNF differentially upregulated the 
protein levels of the NR1, NR2A and NR2B 
NMDA receptor subunits, by a mechanism 
sensitive to transcription and translation 
inhibitors. Accordingly, BDNF also increased 
the mRNA levels for NR1, NR2A and NR2B 
subunits. The neurotrophin NT3 also 
upregulated the protein levels of NR2A and 
NR2B subunits, but was without effect on 
NR1 subunit. The amount of NR1, NR2A and 
NR2B proteins associated with the plasma 
membrane of hippocampal neurons was 
differently increased by BDNF stimulation for 
30 min or 24 h. The rapid upregulation of 
plasma membrane-associated NMDA 
receptor subunits was correlated with an 
increase in NMDA receptor activity. The 
results indicate that BDNF increases the 
abundance of NMDA receptors and their 
delivery to the plasma membrane, thereby 
upregulating receptor activity in cultured 
hippocampal neurons.  
 
 
INTRODUCTION 
 
The neurotrophin brain-derived 
neurotrophic factor (BDNF) promotes 
neuronal survival and differentiation, and 
regulates synaptic transmission and 
plasticity [reviewed in (Bramham and 
Messaoudi, 2005; Kalb, 2005; Lu et al., 
2005)]. BDNF rapidly potentiates excitatory 
synaptic transmission in cultured 
cerebrocortical and hippocampal neurons, in 
part by enhancing presynaptic 
neurotransmitter release (Lessmann and 
Heumann, 1998; Takei et al., 1998). Post-
synaptically, BDNF enhances glutamatergic 
synaptic transmission by regulating the 
phosphorylation of NMDA (N-methyl-D-
aspartate) receptors (Suen et al., 1997; Lin 
et al., 1998; Alder et al., 2005), thereby 
enhancing NMDA receptor activity (Levine et 
al., 1998; Song et al., 1998), increasing 
synaptic clustering of NMDA receptors in 
cultured hippocampal neurons (Elmariah et 
al., 2004), and upregulating AMPA receptor 
protein levels (Narisawa-Saito et al., 1999a). 
Accordingly, BDNF has been implicated in 
activity-dependent synaptic plasticity, 
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including the early- and late phases of long-
term potentiation (LTP) induced by high-
frequency stimulation [reviewed in 
(Bramham and Messaoudi, 2005)]. Activity-
dependent changes in synaptic strength are 
thought to underlie learning and memory 
formation (Lynch, 2004).  
NMDA receptors are glutamate, 
glycine and voltage-dependent ion channels 
characterized by their high calcium 
permeability. In the hippocampus, NMDA 
receptors are heteromeric complexes 
composed of at least one NR1 subunit and 
one or more of the two subunits, NR2A and 
NR2B (Sheng et al., 1994). Both NR1 and 
NR2 subunits are required to form a 
functional ionotropic receptor (Meguro et al., 
1992; Monyer et al., 1994; Dingledine et al., 
1999), but different NR2 subunits confer 
distinct kinetic properties to the NMDA 
receptors (Monyer et al., 1994). Some 
NMDA receptors may also include an NR3 
subunit (either NR3A or NR3B) as part of the 
tetrameric structure (Chatterton et al., 2002). 
Before synapse formation in developing 
hippocampal neurons, NMDA receptors 
consist predominantly of NR1 and NR2B 
subunits (Tovar and Westbrook, 1999). 
NR2B seems to remain in NMDA receptors 
that are primarily extrasynaptic after synapse 
formation. In contrast, NR2A subunit 
progressively increases its expression 
(Monyer et al., 1994; Sheng et al., 1994; 
Margottil and Domenici, 2003) and is 
incorporated at synaptic sites (Stocca and 
Vicini, 1998; Tovar and Westbrook, 1999). 
The mechanisms controlling the switch in the 
composition of synaptic NMDA receptors 
from NR2B- to NR2A-containing receptors 
are not well understood, but studies in 
cortical neurons showed that the expression 
of NMDA receptor subunits is regulated by 
neuronal activity (Muzet and Dupont, 1996). 
BDNF enhances the phosphorylation of NR1 
and NR2B subunits in hippocampal and 
cortical neurons (Lin et al., 1998), and 
increases the open probability of NMDA 
receptor channels (Levine et al., 1998; 
Levine and Kolb, 2000). Phosphorylation of 
NR2B by Fyn was suggested to contribute to 
the increase of glutamatergic synaptic 
transmission by BDNF (Alder et al., 2005), 
and tyrosine phosphorylation of the NR2B 
subunit was also associated with LTP in the 
hippocampal CA1 region (Nakazawa et al., 
2001). In addition to these rapid effects of 
BDNF on NMDA receptors, recent studies 
showed that BDNF increases the translation 
of the mRNA for NR1 in cultured 
cerebrocortical neurons (Schratt et al., 
2004), suggesting that the neurotrophin may 
also regulate the abundance of NMDA 
receptors in the hippocampus. Although 
NMDA receptors were initially thought to be 
relatively stable in the membrane, recent 
studies have indicated that their surface 
expression is dynamic and regulated (Nong 
et al., 2004). Thus, the BDNF-induced 
upregulation of glutamatergic activity may 
also be due to the delivery of NMDA 
receptors to the plasma membrane.  In the 
present study we investigated the short- and 
long-term effects of BDNF on the cellular 
and plasma membrane abundance of NMDA 
receptor subunits in cultured hippocampal 
neurons, and correlated the results with the 
activity of the receptors. 
 
 
EXPERIMENTAL METHODS 
 
Hippocampal cultures- Primary cultures of 
rat hippocampal neurons were prepared 
from the hippocampi of E18-E19 Wistar rat 
embryos, after treatment with trypsin (0.06%, 
15min, 37ºC; GIBCO Invitrogen, Paisley, 
UK) and deoxyribonuclease I (5.36 mg/ml), 
in Ca2+- and Mg2+-free Hank’s balanced salt 
solution (HBSS; 5.36 mM KCl, 0.44 mM 
KH2PO4, 137 mM NaCl, 4.16 mM NaHCO3, 
0.34 mM Na2HPO4.2H2O, 5 mM glucose, 1 
mM sodium pyruvate, 10 mM HEPES and 
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0.001% phenol red). The hippocampi were 
then washed with HBSS containing 10% 
fetal bovine serum (BioWittaker Europe, 
Belgium), to stop trypsin activity, and 
transferred to Neurobasal medium (GIBCO 
Invitrogen) supplemented with B27 
supplement (1:50 dilution; GIBCO 
Invitrogen), 25 µM glutamate, 0.5 mM 
glutamine and 0.12 mg/ml gentamycin. The 
cells were dissociated in this solution and 
were then plated in 6 well plates (91.6x103 
cells/cm2), coated with poly-D-lysine (0.1 
mg/mL), or on poly-D-lysine coated glass 
coverslips, at a density of 37.5x103 cells/cm2. 
The cultures were maintained in a humidified 
incubator of 5% CO2/95% air, at 37 °C, for 
seven days or fourteen days. Cultures were 
stimulated with 100 ng/ml BDNF (kind gift 
from Regeneron, Tarrytown, NY), 100 ng/ml 
heat inactivated (5 min, 95ºC) BDNF or with 
100 ng/ml NT3 (Peprotech, London U.K.) for 
the indicated periods of time. When 
appropriate, 2.0 µM emetine, 2.0 µM 
anisomycin, 1.5 µM α-amanitine or 1.5 µM 
actinomycin D (Calbiochem, La Jolla, CA) 
were added 30 min before stimulation, as 
indicated. Scavenging of endogenous 
extracellular BDNF was performed with 
TrkB-IgG (1 µg/ml; Sigma) for 24 h or 48 h. 
 
Cerebellum cultures- Cerebellar granule 
neurons were isolated from the cerebella of 
7 days-old Sprague Dawley rats as 
previously described (Schousboe, 1999), 
with minor modifications. Briefly, following 
digestion (15 min, 37 ºC) with 0.2% trypsin 
and 0.045 mg/ml deoxyribonuclease (Sigma) 
in Mg2+-free Na+-salt solution (120 mM NaCl, 
5 mM KCl, 1.2 KH2PO4, 13 mM glucose,15 
mM HEPES, 0.3% BSA, pH 7.4), and 
dissociation in 0.03% STI (soybean trypsin 
inhibitor; Sigma) and 0.04 mg/ml 
deoxyribonuclease prepared in Na+-salt 
solution (120 mM NaCl, 5 mM KCl, 1.2 
KH2PO4, 1.2 mM MgSO4, 13 mM glucose,15 
mM HEPES, 0.3% BSA, pH 7.4), the 
dissociated cells were centrifuged at 196 g, 
and washed with basal medium Eagle (BME, 
Sigma), supplemented with 25 mM KCl, 30 
mM glucose, 26 mM NaHCO3, 1% 
penicillin/streptomycin and 10% fetal calf 
serum (BioWittaker Europe). Neurons were 
then plated on 6 well plates (34.4x104 
cells/cm2), coated with poly-D-lysine (0.1 
mg/mL), and cultured in supplemented BME. 
Approximately 24 h after plating, 10 µM 
cytosine-1-β-D-arabino-furanoside (Sigma) 
was added to the culture medium to prevent 
the glial proliferation. The cultures were 
maintained in a humidified incubator of 5% 
CO2/95% air, at 37 °C, for eight days. 
Cultures were stimulated with 100 ng/ml 
BDNF (kind gift from Regeneron) for the 
indicated periods of time. 
 
Preparation of extracts- Hippocampal and 
cerebellar granule neurons were washed 
twice with ice-cold PBS and once more with 
PBS buffer supplemented with 1 mM DTT 
and a cocktail of protease inhibitors (0.1 mM 
PMSF, CLAP: 1 µg/ml chymostatin, 1 µg/ml 
leupeptin, 1 µg/ml antipain, 1 µg/ml 
pepstatin; Sigma-Aldrich Química, Sintra, 
Portugal). The cells were then lysed with 
RIPA (150 mM NaCl, 50 mM Tris-HCl, pH 
7.4, 5 mM EGTA, 1% Triton, 0.5% DOC and 
0.1% SDS at a final pH 7.5) supplemented 
with the cocktail of protease inhibitors. After 
centrifugation at 16,100 g for 10 min, protein 
in the supernatants was quantified using the 
BCA method, and the samples were 
denaturated with 2x concentrated 
denaturating buffer (125 mM Tris, pH 6.8, 
100 mM glycine, 4% SDS, 200 mM DTT, 
40% glycerol, 3 mM sodium orthovanadate, 
and 0.01% bromophenol blue), at 95 ºC for 5 
min. NMDA receptor subunits were then 
analysed by Western blot. 
 
Total RNA isolation and reverse transcription 
for Real-Time PCR- Total RNA from 7 DIV 
cultured hippocampal neurons was extracted 
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with TRizol reagent (Invitrogen, Barcelona, 
Spain), according to the instructions of the 
manufacturer. The full content of a 6 well cell 
cluster plate, with 870,000 cells/well (DIV 7), 
was collected for each experimental 
condition. For first strand cDNA synthesis, 3 
µg of total RNA were reverse-transcribed 
with AMV Reverse Transcriptase (Roche, 
Carnaxide, Portugal), using Random Primer 
p(dN)6 (3.2 µg), dNTPs (1 mM each), MgCl2 
(25 mM), RNase inhibitor (50 units) and 
Gelatine (0.01 µg/µl), in Reaction Buffer (10 
mM Tris, 50 mM KCl, pH 8.3) and in a total 
volume of 40 µl. The reaction was performed 
at 25 ºC for 10 min, followed by 60 min at 42 
ºC, for primer annealing to the RNA template 
and cDNA synthesis, respectively. The 
Reverse Transcriptase was then denatured 
during 5 min at 99 ºC, and the sample was 
cooled to 4 ºC for 5 min and finally stored at 
-80 ºC until further use. 
 
Real-Time PCR- Real-Time PCR analysis of 
gene expression was performed using the 
LightCycler System II (Roche, Portugal). The 
PCR reactions were performed using 
LightCycler FastStart DNA Master SYBR 
Green I (Roche et al.) in 20 µl capillaries. 
The primers used for amplification of genes 
encoding NMDA receptor subunits were, 
respectively, RNFRIF2079 - 5´TAC ACT 
GCC AAC TTG GCA GCT TTC3’ and 
RNRIR2591 - 5´CAT GAA GAC CCC TGC 
CAT GTT3´ for NR1, RNRZAF1961 -5´TGG 
CTG CCT TCA TGA TCC A3´ and 
RNRZAR2312 - 5´TGC AGC GCA ATT CCA 
TAG C3´ for NR2A, and RNRZBF1040 - 
5´GGA TCT ACC AGT CTA ACA TG3´and 
RIRNRZBR1602 - 5´GAT AGT TAG TGA 
TCC CAC TG3´ for NR2B. The primers used 
for the amplification of endogenous control 
gene 18S rRNA were those included in the 
Applied Biosystems TaqMan Ribosomal 
RNA Control Reagents Kit (Porto, Portugal).  
Each primer of a pair was added to the 
reaction mixture (10 µl) at a final 
concentration of 0.8 µM with 3 mM MgCl2, in 
addition to the “Hot Start” LightCycler Fast 
Start DNA Master SYBR Green I mix (1x) 
and 1.2 µl of cDNA sample. Thermal cycling 
was initiated with activation of the FastStart 
Taq DNA Polymerase by denaturation during 
10 min at 95 ºC, followed by 45 cycles of a 
30 s melting step at 95 ºC, a 5 s annealing 
step at 58 ºC, and a 25 s elongation step at 
72 ºC (all temperature transition rates at 20 
ºC/s). After amplification for 45 cycles, at 
least 10 cycles beyond the beginning of the 
linear phase of amplification, samples were 
subjected to a melting curve analysis 
according to the instructions of the 
manufacturer in order to confirm the absence 
of unspecific amplification products and 
primer-dimers. In all experiments, samples 
containing no template were included as 
negative controls. 
 
mRNA quantitative analysis- The mRNA 
levels of the constitutively expressed 
housekeeping gene encoding 18S ribosomal 
RNA were used as a control, in all 
experiments. The relative changes in the 
mRNA levels of glutamate receptor subunits 
in cultured hippocampal neurons were 
determined using the ∆∆Cp method. 
Accordingly, for each experimental condition 
(unstimulated neurons and neurons treated 
with 100 ng/ml BDNF for 30 min or 3 h) the 
“Crossing point” (Cp) values given by the 
LightCycler system II software, for each 
target gene, were subtracted by the 
respective Cp value determined for the 18S 
gene for the same sample and condition 
(∆Cp). This allows normalizing changes in 
target gene expression. Afterwards, the ∆Cp 
values were subtracted by the respective 
values of the control for the target gene 
giving ∆∆Cp. The derivation to the formula 2-
(∆∆Cp) sets each control at the unity (or 
100%), since ∆∆Cp (control) =0, and the 
stimuli conditions as a percentage relative to 
the control. 
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Surface biotinylation and precipitation- 
Hippocampal cell cultures (7 DIV) were 
treated or not with 100 ng/ml BDNF and then 
incubated with 1 mg/ml EZ-LinkTM Sulfo-
NHS-SS-biotin (Pierce, Madison, WI) in ice-
cold PBS containing 1 mM CaCl2 and 1 mM 
MgCl2, for 30 min (Gomes et al., 2004). The 
non-bound biotin was removed by washing 
the cells with PBS containing 100 mM 
glycine. Cell lysates were obtained as 
described above, and were incubated with 
UltraLink Plus™ immobilized streptavidin 
beads (Pierce), for 2 h at 4 °C, under 
constant agitation. Non-biotinylated proteins 
were removed by centrifugation at 2500×g 
for 3 min, and the beads were washed three 
times with RIPA buffer. Biotinylated proteins 
were then eluted with denaturating buffer at 
95 °C for 5 min. Samples were then 
processed for Western blotting analysis. 
 
Western blotting- Protein samples were 
separated by SDS-PAGE, in 6% 
polyacrylamide gels, transferred to 
polyvinylidene (PVDF) membranes (BioRad, 
Amadora, Portugal), and immunoblotted. 
Blots were incubated with primary antibodies 
(overnight at 4 ºC), washed and exposed to 
alkaline phosphatase-conjugated secondary 
antibodies (1:20000 dilution; 1 h at room 
temperature). Alkaline phosphatase activity 
was visualized by ECF on the Storm 860 Gel 
and Blot Imaging System (Amersham 
Biosciences, Buckinghamshire, UK). The 
following primary antibodies were used: anti-
NR1 (1:200, Chemicon International, 
Temecula, CA), anti-NR2A (1:750, 
Chemicon International, Temecula, CA or 
1:300, BD Transduction Laboratories, 
Erembodegem, Belgium) and anti- NR2B 
(1:400, BD Transduction Laboratories). Anti-
β-Tubulin I (1:700000; Sigma) and anti-
transferrin receptor (1:3000; Zymed, South 
San Francisco, CA) antibodies were used as 
loading controls. 
 
Single cell [Ca2+]i measurements- Changes 
in the [Ca2+]i were assessed by monitoring 
the Fura-2 (Invitrogen-Molecular Probes, 
Leiden, The Netherlands) fluorescence ratio 
(F340/F380). Seven DIV hippocampal 
neurons were loaded in a Mg2+-free Na+-salt 
solution (132 mM NaCl, 4 mM KCl, 2.5 mM 
CaCl2, 6 mM Glucose, 10 mM Hepes, 10 mM 
NaHCO3, pH 7.4) containing 5 µg/ml Fura-
2/AM, 0.2% pluronic acid F-127 (Invitrogen-
Molecular Probes) and 0.1% fatty acid-free 
bovine serum albumin, in the presence or 
absence of 100 ng/ml BDNF, for 40 min at 
37 ºC. After incubation, the glass coverslips 
were mounted on a RC-20 chamber in a 
PH3 platform (Warner Instruments, Hamden, 
CT), at room temperature, on the stage of an 
inverted fluorescence microscope Axiovert 
200 (Zeiss). Neurons were continuously 
perfused with a Mg2+-free Na+-salt solution, 
for 5 min, and were then stimulated with 100 
µM NMDA and 10 µM glycine, or with 30 mM 
KCl (Na+ was isoosmotically replaced by 
KCl), for 30 s. After stimulation neurons were 
again perfused with a Mg2+-free Na+-salt 
solution, for 10 min. Solutions were added to 
the cells by a fast-pressurized (95% air, 5% 
CO2 atmosphere) system (AutoMate 
Scientific, Inc, San Francisco, CA). The cells 
were alternately excited at 340 and 380 nm 
using a Lambda DG4 apparatus (Sutter 
Instruments Company, Novato, CA). 
Changes in the fluorescence ratio of Fura-2 
were acquired with a 40x objective and a 
CollSNAP HQ digital camera (Roper 
Scientific, Tucson, AZ), and processed using 
the MetaFluor software (Universal Imaging 
Corporation, Downingtown, PA). The results 
are presented as the ratio of fluorescence 
intensities after excitation at 340 nm and at 
380 nm. 
 
Statistical Analysis- Statistical analysis was 
performed using one-way ANOVA analysis 
of variance followed by the Dunnett’s test, or 
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Bonferroni test, or using the Student´s t test, 
as indicated in the figure captions. 
 
 
RESULTS 
 
Effect of BDNF on the total protein levels of 
NMDA receptor subunits- To evaluate the 
acute effects of BDNF on the abundance of 
NMDA receptor subunits, 7 DIV cultured 
hippocampal neurons were incubated with or 
without 100 ng/ml BDNF, for various periods 
of time (15 min - 24 h). The NMDA receptor 
subunit NR1, NR2A and NR2B protein levels 
were determined by Western Blotting (Fig. 
1A, C and E). BDNF upregulated NR1 
subunits rapidly and in a sustained manner.  
Significant effects were observed after 30 
min to 12 h incubation with BDNF. The 
neurotrophin also did upregulate NR2A and 
NR2B subunits, but with a distinct kinetics. 
NR2A protein levels were significantly 
increased for longer periods of incubation 
with BDNF (3 h to 12 h), while NR2B protein 
levels were enhanced by brief BDNF 
stimulation periods (1 h to 3 h). After 24 h of 
stimulation with BDNF the NR1 and NR2A 
protein levels were still slightly higher than 
the control, whereas a small reduction of 
NR2B was observed. NR2C and NR2D 
subunits were undetectable (data not 
shown), consistent with the lack of these 
NMDA receptor subunits in the hippocampus 
[e.g. (Janssens and Lesage, 2001)]. BDNF 
also upregulated the amount of NR1, NR2A 
and NR2B subunits in more mature 
hippocampal neurons, cultured for 14 DIV 
[(Fletcher et al., 1991); Fig. 1B, D and F]. In 
these cells, BDNF induced a sustained 
increase in NR1 protein levels, particularly 
for incubation periods of 5 h, 6 h and 24 h. 
The NR2A subunit was also upregulated by 
BDNF for long periods of incubation with 
BDNF (6 h, 12 h and 24 h). In contrast, the 
NR2B subunit was upregulated only by short 
incubations with BDNF, as observed for 7 
DIV cultures (Fig. 1F). Activation of Trk 
neurotrophin receptors was required for 
upregulation of NR1, NR2A and NR2B 
receptor subunits by BDNF, since no effect 
was observed when neurons were incubated 
with heat-inactivated BDNF (Fig. 2A, B and 
C). In contrast with the results obtained with 
the hippocampal neurons, incubation of 
cultured cerebellar granule cells with 100 
ng/ml BDNF, for 2 h or 6 h, did not increase 
the protein levels of NR1, NR2A and NR2B 
subunits (Fig. 2D, E and F). These results 
indicate that the BDNF-induced upregulation 
of the NMDA receptor subunits is specific for 
hippocampal neurons.  
 Cultured hippocampal neurons 
produce BDNF and release the neurotrophin 
in an activity-dependent manner (Hartmann 
et al., 2001; Balkowiec and Katz, 2002). In 
order to determine whether endogenous 
BDNF modulate the levels of NMDA receptor 
subunits in cultured hippocampal neurons 
we used the TrkB-IgG fusion protein that 
chelated the endogenous extracellular 
BDNF. Incubation of hippocampal neurons 
with TrkB-IgG for 24 h or 48 h did not affect 
significantly the levels of NR1, NR2A and 
NR2B subunits (Fig. 3). 
Incubation of hippocampal neurons 
with a different neurotrophin, neurotrophin-3 
(NT3), which binds preferentially to the TrkC 
receptors (Dechant, 2001), also increased 
the protein levels of NR2A and NR2B 
subunits (Fig. 4B and C), but was without 
effect on NR1 subunit (Fig. 4A), indicating 
that this neurotrophin also modulates the 
levels of the NMDA receptor subunits.  
Since BDNF is known to upregulate 
translation [e.g. (Takei et al., 2001)], we 
studied whether de novo protein synthesis 
could account for the BDNF-induced 
increase in NR1, NR2A and NR2B NMDA 
receptor subunits. We used two translation 
inhibitors, emetine and anisomycin, and the 
hippocampal neurons were stimulated with 
BDNF for 3 h in the presence or in the  
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BDNF for 3 h, in the presence or in the  
Figure 1- BDNF upregulates the protein levels of the NR1, NR2A and NR2B NMDA receptor subunits cultured
hippocampal neurons. Seven DIV or 14 DIV cultured hippocampal neurons were incubated with or without 100
ng/ml BDNF (15 min, 30 min, 1h, 2 h, 3 h, 4 h, 5 h, 6 h, 12 h and 24 h), as indicated. Total NR1, NR2A and NR2B
protein levels were determined by Western blot. Control (0 h) protein levels of NMDA receptor subunits were set
to 100%. β-tubulin was used as loading control. The results are the average ± SEM of 5-9 independent
experiments, performed in independent preparations. Statistical analysis was performed by One Way ANOVA,
followed by the Dunnett’s test. *P<0.05, **P<0.01. 
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absence of the protein synthesis inhibitors. 
Pre-incubation of cells with emetine (2 µM) 
or anisomycin (2 µM) abolished the effect of 
BDNF on NR1, NR2A and NR2B subunits 
(Fig. 5). None of the protein synthesis 
inhibitors altered the NR1, NR2A and NR2B 
protein levels under control conditions. 
These results are in agreement with the long 
half-life determined for the NR2A/B subunits 
in cultured cerebellar granule cells, and with 
the turn-over rate of NR1 in the same 
preparation (Huh and Wenthold, 1999). 
Taken together, the results indicate that 
BDNF affects NMDA receptor subunits by 
increasing protein synthesis and suggest 
that a reduction in protein degradation is not 
involved. 
 
Effect of BDNF in the transcription activity of 
NMDA receptor subunits- The effects of 
BDNF on protein synthesis may be due to an 
increase in transcription activity (Messaoudi 
et al., 2002) and/or to direct regulation of the 
protein synthesis machinery (Takei et al., 
2001). Therefore, the role of transcription in 
the BDNF-induced upregulation of NR1,  
Figure 2- Heat-inactivated BDNF does not upregulate of NR1, NR2A and NR2B protein levels (A, B, C).
Hippocampal neurons were incubated with or without 100 ng/ml heat-inactivated BDNF (95 ºC, 5 min), for 3 h. NR1, 
NR2A and NR2B protein levels were measured by Western blot. BDNF does not affect the protein levels of NR1,
NR2A and NR2B subunits in cultured cerebellar granule neurons (D, E, F). The cells were incubated with or without
100 ng/ml BDNF (2 h and 6 h), and the NR1, NR2A and NR2B protein levels were measured by Western blot.
Control (unstimulated) protein levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading 
control. The results are the average ± SEM of 4-9 independent experiments, performed in independent 
preparations. Statistical analysis was performed by One Way ANOVA, followed by the Dunnett´s test. 
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NR2A and NR2B protein levels was 
investigated using two transcription 
inhibitors, α-amanitine and actinomycin D. 
As for the translation inhibitors, pre-
incubation of the cultures with α-amanitine 
(1.5 µM) or actinomycin D (1.5 µM) 
abolished the BDNF-induced upregulation of 
the NR1, NR2A and NR2B protein levels, but 
was without effect on the abundance of the 
NMDA receptor subunits in the absence of 
BDNF (Fig. 6). To further confirm that the 
effects of BDNF occur at the transcription 
level, real-time PCR using the SYBR green 
assay was performed (Fig. 7). Stimulation 
with BDNF for 30 min or 3 h significantly 
increased the mRNA levels of NR1 and 
NR2A, although the effect was less 
significant in the latter incubation period. A 
delayed increase in the mRNA levels for 
NR2B was also observed after 3 h of 
stimulation with BDNF (Fig. 7). These results 
point to a regulation of NR1, NR2A and 
NR2B NMDA receptor subunits by BDNF at 
the transcription level. Moreover, they clearly 
correlate the several fold increase in NR1 
and NR2A mRNA with the sustained raise in 
the respective protein levels. On the other 
hand, the transient increase in NR2B protein 
levels induced by BDNF is also correlated 
with a relatively weaker effect on the mRNA 
levels of this specific subunit. 
 
Effect of BDNF on NMDA receptor subunit 
protein levels at the plasma membrane- In 
cerebellar granule neurons there is a large 
intracellular pool of NR1 subunits, whereas 
most NR2A and NR2B subunit proteins are 
present on the cell surface (Huh and 
Wenthold, 1999). Thus, in these cells the 
NR2 subunit availability determines the 
number of cell surface receptors 
(Prybylowski et al., 2002). This may also 
apply to hippocampal neurons, where the 
majority of NR2B is associated with the 
plasma membrane, whereas a significant 
fraction of NR1 is intracellular (Hall and 
Soderling, 1997). Therefore, we investigated 
whether the upregulation of NMDA receptor 
subunits by BDNF affects the NR1 and NR2 
protein levels in the plasma membrane of 
cultured hippocampal neurons. The cell 
surface distribution of the NMDA receptor 
subunits NR1, NR2A and NR2B was 
determined by biotinylation of cell surface  
Figure 3- Chelation of endogenous released BDNF with the fusion protein TrkB-IgG does not affect the protein
levels of NR1, NR2A and NR2B. Fourteen DIV neurons were incubated with or without 1 µg/ml TrkB-IgG for 24 h
and 48 h and the total NR1, NR2A and NR2B protein levels were measured by Western blot. Control protein levels
of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the average ±
SEM of 4-6 independent experiments, performed in independent preparations. Statistical analysis was performed
by One Way ANOVA, followed by the Dunnett’s test. 
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proteins, under control conditions and after 
treatment with 100 ng/ml BDNF. Surface 
proteins were then collected with 
streptavidin-coupled beads, and subjected to 
Western blotting (Fig. 8). BDNF treatment 
during 30 min markedly increased NR1 and 
NR2B proteins associated with the plasma 
membrane, whereas longer incubations with 
the neurotrophin (24 h) were required to 
significantly increase surface NR2A. These 
data suggest that BDNF differentially 
regulates the translocation of the NMDA 
receptors with different subunit compositions 
to the plasma membrane in cultured 
hippocampal neurons. 
 
Effect of BDNF on the NMDA-induced [Ca2+]i 
changes- NMDA receptors are cation 
channels, permeable to Na+ and Ca2+, and 
activation of these receptors increases the 
intracellular free calcium concentration 
([Ca2+]i) [e.g. (Duarte et al., 1996)]. The 
effect of BDNF on the activity of NMDA 
receptors was investigated in single cultured 
hippocampal neurons, by Fura-2 imaging. 
Stimulation of cultured hippocampal neurons 
with NMDA, in a Mg2+-free medium, 
increased the Fura-2 fluorescence ratio 
(F340/F380) (Fig. 9). When the cells were 
pre-incubated with BDNF for 40 min there 
was an increase in the NMDA-induced 
[Ca2+]i rise. The [Ca2+]i response to activation 
of NMDA receptors is due to Ca2+ entry 
through the receptor channels and to Ca2+ 
influx through voltage-gated Ca2+ channels 
(Duarte et al., 1996). To determine whether 
the effect of BDNF on the responses to 
NMDA is due to an increase in the activity of 
voltage-gated Ca2+ channels, rather than to a 
direct change in the activity of the receptors, 
we studied the effect of the neurotrophin on 
the initial [Ca2+]i changes caused by KCl 
depolarization. Perfusion of the cells with a 
solution where NaCl was isoosmotically 
replaced by 30 mM KCl rapidly increased the 
[Ca2+]i, but the magnitude of the response 
was not affected by pre-incubation of the 
cells with BDNF. Taken together, these 
results strongly suggest that the BDNF-
induced increase in the [Ca2+]i responses to 
NMDA are due, at least in part, to an 
upregulation of the plasma membrane- 
associated receptors. 
Figure 4- Incubation of hippocampal neurons with NT3 increased the protein levels of NR2A and NR2B, but was
without effect on NR1 protein levels. Seven DIV neurons were incubated with or without 100 ng/ml NT3 for 2 h and 6 
h and total NR1, NR2A and NR2B protein levels were measured by Western blot. Control (unstimulated) protein
levels of NMDA receptor subunits were set to 100%. β-tubulin was used as loading control. The results are the 
average ± SEM of 5-8 independent experiments, performed in independent preparations. Statistical analysis was
performed by One Way ANOVA, followed by the Dunnett’s test. *P<0.05, **P<0.01. 
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Figure 5- Translation inhibitors impair the BDNF-induced upregulation of NR1, NR2A and NR2B protein levels.
Seven DIV hippocampal neurons were incubated with or without 100 ng/ml BDNF for 3 h, in the presence or in the
absence of emetine (2.0 µM) or anisomycin (2.0 µM). When the inhibitors were used the cells were pre-incubated
with the compounds for 30 min before stimulation with BDNF. Total NR1, NR2A and NR2B protein levels were
measured by Western blot. Control protein levels of NMDA receptor subunits were set to 100%. β-tubulin was
used as loading control. The results are the average ± SEM of 6-12 independent experiments, performed in
independent preparations. Statistical analysis was performed by One Way ANOVA, followed by the Dunnett’s test.
*P<0.05, **P<0.001. 
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Figure 6- Transcription inhibitors prevent the BDNF-induced upregulation of the NR1, NR2A and NR2B protein
levels. Seven DIV cultured hippocampal neurons were incubated with or without 100 ng/ml BDNF for 3 h, in the
presence or in the absence of α-amanitine (1.5 µM) or actinomycin D (1.5 µM). When the inhibitors were used the
cells were pre-incubated with the compounds for 30 min before stimulation with BDNF. Total NR1, NR2A and
NR2B protein levels were measured by Western blot. Control protein levels of NMDA receptor subunits were set
to 100%. β-tubulin was used as loading control. The results are the average ± SEM of 5-10 independent
experiments, performed in independent preparations. Statistical analysis was performed by One Way ANOVA,
followed by the Dunnett’s test. *P<0.05. 
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DISCUSSION 
 
BDNF has been shown to play 
important roles in the regulation of the 
glutamatergic synaptic transmission and in 
the early- and late-phases of LTP [reviewed 
in (Bramham and Messaoudi, 2005)], but the 
underlying mechanisms are still not fully 
understood. The rapid effects of BDNF on 
the post-synaptic responses to glutamate 
have been largely attributed to the 
phosphorylation of NMDA receptor subunits, 
which increases receptor activity (Levine et 
al., 1998; Levine and Kolb, 2000). In the 
present study, we showed that BDNF also 
induces a rapid delivery of NR2B-containing 
NMDA receptors to the plasma membrane, 
which correlated with an increased [Ca2+]i 
response to the activation of the receptors. 
Furthermore, we showed that BDNF 
differentially upregulates the NR1, NR2A and 
NR2B NMDA receptor subunits in cultured 
hippocampal neurons through an increase in 
transcription activity. The NT3, which binds 
to a different Trk receptor (TrkC), increased 
the protein levels of NR2A and NR2B 
subunits, but was without effect on NR1. The 
results showing the BDNF-induced rapid 
delivery of NR1 and NR2 subunits to the 
plasma membrane contribute to the growing 
evidence that the surface expression of 
NMDA receptors is dynamic and regulated 
(Lan et al., 2001; Roche et al., 2001), as 
previously documented for AMPA receptors 
(Gomes et al., 2003). If BDNF has a similar 
effect on the delivery of NMDA receptors to 
the synapse, this may account, at least in 
part, for the role of the neurotrophin in 
synaptic plasticity. The delivery of NMDA 
receptors to the synapse plays an important 
role in long-term potentiation, although the 
NR2 subunit involved may depend on the 
development stage (Barria and Malinow, 
2005; Kim et al., 2005). 
Stimulation of hippocampal neurons 
with BDNF induced a rapid delivery of NR1- 
and NR2B-containing NMDA receptors to the 
plasma membrane, but no increase in NR2A 
was observed for short incubations with the 
neurotrophin (Fig. 8). This upregulation in 
plasma membrane-associated NMDA 
receptor subunits correlated with an increase 
in the [Ca2+]i responses mediated by the 
receptor (Fig. 7). The simultaneous effect on 
the delivery of NR1 and NR2 subunits was 
as expected, since both subunits are 
required to form a functional NMDA receptor 
(Meguro et al., 1992; Monyer et al., 1994; 
Dingledine et al., 1999), and occurred at a 
time point when the amount of NR2B was 
still not significantly changed. The rapid 
effect of BDNF on the traffic of NR1/NR2B 
subunits changes the ratio of NR2A- and 
NR2B-containing NMDA receptors 
associated with the membrane, and is likely 
Figure 7- BDNF increases the mRNA levels of the NR1,
NR2A and NR2B NMDA receptor subunits. The
variation of NR1, NR2A and NR2B mRNA levels was
assayed by SYBR Green Real-Time PCR of total RNA
samples, converted to cDNA in reactions normalized to
contain equal amounts of mRNA. The cells were
incubated in the presence or in the absence of 100
ng/ml BDNF, during 30 min (gray columns) or 3 h (black
columns). The results are presented as mean
percentage ± SEM compared to the control
(unstimulated), and normalized to the reference gene
18S, and are the average ± SEM of 3-7 independent
experiments, performed in independent preparations.
Statistical analysis was performed by One Way
ANOVA, followed by the Dunnett’s test. **P<0.01,
***P<0.001. 
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to result in slower excitatory postsynaptic 
currents (EPSCs) (Monyer et al., 1994). 
BDNF was previously shown to acutely 
increase tyrosine phosphorylation of NR2B 
(but not NR2A) subunits in cortical and 
hippocampal postsynaptic densities (Lin et 
al., 1998) and in cultured hippocampal 
neurons (Alder et al., 2005), and the effect of 
the neurotrophin on the activity of NMDA 
receptors in cultured hippocampal neurons is 
sensitive to inhibitors of NR2B (Crozier et al., 
1999; Levine and Kolb, 2000). Our findings 
indicate that the upregulation of NR2B-
containing receptors associated with the 
membrane accounts, at least in part, for the 
effect of the neurotrophin on the receptor 
activity, but the molecular mechanisms 
involved remain to be determined. The 
mechanisms mediating the effect of 
neurotrophins may be similar to those 
involved in insulin-induced rapid delivery of 
NMDA receptors to the cell surface, since 
both receptors have tyrosine kinase activity. 
The effect of insulin occurs via a SNAP-25 
mediated form of SNARE-dependent 
exocytosis, and does not require direct 
phosphorylation of the C-terminal tails of the 
receptor protein, but rather of associated 
targeting, anchoring, or signalling protein(s) 
(Skeberdis et al., 2001). 
In addition to the effect resulting 
from the upregulation of plasma membrane-
associated receptors, phosphorylation of 
NMDA receptors may also change their 
electrophysiological properties, and therefore 
may contribute to the change in activity 
induced by BDNF (Fig. 9). BDNF acutely 
induces phosphorylation of NR1 and NR2B 
subunits in rat hippocampal postsynaptic 
densities (Suen et al., 1997; Lin et al., 1998; 
Alder et al., 2005), and increases NMDA 
single channel open probability in cultured 
hippocampal neurons (Levine et al., 1998; 
Levine and Kolb, 2000). Phosphorylation of 
NR2B may be mediated by Fyn, a member 
of the Src family, since this kinase is 
activated by TrkB receptors (Narisawa-Saito 
et al., 1999b), and increases currents 
mediated by recombinant NMDA receptor 
(Kohr and Seeburg, 1996). The activity of 
NMDA receptors in CNS neurons was also 
shown to increase following intracellular 
Figure 8- BDNF increases the NR1, NR2A and NR2B subunits in the plasma membrane. Neurons were treated with
or without 100 ng/ml BDNF (30 min, 3 h and 24 h). Following treatment, cell surface proteins were labelled by
biotinylation, followed by precipitation with streptavidin beads. The abundance of each subunit in the plasma
membrane was then determined by Western blot. Control (0 h) expression of NMDA subunits protein was set to
100%. The transferrin receptor was used as loading control. The results are the average ± SEM of 3-8 independent
experiments, performed in independent preparations. Statistical analysis was performed by One Way ANOVA,
followed by the Dunnett’s test. *P<0.05, **P<0.01. 
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application of recombinant Src (Wang and 
Salter, 1994; Kalia et al., 2004; Salter and 
Kalia, 2004), and Fyn-mediated interaction 
between BDNF signalling and NMDA 
receptors may play an important role in 
spatial learning and memory (Mizuno et al., 
2003). The signalling activity induced by 
BDNF may also affect NMDA receptors 
through protein kinase C, which modulates 
NMDA receptor trafficking and gating in 
cultured hippocampal neurons (Lan et al., 
2001). In fact, activation of Trk receptors 
promotes PLCγ activity (Chao, 2003), giving 
rise to diacylglicerol which activates PKC. 
In contrast with the short-term 
effects of BDNF on the surface expression of 
NR1 and NR2B subunits, longer incubations 
with BDNF (24 h) increased the amount of 
NR2A subunits associated with the plasma 
membrane, but not of NR2B, further 
indicating that the traffic of the two subunits 
to the membrane is differentially affected by 
the neurotrophin. The delayed increase in 
NR2A in the membrane induced by BDNF 
may be secondary to the upregulation of the 
subunit induced by BDNF (Fig. 1) and/or due 
to changes in abundance of regulatory, 
motor or anchoring proteins that regulate 
traffic of the receptor, since after 24 h of 
stimulation of the Trk receptors with the 
neurotrophin the receptors are no longer 
active (Almeida et al., 2005). However, it 
was surprising not to observe an increase of 
NR1 subunit associated with the membrane, 
together with NR2A, after long incubations 
with BDNF. Although this may suggest that 
the delivered receptors contain more NR2A 
than NR1 subunits, this hypothesis is against 
evidences suggesting that the NMDA 
receptor channels are formed as dimers of 
dimers (an NR1 dimmer and a NR2 dimmer) 
(Schorge and Colquhoun, 2003). This 
BDNF-induced upregulation of NR2A 
associated with the plasma membrane after 
long incubation periods with the neurotrophin 
resembles the shift from NR2B to NR2A 
observed in developing neurons (Watanabe 
et al., 1992; Sheng et al., 1994; Barria and 
Malinow, 2002; Erisir and Harris, 2003; 
Kobayashi et al., 2006), resulting in faster 
excitatory postsynaptic currents (EPSCs) 
and lower sensitivity to NR2B-selective 
Figure 9- BDNF increases in the [Ca2+]i responses to NMDA. Cultured hippocampal neurons were loaded with
Fura-2/AM fluorescence probe in the presence or in the absence of 100 ng/ml BDNF for 40 min. Following
incubation, cells were perfused with Mg2+-free Na+-salt solution for 5 min and were stimulated with 100 µM NMDA 
and 10 µM glycine or 30 mM KCl for 30 sec. After stimulation neurons were perfused with Mg2+-free Na+-salt 
solution for 10 min. The [Ca2+]i response to K+ depolarization or to NMDA-receptor stimulation was monitored in 
single cells as the ratio between the fluorescence at 340 nm and 380 nm. For each experimental condition, the 
control [Ca2+]i responses were set to 100%. The results are the average ± SEM of 3-4 independent experiments, 
performed in independent preparations. Statistical analysis was performed using Student t test. **P<0.01. 
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antagonists (Carmignoto and Vicini, 1992; 
Flint et al., 1997). This change is also 
thought to contribute to the developmental 
changes in NMDA-receptor mediated 
plasticity at glutamatergic synapses (Philpot 
et al., 2001).  
In addition to the translocation of 
NMDA receptor subunits to the plasma 
membrane, we also found that BDNF 
upregulated NR1, NR2A and NR2B subunits, 
by a mechanism involving transcription 
activation. This is supported by the results 
showing an increase in the mRNA levels for 
the three subunits in hippocampal neurons 
stimulated with BDNF (Fig. 7) and the 
inhibition of neurotrophin-induced 
upregulation of NR1, NR2A and NR2B in the 
presence of transcription inhibitors (Fig. 6). 
Therefore, although Trk receptor activation 
by neurotrophins may stimulate protein 
synthesis directly (Takei et al., 2004), without 
transcription induction, this mechanism is not 
involved in the upregulation of NMDA 
receptor subunits by BDNF in hippocampal 
neurons. The effects of BDNF on NMDA 
receptor subunits were transient in 7 DIV 
cultures, most likely due to the 
desensitization of the Trk receptors, followed 
by a decrease in the intracellular signalling 
activity (Sommerfeld et al., 2000; Almeida et 
al., 2005). However, in 14 DIV cultures 
BDNF induced a sustained increase in the 
NR1 and NR2A protein levels, but not of 
NR2B (Fig. 1), which may be due to a 
change in the turn-over rate of the subunits 
in the more mature cultures. Interestingly, 
the expression of NR2A but not NR2B 
subunit is markedly reduced in the 
developing cortex of BDNF knockout mice 
(Margottil and Domenici, 2003). NR1 
expression is regulated by different 
transcription factors, including the NF-
kappaB (Liu et al., 2004) or CREB (Lau et 
al., 2004), and the latter is a major mediator 
of neuronal neurotrophin responses 
(Finkbeiner et al., 1997). NR2B expression is 
also regulated by CREB (Rani et al., 2005), 
in addition to AP-1 (Qiang and Ticku, 2005), 
which may also be activated by BDNF-
induced signalling (Li et al., 2004). 
Neurotrophin-4/5 was shown to upregulate 
NR2A through the immediate early 
transcription factor Egr-1 in cultured 
cerebrocortical neurons (Choi et al., 2004). 
Stimulation of hippocampal neurons 
with NT3 also upregulated NR2A and NR2B 
protein levels, but was without effect on 
NR1. In contrast with the effect of BDNF, 
NT3 did not change the NMDA receptor 
subunit protein levels when 2 h of incubation 
with the neurotrophin was used. Although 
the effects of both neurotrophins are likely 
mediated by Trk receptors (TrkB and TrkC, 
respectively), the differential responses may 
be due to a distinct cellular localization of the 
receptors and/or to differences in the 
magnitude of the signalling responses 
induced.  
The BDNF-induced upregulation of 
NMDA receptor subunits and activity that we 
observed in cultured hippocampal neurons 
contrast with the lack of effect of BDNF in 
cerebellar granule neurons incubated with 
the neurotrophin for 2 h or 6 h (Fig. 2D, E 
and F), indicating that BDNF has a specific 
effect on hippocampal neurons. These 
results contrast with the previously reported 
downregulation of the NR2A receptor 
subunits evoked by BDNF in cerebellar 
granule neurons (Brandoli et al., 1998). This 
discrepancy may be due to differences in the 
composition of the culture medium, as well 
as the use of a distinct concentration of 
BDNF. 
In conclusion, our work shows that 
BDNF differentially upregulates the plasma 
membrane associated NMDA receptors, and 
the protein levels of the receptor subunits in 
cultured hippocampal neurons. NMDA 
receptors play an important role in synaptic 
plasticity, and there is a selective activation 
of NMDA receptors in specific circuits during 
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memory formation (Tang et al., 1999; Lynch, 
2004). The activation of NMDA receptors, 
together with non-NMDA receptors, induces 
the synthesis and release of BDNF (Zafra et 
al., 1990; Hughes et al., 1993) which may 
further promote NMDA receptor activity by 
increasing the number of receptors 
associated with the membrane. The resulting 
increase in calcium entry through the NMDA 
receptors will also regulate numerous other 
downstream signalling pathways, leading to 
both short-term and long-term neuronal 
changes (Hardingham and Bading, 2003). If 
BDNF induces a rapid synaptic delivery of 
NR2B-containing receptors to the synapse, 
similarly to the effect observed on the overall 
surface expression of NMDA receptor 
subunits, this may be important to allow 
binding of active CaMKII to synaptic NMDA 
receptors, thereby contributing to synaptic 
potentiation (Barria and Malinow, 2005). This 
model, proposed for developing synapses, 
contrasts with the role played by NR2A-
NMDA receptors in promoting surface 
expression of GluR1-containing AMPA 
receptors, a key event in LTP in more 
mature synapses (Malinow and Malenka, 
2002). Interestingly, BDNF also caused a 
delayed increase in NR2A associated with 
the plasma membrane. 
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General conclusions 
 
BDNF plays important roles in the regulation of the glutamatergic synaptic 
transmission, particularly in synaptic plasticity (Lu, 2003; Alder et al., 2005). However, the 
underlying mechanisms are not fully understood. In the present work, we studied the effect 
of BDNF on AMPA and NMDA receptors in cultured hippocampal neurons, which may 
contribute, at least in part, to synaptic plasticity. 
In this study, we show that BDNF differentially increases the total amount of GluR1, 
GluR2 and GluR3 subunits of AMPA receptors, and NR1, NR2A and NR2B subunits of 
NMDA receptors. In 14 DIV cultures of hippocampal neurons, the endogenous extracellular 
BDNF was also shown to be important in the upregulation of the GluR1 protein levels. 
Incubation of 7 DIV hippocampal neurons with BDNF also upregulated the mRNA levels of 
GluR1, GluR2, NR1, NR2A and NR2B, and pre-incubation of neurons with two different 
transcription inhibitors (α-amanitine and actinomycin D) or two translation inhibitors (emetine 
and anisomycin) abolished the upregulation of the protein levels of AMPA receptor and 
NMDA receptor subunits. Thus, we conclude that BDNF increases the abundance of AMPA 
and NMDA receptor subunits through a mechanism dependent on the activation of 
transcription. The effect of BDNF on GluR1 and GluR2 protein levels may be mediated by 
CREB, a transcription factor activated by TrkB (Finkbeiner et al., 1997), since GluR1 and 
GluR2 gene promoters possess a CREB binding site (Borges and Dingledine, 2001). 
However, the role of CREB in the regulation of the genes encoding for these subunits 
remains to be investigated. In contrast, CREB was shown to regulate the expression of NR1 
and NR2B (Lau et al., 2004; Rani et al., 2005). The transcription factors NF-κB and AP1, 
which are known to be activated by BDNF signalling (Liu et al., 2004; Qiang and Ticku, 
2005), are also involved in the expression of these subunits (Liu et al., 2004; Qiang and 
Ticku, 2005). Therefore, BDNF acting through TrkB receptors may induce the activation of 
several transcription factors, regulating the expression of AMPA and NMDA receptors. It 
remains to be determined the signalling pathways used by BDNF to regulate the expression 
of AMPA and NMDA receptor subunits, and which specific transcription factors are activated 
by BDNF in the modulation of AMPA and NMDA receptor subunits expression.  
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We also showed that BDNF increases the abundance of GluR1, NR1, NR2A and 
NR2B in the plasma membrane of cultured hippocampal neurons. Since the observed effects 
were quite fast (within 30 min of BDNF incubation for GluR1 subunit) and translation 
dependent (for GluR1 and GluR2 subunits), it will be of interest to distinguish between the 
contribution of local dendritic synthesis and soma mRNA translation to the observed 
upregulation of AMPA and NMDA receptor subunits. The surface increase in the GluR1 
protein levels was further supported by the electrophysiology studies in hippocampal slices 
that showed synaptic delivery of GluR1-GFP homomeric receptors by BDNF stimulation. The 
plasma membrane enrichment in NMDA receptor subunits upon BDNF stimulation was also 
correlated with the increases in NMDA-induced changes in [Ca2+]i. Besides supporting the 
idea that BDNF induces the delivery of NMDA receptor subunits to the plasma membrane, 
the increased [Ca2+]i response to NMDA stimulation in the presence of BDNF may also be 
due to an effect of BDNF on the activity of NMDA receptors by phosphorylation of the 
receptor subunits. Therefore, it will be of interest to determine weather the effects of BDNF 
are mediated by delivery of receptors to the plasma membrane, presumably by enhancing 
the exocytosis of NMDA-containing vesicles, and/or to phosphorylation of the receptor 
subunits. For this purpose, the NMDA-induced [Ca2+]i responses should be studied in the 
presence of exocytosis inhibitors, such as botulinum toxin or N-ethylmaleimide. These 
studies would further clarify the mechanism by which BDNF modulates synaptic plasticity. In 
fact, the BDNF-induced increase in the plasma membrane associated-NMDA receptors and 
the concomitant increase in the [Ca2+]i responses to receptor stimulation may activate 
CaMKII, which phosphorylates the GluR1 subunit of AMPA receptors on Ser 831 (Mammen 
et al., 1997), and constitutes a signal for synaptic delivery of AMPA receptors (Shi et al., 
1999). Accordingly, BDNF was shown to induce synaptic delivery of AMPA receptors in 
GluR1-GFP infected hippocampal slices. However, this AMPA receptor delivery to the 
synapse was shown to be independent on the NMDA receptor activity, suggesting that 
BDNF itself, through binding to its receptor, induces the delivery of AMPA receptors through 
activation of CaMKII and/or other protein kinases. In fact, in this study we observed an 
increase in the phosphorylation levels of GluR1 on Ser 831 in both cultured hippocampal 
neurons and slices. This residue is also known to be phosphorylated by PKC (Roche et al., 
1996). The activation of this kinase by TrkB receptors may also contribute to the synaptic 
delivery of GluR1-containing AMPA receptors. Similarly to the effects observed in 
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hippocampal slices, BDNF also induced phosphorylation of GluR1 on Ser 831 in cultured 
hippocampal neurons, and this phosphorylation was shown to be mediated by PKC or 
CaMKII. Interestingly, exposure of hippocampal slices to BDNF did not induce 
phosphorylation of GluR1 on Ser 845. Since phosphorylation of Ser 831 is known to be 
necessary, but not sufficient to induce synaptic delivery (Hayashi et al., 2000), the 
identification of new GluR1 phosphorylation sites should be helpful to understand BDNF-
induced synaptic delivery of AMPA receptors. Recently, GluR1 Ser 818 phosphorylation by 
PKC was shown to be increased during LTP (Boehm et al., 2006), but it remains to be 
determined whether phosphorylation of this residue plays a role in BDNF-induced synaptic 
delivery of GluR1-containing AMPA receptors. 
Not only subunit phosphorylation accounts for changes in the activity and synaptic 
distribution of AMPA and NMDA receptors. Changes in the abundance of AMPA and NMDA 
receptor-binding proteins may also affect their cellular distribution. Therefore, it will be of 
interest to determine whether BDNF also affects synthesis or induces postranslational 
modifications of AMPA and NMDA receptor-interacting proteins, thereby promoting the 
insertion of receptors at the synapse or preventing receptor endocytosis. 
The BDNF induced increase in the transcription activity and in the AMPA and NMDA 
receptor protein levels, together with the delivery of AMPA receptors to the synapse and the 
increase in the [Ca2+]i responses to NMDA stimulation provide a strong evidence for the 
importance of BDNF on the modulation of synaptic activity. In fact, these alterations may, at 
least partially, account for the short- or long-term effects of BDNF on synaptic transmission 
important for LTP. 
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